drug1	drug2	strength	RR	severity	patients.fem.mal	description	color	onethousand	fdr
Amiodarone	Acenocoumarol	0.331	-1.662	None	4372 (1794/2578)	The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Amiodarone.	#B1CFE5	599.063312715982	0
Omeprazole	Alprazolam	0.292	2.24	Moderate	23505 (16959/6546)	The metabolism of Alprazolam can be decreased when combined with Omeprazole.	#F7B7B7	3220.71893078435	1
Omeprazole	Diazepam	0.234	1.797	Moderate	26342 (17784/8558)	The metabolism of Diazepam can be decreased when combined with Omeprazole.	#F7B9B9	3609.45237501473	1
Digoxin	Furosemide	0.339	-1.084	Moderate	4283 (2211/2072)	The risk or severity of adverse effects can be increased when Furosemide is combined with Digoxin.	#B4D1E6	586.868291025286	0
Digoxin	Spironolactone	0.365	-1.023	Minor	1468 (779/689)	The serum concentration of Digoxin can be increased when it is combined with Spironolactone.	#B4D1E6	201.149346538669	0
Acetaminophen	Acenocoumarol	0.226	-1.237	None	16868 (8151/8717)	Acetaminophen may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	2311.29916717593	1
Alendronic acid	Ibuprofen	0.163	11.306	Moderate	8459 (7858/601)	The risk or severity of adverse effects can be increased when Ibuprofen is combined with Alendronic acid.	#E38B8B	1159.07515147861	1
Acetylsalicylic acid	Ibuprofen	0.127	-1.393	Major	22862 (10371/12491)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ibuprofen.	#B2D0E5	3132.61332463696	1
Rivastigmine	Quetiapine	0.312	-1.133	Moderate	677 (342/335)		#B4D1E6	92.7643784786642	0
Haloperidol	Biperiden	0.467	-1.148	Moderate	279 (140/139)		#B4D1E6	38.2293376595972	3.57118396893126e-309
Acetylsalicylic acid	Gliclazide	0.371	-2.179	None	8772 (3041/5731)	Acetylsalicylic acid may increase the hypoglycemic activities of Gliclazide.	#AFCEE4	1201.96326146949	3.23620492918104e-39
Omeprazole	Clonazepam	0.244	1.55	Moderate	6187 (3971/2216)		#F8BABA	847.759541576803	1
Donepezil	Quetiapine	0.343	1.088	Moderate	560 (312/248)		#F9BCBC	76.732720750446	0
Risperidone	Donepezil	0.298	1.275	Moderate	428 (255/173)		#F9BCBC	58.6457222878409	3.9896463882946e-310
Acetylsalicylic acid	Insulin aspart	0.314	-1.54	Moderate	3868 (1659/2209)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Aspart.	#B2D0E5	530.003864040581	5.69614721290844e-160
Acetylsalicylic acid	Glyburide	0.34	-2.095	Moderate	5238 (1863/3375)	Acetylsalicylic acid may increase the hypoglycemic activities of Glyburide.	#AFCEE4	717.724984447922	2.73555885884148e-80
Indomethacin	Methotrexate	0.29	1.394	Major	491 (303/188)	The serum concentration of Methotrexate can be increased when it is combined with Indomethacin.	#F8BABA	67.2781533722661	1.29669966135909e-234
Omeprazole	Methotrexate	0.304	1.394	Major	3276 (2022/1254)	The serum concentration of Methotrexate can be increased when it is combined with Omeprazole.	#F8BABA	448.886416390109	5.98258004626052e-12
Trimethoprim	Leucovorin	0.564	-2.107	Major	364 (129/235)		#AFCEE4	49.8762684877899	0
Digoxin	Carvedilol	0.322	-1.99	Moderate	1110 (408/702)	Digoxin may increase the bradycardic activities of Carvedilol.	#B1CFE5	152.095214344634	0
Entacapone	Apomorphine	0.151	-1.156	Moderate	10 (5/5)		#B4D1E6	1.37022715625796	9.00747644712814e-18
Diclofenac	Alendronic acid	0.149	9.326	Moderate	3076 (2815/261)	The risk or severity of adverse effects can be increased when Diclofenac is combined with Alendronic acid.	#E79494	421.48187326495	1
Warfarin	Amiodarone	0.323	-1.778	Major	477 (188/289)	The therapeutic efficacy of Warfarin can be increased when used in combination with Amiodarone.	#B1CFE5	65.3598353535049	4.74972073271625e-219
Acetylsalicylic acid	Insulin detemir	0.323	-1.463	Moderate	2016 (890/1126)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Detemir.	#B2D0E5	276.237794701606	2.73005951755987e-65
Galantamine	Risperidone	0.283	-1.053	Moderate	193 (101/92)		#B4D1E6	26.4453841157787	1.02863586397761e-146
Bisoprolol	Ibuprofen	0.128	-1.052	Moderate	7189 (3765/3424)	Ibuprofen may decrease the antihypertensive activities of Bisoprolol.	#B4D1E6	985.056302633851	1
Mesalazine	Azathioprine	0.353	-2.176	Moderate	170 (59/111)	The metabolism of Azathioprine can be decreased when combined with Mesalazine.	#AFCEE4	23.2938616563854	3.82522239880131e-181
Trazodone	Rivastigmine	0.281	1.051	Moderate	390 (214/176)		#F9BCBC	53.4388590940606	2.91038490018885e-195
Allopurinol	Acenocoumarol	0.319	-4.958	None	3897 (737/3160)	Allopurinol may increase the anticoagulant activities of Acenocoumarol.	#A3C5DF	533.977522793729	2.32590112421452e-98
Levothyroxine	Acenocoumarol	0.287	2.085	None	2282 (1613/669)	Levothyroxine may increase the anticoagulant activities of Acenocoumarol.	#F7B7B7	312.685837058067	1
Atenolol	Ibuprofen	0.149	1.319	Moderate	4598 (2777/1821)	Ibuprofen may decrease the antihypertensive activities of Atenolol.	#F9BCBC	630.030446447412	1
Prednisone	Acetylsalicylic acid	0.152	-2.104	Moderate	7024 (2491/4533)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisone.	#AFCEE4	962.447554555594	1
Propafenone	Acenocoumarol	0.343	1.392	None	428 (264/164)	The serum concentration of Acenocoumarol can be increased when it is combined with Propafenone.	#F8BABA	58.6457222878409	3.31215662524585e-104
Galantamine	Quetiapine	0.314	-1.257	Moderate	217 (104/113)	Galantamine may increase the QTc-prolonging activities of Quetiapine.	#B4D1E6	29.7339292907978	5.14946755588321e-147
Methotrexate	Hydroxychloroquine	0.287	2.1	Minor	144 (102/42)		#F7B7B7	19.7312710501147	2.47642316186611e-103
Digoxin	Amiodarone	0.333	-1.636	Major	652 (270/382)	The serum concentration of Digoxin can be increased when it is combined with Amiodarone.	#B2D0E5	89.3388105880193	4.92374394843394e-142
Alendronic acid	Naproxen	0.135	12.208	Moderate	2298 (2146/152)	The risk or severity of adverse effects can be increased when Naproxen is combined with Alendronic acid.	#E18888	314.87820050808	1
Tramadol	Citalopram	0.214	4.042	Major	2525 (2080/445)	Citalopram may increase the neuroexcitatory activities of Tramadol.	#F2AEAE	345.982356955136	1
Trazodone	Donepezil	0.309	1.059	Moderate	367 (202/165)		#F9BCBC	50.2873366346673	6.11837947522992e-168
Bisoprolol	Gliclazide	0.34	-1.886	None	2802 (1065/1737)	Bisoprolol may increase the hypoglycemic activities of Gliclazide.	#B1CFE5	383.937649183482	1
Simvastatin	Clarithromycin	0.062	1.193	Major	3237 (1877/1360)	The serum concentration of Simvastatin can be increased when it is combined with Clarithromycin.	#F9BCBC	443.542530480703	1
Omeprazole	Ketazolam	0.281	2.412	None	1459 (1074/385)		#F6B6B6	199.916142098037	1
Furosemide	Ibuprofen	0.196	1.098	Moderate	5118 (2863/2255)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Ibuprofen.	#F9BCBC	701.282258572826	1
Torasemide	Ibuprofen	0.166	1.499	Moderate	3283 (2082/1201)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Ibuprofen.	#F8BABA	449.84557539949	1
Diltiazem	Atorvastatin	0.468	-2.089	Moderate	2099 (748/1351)	The serum concentration of Diltiazem can be increased when it is combined with Atorvastatin.	#AFCEE4	287.610680098547	2.47936152671598e-09
Tramadol	Paroxetine	0.2	5.603	Major	2012 (1743/269)	Paroxetine may increase the neuroexcitatory activities of Tramadol.	#F0A7A7	275.689703839102	1
Ceftazidime	Tobramycin	1	Inf	Moderate	1 (1/0)		#B32020	0.137022715625796	1
Warfarin	Propafenone	0.28	1.455	Moderate	110 (69/41)	The serum concentration of Warfarin can be increased when it is combined with Propafenone.	#F8BABA	15.0724987188376	7.3307677313653e-58
Digoxin	Verapamil	0.398	-1.144	Moderate	364 (183/181)	The metabolism of Digoxin can be decreased when combined with Verapamil.	#B4D1E6	49.8762684877899	1.00452501940818e-99
Diltiazem	Simvastatin	0.442	-1.637	Major	2845 (1178/1667)	The serum concentration of Simvastatin can be increased when it is combined with Diltiazem.	#B2D0E5	389.829625955391	1
Pravastatin	Fenofibrate	0.752	-1.789	Major	866 (340/526)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Pravastatin.	#B1CFE5	118.66167173194	3.78760950418577e-88
Bisoprolol	Salbutamol	0.165	-1.621	Moderate	3057 (1273/1784)	Bisoprolol may decrease the bronchodilatory activities of Salbutamol.	#B2D0E5	418.87844166806	1
Acetaminophen	Warfarin	0.225	-1.325	Minor	1807 (842/965)	Acetaminophen may increase the anticoagulant activities of Warfarin.	#B4D1E6	247.600047135814	1
Spironolactone	Enalapril	0.341	-1.822	Major	2382 (925/1457)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Enalapril.	#B1CFE5	326.388108620647	1
Propranolol	Primidone	0.232	-1.569	Moderate	132 (56/76)	The metabolism of Propranolol can be increased when combined with Primidone.	#B2D0E5	18.0869984626051	6.67792351866383e-89
Citalopram	Acenocoumarol	0.308	1.339	None	1328 (807/521)	The metabolism of Acenocoumarol can be decreased when combined with Citalopram.	#F8BABA	181.966166351058	1
Prednisone	Acenocoumarol	0.158	-1.62	None	2170 (904/1266)		#B2D0E5	297.339292907978	1
Omeprazole	Itraconazole	0.106	1.396	Moderate	1587 (980/607)	The serum concentration of Itraconazole can be decreased when it is combined with Omeprazole.	#F8BABA	217.455049698139	1
Bisoprolol	Formoterol	0.218	-1.834	Moderate	2206 (853/1353)	Bisoprolol may decrease the bronchodilatory activities of Formoterol.	#B1CFE5	302.272110670507	1
Tramadol	Fluoxetine	0.224	5.653	Major	1191 (1033/158)	Fluoxetine may increase the neuroexcitatory activities of Tramadol.	#EFA6A6	163.194054310324	1
Bisoprolol	Insulin aspart	0.298	-1.586	Moderate	1105 (466/639)		#B2D0E5	151.410100766505	1
Atenolol	Gliclazide	0.332	-1.388	None	1254 (570/684)	Atenolol may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	171.826485394749	1
Trimethoprim	Rifampicin	0.623	-1.13	Moderate	85 (43/42)	The metabolism of Trimethoprim can be increased when combined with Rifampicin.	#B4D1E6	11.6469308281927	1.83075894772004e-46
Propranolol	Ibuprofen	0.152	1.499	Moderate	1583 (1004/579)	Ibuprofen may decrease the antihypertensive activities of Propranolol.	#F8BABA	216.906958835636	1
Trazodone	Galantamine	0.299	-1.069	Moderate	152 (79/73)		#B4D1E6	20.8274527751211	1.31827826512614e-69
Bisoprolol	Repaglinide	0.335	-1.935	Moderate	1227 (459/768)		#B1CFE5	168.126872072852	1
Repaglinide	Gliclazide	0.233	-1.259	None	637 (305/332)	Repaglinide may increase the hypoglycemic activities of Gliclazide.	#B4D1E6	87.2834698536323	1
Phenytoin	Lamotrigine	0.468	1.003	Moderate	54 (29/25)	The serum concentration of Lamotrigine can be decreased when it is combined with Phenytoin.	#F9BCBC	7.39922664379301	5.30990778847398e-37
Donepezil	Sertraline	0.403	1.839	Minor	297 (202/95)	The metabolism of Donepezil can be decreased when combined with Sertraline.	#F7B9B9	40.6957465408615	1.39261127067441e-39
Paroxetine	Acenocoumarol	0.307	1.628	None	1003 (655/348)	Paroxetine may increase the anticoagulant activities of Acenocoumarol.	#F8BABA	137.433783772674	1
Ibuprofen	Acenocoumarol	0.124	-1.43	None	3511 (1570/1941)	Ibuprofen may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	481.086754562171	1
Levofloxacin	Acenocoumarol	0.097	-2.124	None	1722 (607/1115)	Levofloxacin may increase the anticoagulant activities of Acenocoumarol.	#AFCEE4	235.953116307621	1
Fenofibrate	Atorvastatin	0.431	-2.463	Major	1371 (438/933)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Atorvastatin.	#AECDE3	187.858143122967	1
Propranolol	Paroxetine	0.356	2.999	Moderate	487 (378/109)	The metabolism of Propranolol can be decreased when combined with Paroxetine.	#F5B2B2	66.7300625097629	1
Carbamazepine	Levetiracetam	0.468	-1.198	Moderate	114 (56/58)	The risk or severity of adverse effects can be increased when Carbamazepine is combined with Levetiracetam.	#B4D1E6	15.6205895813408	1.26741325977607e-49
Carvedilol	Insulin aspart	0.276	-2.113	Moderate	506 (179/327)		#AFCEE4	69.333494106653	7.71778199878065e-51
Acetylsalicylic acid	Acenocoumarol	0.229	-2.677	None	3746 (1130/2616)	Acetylsalicylic acid may increase the anticoagulant activities of Acenocoumarol.	#ACCCE3	513.287092734234	1
Simvastatin	Amiodarone	0.304	-2.163	Major	1975 (688/1287)	The serum concentration of Simvastatin can be increased when it is combined with Amiodarone.	#AFCEE4	270.619863360948	1
Ranitidine	Acenocoumarol	0.282	-1.516	None	1248 (540/708)		#B2D0E5	171.004349100994	1
Digoxin	Levothyroxine	0.327	2.107	Moderate	701 (497/204)		#F7B7B7	96.0529236536833	1
Amitriptyline	Duloxetine	0.347	6.275	Major	322 (283/39)	Duloxetine may increase the serotonergic activities of Amitriptyline.	#EEA4A4	44.1213144315065	3.2228118877744e-08
Acetylsalicylic acid	Ginkgo biloba	0.268	1.067	Moderate	896 (495/401)	Ginkgo biloba may increase the anticoagulant activities of Acetylsalicylic acid.	#F9BCBC	122.772353200714	1
Carbamazepine	Simvastatin	0.334	1.059	Moderate	763 (420/343)	The metabolism of Simvastatin can be increased when combined with Carbamazepine.	#F9BCBC	104.548332022483	1
Fluconazole	Simvastatin	0.09	1.179	Major	1132 (653/479)	The serum concentration of Simvastatin can be increased when it is combined with Fluconazole.	#F9BCBC	155.109714088402	1
Valproic acid	Acetylsalicylic acid	0.374	-1.576	Moderate	730 (309/421)	The serum concentration of Valproic Acid can be increased when it is combined with Acetylsalicylic acid.	#B2D0E5	100.026582406831	1
Omeprazole	Midazolam	0.239	1.358	Moderate	622 (380/242)		#F8BABA	85.2281291192454	1
Acetylsalicylic acid	Insulin glulisine	0.274	-1.556	Moderate	462 (197/265)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Glulisine.	#B2D0E5	63.304494619118	1.30252931712664e-12
Atenolol	Glyburide	0.332	-1.353	Moderate	753 (347/406)	Atenolol may increase the hypoglycemic activities of Glyburide.	#B2D0E5	103.178104866225	1
Mesalazine	Mercaptopurine	0.315	-1.156	Moderate	16 (8/8)	The metabolism of Mercaptopurine can be decreased when combined with Mesalazine.	#B4D1E6	2.19236345001274	1.75701697664729e-17
Diltiazem	Amiodarone	0.339	-1.731	Major	392 (157/235)	The risk or severity of bradycardia can be increased when Diltiazem is combined with Amiodarone.	#B1CFE5	53.7129045253122	1.44661691505222e-18
Ciprofloxacin	Acenocoumarol	0.106	-2.253	None	1890 (641/1249)		#AFCEE4	258.972932532755	1
Levothyroxine	Raloxifene	0.294	34.038	Moderate	444 (433/11)	Raloxifene can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	60.8380857378536	1
Hydrocortisone	Acetylsalicylic acid	0.167	-1.297	Moderate	1273 (600/673)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Hydrocortisone.	#B4D1E6	174.429916991639	1
Tacrolimus	Atorvastatin	0.374	-1.784	Moderate	689 (271/418)	The risk or severity of adverse effects can be increased when Tacrolimus is combined with Atorvastatin.	#B1CFE5	94.4086510661737	1
Tramadol	Escitalopram	0.218	3.523	Major	888 (713/175)	Escitalopram may increase the neuroexcitatory activities of Tramadol.	#F4B1B1	121.676171475707	1
Gliclazide	Carvedilol	0.329	-1.927	None	688 (258/430)	Carvedilol may increase the hypoglycemic activities of Gliclazide.	#B1CFE5	94.271628350548	1
Mirtazapine	Rivastigmine	0.291	1.341	Moderate	176 (107/69)		#F8BABA	24.1159979501402	5.34141708258098e-33
Digoxin	Hydrochlorothiazide	0.297	-1	Moderate	1063 (570/493)	The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Digoxin.	#B4D1E6	145.655146710222	1
Bisoprolol	Glyburide	0.306	-2.007	Moderate	1179 (431/748)	Bisoprolol may increase the hypoglycemic activities of Glyburide.	#AFCEE4	161.549781722814	1
Ibuprofen	Carvedilol	0.126	-1.385	Moderate	1668 (759/909)	Ibuprofen may decrease the antihypertensive activities of Carvedilol.	#B2D0E5	228.553889663828	1
Omeprazole	Flurazepam	0.263	1.674	Moderate	552 (364/188)		#F7B9B9	75.6365390254396	1
Spironolactone	Losartan	0.338	-1.337	Major	886 (411/475)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Losartan.	#B2D0E5	121.402126044456	1
Alprazolam	Clarithromycin	0.12	3.037	Moderate	722 (562/160)	The serum concentration of Alprazolam can be increased when it is combined with Clarithromycin.	#F5B2B2	98.930400681825	1
Fluoxetine	Acenocoumarol	0.318	1.499	None	626 (397/229)	The metabolism of Acenocoumarol can be decreased when combined with Fluoxetine.	#F8BABA	85.7762199817486	1
Bisoprolol	Salmeterol	0.288	-2.589	Moderate	1736 (536/1200)	Bisoprolol may decrease the bronchodilatory activities of Salmeterol.	#AECDE3	237.871434326383	1
Levothyroxine	Iron	0.172	4.293	Moderate	507 (422/85)	The serum concentration of Levothyroxine can be decreased when it is combined with Iron.	#F2AEAE	69.4705168222788	1
Simvastatin	Fenofibrate	0.365	-1.753	Major	1590 (632/958)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Simvastatin.	#B1CFE5	217.866117845016	1
Mirtazapine	Donepezil	0.368	1.745	Moderate	166 (111/55)		#F7B9B9	22.7457707938822	6.56716132805557e-26
Digoxin	Propafenone	0.344	1.6	Moderate	114 (74/40)	The serum concentration of Digoxin can be increased when it is combined with Propafenone.	#F8BABA	15.6205895813408	1.48759381842895e-21
Lamotrigine	Carbamazepine	0.518	-1.317	Moderate	77 (36/41)	The risk or severity of adverse effects can be increased when Lamotrigine is combined with Carbamazepine.	#B4D1E6	10.5507491031863	2.72410524923387e-44
Atenolol	Salbutamol	0.156	-1.266	Moderate	1330 (635/695)	Atenolol may decrease the bronchodilatory activities of Salbutamol.	#B4D1E6	182.240211782309	1
Azithromycin	Acenocoumarol	0.099	-1.418	None	1398 (628/770)	The metabolism of Acenocoumarol can be decreased when combined with Azithromycin.	#B2D0E5	191.557756444863	1
Phenytoin	Omeprazole	0.341	-1.548	Moderate	767 (328/439)	The serum concentration of Omeprazole can be decreased when it is combined with Phenytoin.	#B2D0E5	105.096422884986	1
Citalopram	Propranolol	0.295	1.962	Moderate	461 (320/141)	The metabolism of Propranolol can be decreased when combined with Citalopram.	#F7B9B9	63.1674719034922	1
Prazosin	Nadolol	0.62	-1.446	Moderate	9 (4/5)	Nadolol may increase the orthostatic hypotensive activities of Prazosin.	#B2D0E5	1.23320444063217	5.87350509992253e-11
Carbamazepine	Atorvastatin	0.378	-1.083	Moderate	399 (206/193)	The metabolism of Atorvastatin can be increased when combined with Carbamazepine.	#B4D1E6	54.6720635346928	1
Methimazole	Acenocoumarol	0.273	1.083	None	223 (124/99)	Methimazole may decrease the anticoagulant activities of Acenocoumarol.	#F9BCBC	30.5560655845526	6.33839120596628e-16
Acetylsalicylic acid	Glipizide	0.367	-2.137	Moderate	450 (158/292)	Acetylsalicylic acid may increase the hypoglycemic activities of Glipizide.	#AFCEE4	61.6602220316084	1.48280626038042e-12
Digoxin	Alprazolam	0.267	1.571	Moderate	552 (356/196)		#F8BABA	75.6365390254396	1
Cholestyramine	Ursodeoxycholic acid	0.272	1.135	None	74 (42/32)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Cholestyramine.	#F9BCBC	10.1396809563089	8.78734570621743e-34
Carvedilol	Insulin detemir	0.341	-1.586	Moderate	249 (105/144)		#B2D0E5	34.1186561908233	2.49338947994951e-18
Ramipril	Spironolactone	0.384	-1.892	Major	514 (195/319)	The risk or severity of adverse effects can be increased when Ramipril is combined with Spironolactone.	#B1CFE5	70.4296758316594	1
Verapamil	Atorvastatin	0.431	-1.211	Moderate	518 (253/265)	Atorvastatin can cause a decrease in the absorption of Verapamil resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	70.9777666941626	1
Raloxifene	Estriol	0.248	23.347	None	84 (81/3)		#C95252	11.5099081125669	4.3876478178507e-26
Propranolol	Sertraline	0.326	2.387	Moderate	346 (254/92)	The metabolism of Propranolol can be decreased when combined with Sertraline.	#F6B6B6	47.4098596065256	1
Fluoxetine	Propranolol	0.302	4.838	Moderate	244 (207/37)	The metabolism of Propranolol can be decreased when combined with Fluoxetine.	#F1ABAB	33.4335426126943	1
Cyclosporine	Omeprazole	0.389	-1.476	Moderate	478 (210/268)	The serum concentration of Cyclosporine can be increased when it is combined with Omeprazole.	#B2D0E5	65.4968580691307	1
Simvastatin	Colchicine	0.15	-4.371	Major	1477 (309/1168)	Colchicine may increase the myopathic rhabdomyolysis activities of Simvastatin.	#A5C6DF	202.382550979301	1
Amitriptyline	Fluoxetine	0.303	4.68	Major	327 (276/51)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Amitriptyline.	#F1ABAB	44.8064280096354	1
Citalopram	Carvedilol	0.359	1.033	Moderate	518 (282/236)	The metabolism of Carvedilol can be decreased when combined with Citalopram.	#F9BCBC	70.9777666941626	1
Methotrexate	Naproxen	0.213	1.372	Major	445 (273/172)	The serum concentration of Methotrexate can be increased when it is combined with Naproxen.	#F8BABA	60.9751084534794	1
Omeprazole	Halazepam	0.221	1.999	Moderate	361 (252/109)		#F7B7B7	49.4652003409125	1
Bisoprolol	Insulin detemir	0.289	-1.417	Moderate	503 (226/277)		#B2D0E5	68.9224259597756	1
Salbutamol	Carvedilol	0.169	-2.204	Major	924 (318/606)	Carvedilol may decrease the vasoconstricting activities of Salbutamol.	#AFCEE4	126.608989238236	1
Acetylsalicylic acid	Methylprednisolone	0.173	-1.836	Moderate	1079 (417/662)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Methylprednisolone.	#B1CFE5	147.847510160234	1
Methotrexate	Acetylsalicylic acid	0.252	-1.385	Major	712 (324/388)	The serum concentration of Methotrexate can be increased when it is combined with Acetylsalicylic acid.	#B2D0E5	97.5601735255671	1
Sucralfate	Lansoprazole	0.314	1.473	Moderate	173 (109/64)		#F8BABA	23.7049298032628	5.54269811200336e-11
Indomethacin	Alendronic acid	0.221	4.992	Moderate	359 (306/53)	The risk or severity of adverse effects can be increased when Indomethacin is combined with Alendronic acid.	#F0A9A9	49.1911549096609	1
Dextropropoxyphene	Naltrexone	0.5	Inf	None	1 (1/0)	The therapeutic efficacy of Dextropropoxyphene can be decreased when used in combination with Naltrexone.	#B32020	0.137022715625796	1
Metformin	Glucosamine	0.194	-1.011	None	1104 (589/515)		#B4D1E6	151.273078050879	1
Repaglinide	Carvedilol	0.338	-2.582	Moderate	430 (133/297)		#AECDE3	58.9197677190925	3.34935592134391e-14
Amitriptyline	Salbutamol	0.172	1.765	Moderate	657 (441/216)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Salbutamol.	#F7B9B9	90.0239241661483	1
Atorvastatin	Clarithromycin	0.083	-1.216	Major	1030 (502/528)	The serum concentration of Atorvastatin can be increased when it is combined with Clarithromycin.	#B4D1E6	141.13339709457	1
Simvastatin	Itraconazole	0.082	1.186	Major	702 (406/296)	The serum concentration of Simvastatin can be increased when it is combined with Itraconazole.	#F9BCBC	96.1899463693091	1
Paroxetine	Risperidone	0.314	1.376	Moderate	311 (191/120)	The metabolism of Risperidone can be decreased when combined with Paroxetine.	#F8BABA	42.6140645596227	1
Valproic acid	Carbamazepine	0.541	1.333	Moderate	61 (37/24)	The serum concentration of the active metabolites of Carbamazepine can be increased when Carbamazepine is used in combination with Valproic Acid.	#F8BABA	8.35838565317358	1.72958593472462e-17
Dextromethorphan	Paroxetine	0.133	3.826	Major	396 (323/73)	Paroxetine may increase the serotonergic activities of Dextromethorphan.	#F3AFAF	54.2609953878154	1
Cyclosporine	Allopurinol	0.329	-3.598	Moderate	148 (36/112)		#A9C9E1	20.2793619126179	9.63681169995929e-27
Methotrexate	Amoxicillin	0.106	1.214	Major	678 (396/282)	The serum concentration of Methotrexate can be increased when it is combined with Amoxicillin.	#F9BCBC	92.90140119429	1
Propranolol	Escitalopram	0.296	1.994	None	238 (166/72)		#F7B7B7	32.6114063189396	1
Digoxin	Diazepam	0.246	1.613	Moderate	510 (332/178)		#F8BABA	69.8815849691562	1
Norfloxacin	Acenocoumarol	0.104	1.903	None	573 (394/179)	Norfloxacin may increase the anticoagulant activities of Acenocoumarol.	#F7B9B9	78.5140160535814	1
Amitriptyline	Carbamazepine	0.394	1.55	Moderate	148 (95/53)	The metabolism of Amitriptyline can be increased when combined with Carbamazepine.	#F8BABA	20.2793619126179	6.74202858054782e-12
Simvastatin	Gemfibrozil	0.23	-1.833	Major	1259 (487/772)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Simvastatin.	#B1CFE5	172.511598972878	1
Sertraline	Carvedilol	0.38	1.285	Moderate	348 (208/140)	The metabolism of Carvedilol can be decreased when combined with Sertraline.	#F9BCBC	47.6839050377772	1
Atenolol	Repaglinide	0.312	-1.477	Moderate	476 (209/267)		#B2D0E5	65.2228126378791	1
Sertraline	Clarithromycin	0.101	4.581	Moderate	359 (302/57)	The metabolism of Sertraline can be decreased when combined with Clarithromycin.	#F2ACAC	49.1911549096609	1
Erythromycin	Simvastatin	0.081	1.46	Major	605 (380/225)	The serum concentration of Simvastatin can be increased when it is combined with Erythromycin.	#F8BABA	82.8987429536068	1
Paroxetine	Carvedilol	0.359	1.266	Moderate	382 (227/155)	The metabolism of Carvedilol can be decreased when combined with Paroxetine.	#F9BCBC	52.3426773690542	1
Atorvastatin	Gemfibrozil	0.275	-2.22	Major	803 (275/528)	The risk or severity of adverse effects can be increased when Gemfibrozil is combined with Atorvastatin.	#AFCEE4	110.029240647515	1
Citalopram	Clarithromycin	0.11	3.022	Major	454 (353/101)	Clarithromycin may increase the QTc-prolonging activities of Citalopram.	#F5B2B2	62.2083128941116	1
Omeprazole	Cilostazol	0.241	-6.21	Major	1274 (200/1074)	The serum concentration of Cilostazol can be increased when it is combined with Omeprazole.	#9DC0DC	174.566939707265	1
Venlafaxine	Metoclopramide	0.148	3.898	Moderate	347 (284/63)	The risk or severity of adverse effects can be increased when Metoclopramide is combined with Venlafaxine.	#F3AFAF	47.5468823221514	1
Fenofibrate	Acenocoumarol	0.319	-2.374	None	580 (190/390)	Fenofibrate may increase the anticoagulant activities of Acenocoumarol.	#AECDE3	79.4731750629619	1
Prazosin	Oxprenolol	1	Inf	None	1 (1/0)	Oxprenolol may increase the orthostatic hypotensive activities of Prazosin.	#B32020	0.137022715625796	1
Cyclosporine	Ursodeoxycholic acid	0.481	-1.565	Minor	40 (17/23)		#B2D0E5	5.48090862503186	1.56306132486441e-22
Pyridostigmine	Prednisone	0.372	-2.293	Moderate	173 (58/115)	The risk or severity of adverse effects can be increased when Prednisone is combined with Pyridostigmine.	#AFCEE4	23.7049298032628	1.9594687261004e-41
Fluconazole	Alprazolam	0.186	2.774	Major	303 (231/72)	The metabolism of Alprazolam can be decreased when combined with Fluconazole.	#F5B4B4	41.5178828346163	1
Propranolol	Rizatriptan	0.343	2.402	Moderate	68 (50/18)	The serum concentration of Rizatriptan can be increased when it is combined with Propranolol.	#F6B6B6	9.31754466255416	5.37548051449597e-12
Olanzapine	Rivastigmine	0.284	-1.068	Moderate	75 (39/36)		#B4D1E6	10.2767036719347	9.10896065660299e-21
Folic acid	Phenobarbital	0.304	1.297	Moderate	65 (39/26)	The serum concentration of Phenobarbital can be decreased when it is combined with Folic Acid.	#F9BCBC	8.90647651567677	4.41485681885961e-08
Glyburide	Carvedilol	0.331	-2.204	Moderate	369 (127/242)	Carvedilol may increase the hypoglycemic activities of Glyburide.	#AFCEE4	50.5613820659189	1
Repaglinide	Glyburide	0.209	-1.577	None	286 (121/165)	Repaglinide may increase the hypoglycemic activities of Glyburide.	#B2D0E5	39.1884966689778	1
Spironolactone	Tolevamer	0.253	-2.082	Moderate	84 (30/54)		#AFCEE4	11.5099081125669	2.67684689745388e-13
Tacrolimus	Nifedipine	0.367	-2.244	Moderate	147 (50/97)	The serum concentration of Tacrolimus can be increased when it is combined with Nifedipine.	#AFCEE4	20.1423391969921	9.94122184945292e-26
Fluoxetine	Clomipramine	0.395	1.842	Major	144 (98/46)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Clomipramine.	#F7B9B9	19.7312710501147	3.98258487925549e-08
Lidocaine	Bisoprolol	0.121	1.455	Moderate	338 (212/126)	The serum concentration of Lidocaine can be increased when it is combined with Bisoprolol.	#F8BABA	46.3136778815192	1
Moxifloxacin	Acenocoumarol	0.114	-1.788	None	471 (185/286)		#B1CFE5	64.5376990597501	1
Propranolol	Gliclazide	0.285	-1.149	None	331 (166/165)	Propranolol may increase the hypoglycemic activities of Gliclazide.	#B4D1E6	45.3545188721386	1
Indomethacin	Losartan	0.157	-1.255	Moderate	467 (224/243)	The metabolism of Indomethacin can be decreased when combined with Losartan.	#B4D1E6	63.9896081972469	1
Salmeterol	Carvedilol	0.305	-3.406	Major	572 (145/427)	Carvedilol may decrease the vasoconstricting activities of Salmeterol.	#A9C9E1	78.3769933379556	1
Olanzapine	Donepezil	0.367	2	Moderate	53 (37/16)		#F7B7B7	7.26220392816721	1.1629089450303e-07
Atenolol	Formoterol	0.203	-1.534	Moderate	684 (294/390)	Atenolol may decrease the bronchodilatory activities of Formoterol.	#B2D0E5	93.7235374880448	1
Fluvoxamine	Olanzapine	0.541	-1.099	Moderate	39 (20/19)	The metabolism of Olanzapine can be decreased when combined with Fluvoxamine.	#B4D1E6	5.34388590940606	1.6789405983504e-18
Atenolol	Insulin aspart	0.28	-1.066	Moderate	319 (166/153)		#B4D1E6	43.7102462846291	1
Triamcinolone	Acetylsalicylic acid	0.091	-1.834	Moderate	675 (261/414)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Triamcinolone.	#B1CFE5	92.4903330474126	1
Fluoxetine	Carvedilol	0.343	1.243	Moderate	234 (138/96)	The metabolism of Carvedilol can be decreased when combined with Fluoxetine.	#F9BCBC	32.0633154564364	1
Escitalopram	Rasagiline	0.405	1.159	Major	103 (59/44)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Rasagiline.	#F9BCBC	14.113339709457	0.000808282135429517
Trazodone	Acenocoumarol	0.264	-1.235	None	397 (192/205)		#B4D1E6	54.3980181034412	1
Spironolactone	Cholestyramine	0.306	1.136	Moderate	81 (46/35)	The risk or severity of adverse effects can be increased when Cholestyramine is combined with Spironolactone.	#F9BCBC	11.0988399656895	7.03978917810083e-06
Methotrexate	Ibuprofen	0.183	1.428	Major	509 (317/192)	The serum concentration of Methotrexate can be increased when it is combined with Ibuprofen.	#F8BABA	69.7445622535304	1
Citalopram	Rasagiline	0.322	1.047	Major	168 (92/76)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rasagiline.	#F9BCBC	23.0198162251338	1
Amiodarone	Flecainide	0.183	-1.229	Major	132 (64/68)	The serum concentration of Flecainide can be increased when it is combined with Amiodarone.	#B4D1E6	18.0869984626051	0.803336661735113
Fluoxetine	Dextromethorphan	0.128	3.459	Major	225 (180/45)	Fluoxetine may increase the serotonergic activities of Dextromethorphan.	#F4B1B1	30.8301110158042	1
Cyclosporine	Carvedilol	0.417	-1.86	Moderate	60 (23/37)	The serum concentration of Cyclosporine can be increased when it is combined with Carvedilol.	#B1CFE5	8.22136293754779	2.41980774641172e-12
Acetylsalicylic acid	Dexamethasone	0.158	-2.634	Moderate	826 (252/574)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Dexamethasone.	#AECDE3	113.180763106908	1
Gemfibrozil	Acenocoumarol	0.315	-2.996	None	553 (154/399)	The metabolism of Acenocoumarol can be decreased when combined with Gemfibrozil.	#ABCBE2	75.7735617410654	1
Phenytoin	Furosemide	0.347	-1.45	Minor	160 (71/89)	Phenytoin may decrease the diuretic activities of Furosemide.	#B2D0E5	21.9236345001274	1
Fluvastatin	Acenocoumarol	0.354	-1.924	None	325 (122/203)	The metabolism of Acenocoumarol can be decreased when combined with Fluvastatin.	#B1CFE5	44.5323825783838	1
Carbamazepine	Risperidone	0.347	-1.038	Moderate	74 (39/35)	The serum concentration of Risperidone can be decreased when it is combined with Carbamazepine.	#B4D1E6	10.1396809563089	1.17535806366855e-08
Fentanyl	Amiodarone	0.301	-1.098	Major	193 (99/94)	The serum concentration of Fentanyl can be increased when it is combined with Amiodarone.	#B4D1E6	26.4453841157787	1
Fluconazole	Atorvastatin	0.112	-1.22	Major	409 (199/210)	The serum concentration of Atorvastatin can be increased when it is combined with Fluconazole.	#B4D1E6	56.0422906909507	1
Topiramate	Carbamazepine	0.482	1.606	Moderate	40 (26/14)	The serum concentration of Topiramate can be decreased when it is combined with Carbamazepine.	#F8BABA	5.48090862503186	6.62123344930794e-09
Fluvoxamine	Clomipramine	0.445	3.459	Major	25 (20/5)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Clomipramine.	#F4B1B1	3.42556789064491	4.13373276442469e-07
Formoterol	Carvedilol	0.23	-3.198	Major	561 (149/412)	Carvedilol may decrease the vasoconstricting activities of Formoterol.	#ABCBE2	76.8697434660718	1
Glimepiride	Repaglinide	0.218	-1.569	None	165 (70/95)	Glimepiride may increase the hypoglycemic activities of Repaglinide.	#B2D0E5	22.6087480782564	1
Pentoxifylline	Acenocoumarol	0.327	-4.155	None	620 (135/485)	Pentoxifylline may increase the anticoagulant activities of Acenocoumarol.	#A6C7E0	84.9540836879938	1
Fenofibrate	Rosuvastatin	0.463	-2.641	Major	220 (67/153)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Rosuvastatin.	#AECDE3	30.1449974376752	6.37532631496436e-07
Sertraline	Rasagiline	0.395	-1.305	Major	149 (70/79)	The risk or severity of adverse effects can be increased when Sertraline is combined with Rasagiline.	#B4D1E6	20.4163846282437	0.0206803164425844
Erythromycin	Alprazolam	0.126	4.804	Moderate	177 (150/27)	The serum concentration of Alprazolam can be increased when it is combined with Erythromycin.	#F1ABAB	24.253020665766	1
Mirtazapine	Rasagiline	0.341	1.07	Major	85 (47/38)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Mirtazapine.	#F9BCBC	11.6469308281927	0.0234800759206744
Indomethacin	Furosemide	0.217	-1.515	Moderate	395 (171/224)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Indomethacin.	#B2D0E5	54.1239726721896	1
Diltiazem	Amlodipine	0.306	-2.308	Moderate	728 (243/485)	The metabolism of Amlodipine can be decreased when combined with Diltiazem.	#AFCEE4	99.7525369755798	1
Galantamine	Sertraline	0.358	-1.112	Moderate	102 (52/50)	The metabolism of Galantamine can be decreased when combined with Sertraline.	#B4D1E6	13.9763169938312	2.93091347633233e-08
Enalapril	Tizanidine	0.157	-1.267	Major	350 (167/183)	The risk or severity of hypotension can be increased when Tizanidine is combined with Enalapril.	#B4D1E6	47.9579504690288	1
Citalopram	Oxycodone	0.299	2.011	Moderate	153 (107/46)	The metabolism of Oxycodone can be decreased when combined with Citalopram.	#F7B7B7	20.9644754907469	1
Propranolol	Salbutamol	0.158	-1.533	Major	486 (209/277)		#B2D0E5	66.5930397941371	1
Atenolol	Salmeterol	0.263	-1.924	Moderate	578 (217/361)	Atenolol may decrease the bronchodilatory activities of Salmeterol.	#B1CFE5	79.1991296317103	1
Alprazolam	Carbamazepine	0.256	1.625	Moderate	167 (109/58)	The metabolism of Alprazolam can be increased when combined with Carbamazepine.	#F8BABA	22.882793509508	1
Tramadol	Carbamazepine	0.263	1.476	Moderate	249 (157/92)	Tramadol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.	#F8BABA	34.1186561908233	1
Nabumetone	Alendronic acid	0.188	15.565	Moderate	114 (108/6)	The risk or severity of adverse effects can be increased when Nabumetone is combined with Alendronic acid.	#DA7676	15.6205895813408	1
Allopurinol	Warfarin	0.281	-4.202	Moderate	278 (60/218)	Allopurinol may increase the anticoagulant activities of Warfarin.	#A6C7E0	38.0923149439714	1
Digoxin	Telmisartan	0.295	-1.322	Moderate	195 (91/104)	The serum concentration of Digoxin can be increased when it is combined with Telmisartan.	#B4D1E6	26.7194295470303	1
Fluconazole	Fentanyl	0.399	-1.324	Major	193 (90/103)	The serum concentration of Fentanyl can be increased when it is combined with Fluconazole.	#B4D1E6	26.4453841157787	1
Sumatriptan	Ergotamine	0.372	2.248	Major	18 (13/5)	Ergotamine may increase the vasoconstricting activities of Sumatriptan.	#F7B7B7	2.46640888126434	3.62244527382937e-08
Mirtazapine	Galantamine	0.406	1.547	Moderate	53 (34/19)		#F8BABA	7.26220392816721	0.000744050191910364
Carvedilol	Escitalopram	0.349	-1.07	None	206 (107/99)		#B4D1E6	28.2266794189141	1
Levothyroxine	Warfarin	0.268	1.784	Moderate	193 (130/63)	Levothyroxine may increase the anticoagulant activities of Warfarin.	#F7B9B9	26.4453841157787	1
Cyclosporine	Atorvastatin	0.441	-1.966	Major	135 (50/85)	The serum concentration of Atorvastatin can be increased when it is combined with Cyclosporine.	#B1CFE5	18.4980666094825	0.480648079631695
Oxycodone	Sertraline	0.247	2.687	Moderate	115 (87/28)	The metabolism of Oxycodone can be decreased when combined with Sertraline.	#F5B4B4	15.7576122969666	1
Venlafaxine	Rasagiline	0.322	-1.001	Major	97 (52/45)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Rasagiline.	#B4D1E6	13.2912034157023	0.0212080449327052
Diazepam	Clarithromycin	0.249	2.275	Moderate	443 (321/122)	The metabolism of Diazepam can be decreased when combined with Clarithromycin.	#F7B7B7	60.7010630222278	1
Clozapine	Lamotrigine	0.656	1.729	Moderate	3 (2/1)	The risk or severity of adverse effects can be increased when Clozapine is combined with Lamotrigine.	#F7B9B9	0.411068146877389	0.101809408881365
Ranolazine	Diltiazem	0.408	-1.508	Major	53 (23/30)	The serum concentration of Ranolazine can be increased when it is combined with Diltiazem.	#B2D0E5	7.26220392816721	0.0113410221973965
Topiramate	Lithium cation	0.412	6.485	Moderate	17 (15/2)	The serum concentration of Lithium can be increased when it is combined with Topiramate.	#EDA3A3	2.32938616563854	0.00273092778533107
Propranolol	Formoterol	0.219	-1.156	Major	286 (143/143)		#B4D1E6	39.1884966689778	1
Trihexyphenidyl	Haloperidol	0.367	-1.156	Moderate	16 (8/8)		#B4D1E6	2.19236345001274	5.31791493796049e-07
Rivastigmine	Methotrimeprazine	0.212	3.675	Moderate	21 (17/4)		#F3AFAF	2.87747702814173	0.0275412213383559
Galantamine	Paroxetine	0.29	1.668	Moderate	82 (54/28)	The metabolism of Galantamine can be decreased when combined with Paroxetine.	#F7B9B9	11.2358626813153	1
Spironolactone	Irbesartan	0.327	-1.449	Major	214 (95/119)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Irbesartan.	#B2D0E5	29.3228611439204	1
Salbutamol	Clomipramine	0.157	2.553	Moderate	166 (124/42)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Salbutamol.	#F6B6B6	22.7457707938822	1
Clarithromycin	Acenocoumarol	0.078	-1.358	None	461 (212/249)	The metabolism of Acenocoumarol can be decreased when combined with Clarithromycin.	#B2D0E5	63.1674719034922	1
Duloxetine	Ciprofloxacin	0.136	1.441	Major	296 (185/111)		#F8BABA	40.5587238252357	1
Metoprolol	Ibuprofen	0.153	1.069	Moderate	237 (131/106)	Ibuprofen may decrease the antihypertensive activities of Metoprolol.	#F9BCBC	32.4743836033138	1
Fluoxetine	Risperidone	0.308	1.148	Moderate	149 (85/64)	The metabolism of Risperidone can be decreased when combined with Fluoxetine.	#F9BCBC	20.4163846282437	1
Bisoprolol	Terbutaline	0.112	-1.213	Moderate	336 (164/172)	Bisoprolol may decrease the bronchodilatory activities of Terbutaline.	#B4D1E6	46.0396324502676	1
Azithromycin	Lovastatin	0.072	1.218	Moderate	265 (155/110)	The serum concentration of Lovastatin can be increased when it is combined with Azithromycin.	#F9BCBC	36.3110196408361	1
Torasemide	Indomethacin	0.192	-1.146	Moderate	221 (111/110)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Indomethacin.	#B4D1E6	30.282020153301	1
Zolmitriptan	Ergotamine	0.317	1.297	Major	25 (15/10)	Ergotamine may increase the vasoconstricting activities of Zolmitriptan.	#F9BCBC	3.42556789064491	1.78765625100795e-10
Amiodarone	Levofloxacin	0.153	-3.028	Major	427 (118/309)	Levofloxacin may increase the QTc-prolonging activities of Amiodarone.	#ABCBE2	58.5086995722151	1
Donepezil	Tolterodine	0.403	1.364	Moderate	67 (41/26)	The therapeutic efficacy of Tolterodine can be decreased when used in combination with Donepezil.	#F8BABA	9.18052194692836	0.145137890578342
Atorvastatin	Colchicine	0.176	-6.319	Major	627 (97/530)	The risk or severity of adverse effects can be increased when Colchicine is combined with Atorvastatin.	#9CBFDB	85.9132426973744	1
Glimepiride	Gemfibrozil	0.271	-2.767	Moderate	190 (56/134)	The metabolism of Glimepiride can be decreased when combined with Gemfibrozil.	#ACCCE3	26.0343159689013	1
Omeprazole	Triazolam	0.246	1.729	Moderate	111 (74/37)		#F7B9B9	15.2095214344634	1
Tramadol	Rasagiline	0.176	1.134	Major	215 (122/93)	Tramadol may increase the neuroexcitatory activities of Rasagiline.	#F9BCBC	29.4598838595462	1
Lorazepam	Phenytoin	0.341	-1.481	Moderate	203 (89/114)	The serum concentration of Phenytoin can be increased when it is combined with Lorazepam.	#B2D0E5	27.8156112720367	1
Olanzapine	Galantamine	0.354	-1.373	Moderate	35 (16/19)		#B2D0E5	4.79579504690288	5.91107322158097e-10
Fluoxetine	Clarithromycin	0.137	3.78	Moderate	188 (153/35)	Clarithromycin may increase the QTc-prolonging activities of Fluoxetine.	#F3AFAF	25.7602705376497	1
Gentamicin	Cefonicid	0.633	3.459	Moderate	5 (4/1)		#F4B1B1	0.685113578128982	0.617126020706195
Erythromycin	Atorvastatin	0.109	1.297	Major	230 (138/92)	The serum concentration of Atorvastatin can be increased when it is combined with Erythromycin.	#F9BCBC	31.5152245939332	1
Citalopram	Rizatriptan	0.249	5.957	Major	71 (62/9)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rizatriptan.	#EEA4A4	9.72861280943155	1
Lovastatin	Verapamil	0.478	1.853	Major	66 (45/21)	The serum concentration of Lovastatin can be increased when it is combined with Verapamil.	#F7B9B9	9.04349923130257	1
Prednisone	Warfarin	0.193	-1.463	Moderate	222 (98/124)	Prednisone may increase the anticoagulant activities of Warfarin.	#B2D0E5	30.4190428689268	1
Methotrexate	Diclofenac	0.197	1.225	Major	261 (153/108)	The serum concentration of Methotrexate can be increased when it is combined with Diclofenac.	#F9BCBC	35.7629287783329	1
Spironolactone	Captopril	0.324	-1.441	Major	137 (61/76)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Captopril.	#B2D0E5	18.7721120407341	1
Propranolol	Glyburide	0.296	-1.329	Moderate	187 (87/100)	Propranolol may increase the hypoglycemic activities of Glyburide.	#B4D1E6	25.6232478220239	1
Ibuprofen	Lithium cation	0.131	1.672	Moderate	176 (116/60)	The serum concentration of Lithium can be increased when it is combined with Ibuprofen.	#F7B9B9	24.1159979501402	1
Phenytoin	Alprazolam	0.338	1.393	Moderate	94 (58/36)	The serum concentration of Phenytoin can be increased when it is combined with Alprazolam.	#F8BABA	12.8801352688249	1
Hydrocortisone	Acenocoumarol	0.153	-1.484	None	306 (134/172)		#B2D0E5	41.9289509814937	1
Digoxin	Methimazole	0.244	1.014	Moderate	63 (34/29)	The serum concentration of Digoxin can be increased when it is combined with Methimazole.	#F9BCBC	8.63243108442518	0.0104701826268308
Warfarin	Acetylsalicylic acid	0.223	-2.944	Major	500 (141/359)	Acetylsalicylic acid may increase the anticoagulant activities of Warfarin.	#ACCCE3	68.5113578128982	1
Aprepitant	Dexamethasone	1	Inf	Moderate	1 (1/0)	The serum concentration of Dexamethasone can be increased when it is combined with Aprepitant.	#B32020	0.137022715625796	1
Bisoprolol	Insulin glulisine	0.22	-1.745	Moderate	138 (55/83)		#B1CFE5	18.9091347563599	1
Alprazolam	Itraconazole	0.143	2.662	Major	155 (117/38)	The serum concentration of Alprazolam can be increased when it is combined with Itraconazole.	#F5B4B4	21.2385209219985	1
Ciprofloxacin	Methotrexate	0.11	-1.057	Moderate	201 (105/96)	The serum concentration of Methotrexate can be increased when it is combined with Ciprofloxacin.	#B4D1E6	27.5415658407851	1
Cyclosporine	Sulfamethoxazole	0.203	-2.523	Major	35 (11/24)	Sulfamethoxazole may increase the nephrotoxic activities of Cyclosporine.	#AECDE3	4.79579504690288	2.06013777151711e-12
Indomethacin	Bisoprolol	0.156	-2.281	Moderate	428 (144/284)	Indomethacin may decrease the antihypertensive activities of Bisoprolol.	#AFCEE4	58.6457222878409	1
Folic acid	Phenytoin	0.293	-2.313	Moderate	75 (25/50)	The serum concentration of Phenytoin can be decreased when it is combined with Folic Acid.	#AFCEE4	10.2767036719347	4.46418429480899e-08
Haloperidol	Lithium cation	0.365	-1.957	Major	35 (13/22)	Lithium may increase the neurotoxic activities of Haloperidol.	#B1CFE5	4.79579504690288	5.26266547573189e-12
Citalopram	Warfarin	0.317	1.49	Moderate	128 (81/47)	The metabolism of Warfarin can be decreased when combined with Citalopram.	#F8BABA	17.5389076001019	1
Rivastigmine	Diphenhydramine	0.077	Inf	Moderate	1 (1/0)		#B32020	0.137022715625796	1
Zolmitriptan	Paroxetine	0.276	8.359	Major	64 (58/6)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Paroxetine.	#E99999	8.76945380005097	1
Cyclosporine	Nifedipine	0.438	-2.506	Moderate	38 (12/26)	The metabolism of Nifedipine can be decreased when combined with Cyclosporine.	#AECDE3	5.20686319378026	3.57882809391484e-11
Donepezil	Solifenacin	0.344	-1.209	Moderate	90 (44/46)	The therapeutic efficacy of Solifenacin can be decreased when used in combination with Donepezil.	#B4D1E6	12.3320444063217	1
Lovastatin	Acenocoumarol	0.347	-1.311	None	224 (105/119)	The metabolism of Acenocoumarol can be decreased when combined with Lovastatin.	#B4D1E6	30.6930883001784	1
Propranolol	Repaglinide	0.289	-1.057	Moderate	134 (70/64)		#B4D1E6	18.3610438938567	1
Bisoprolol	Glipizide	0.31	-1.817	Moderate	126 (49/77)	Bisoprolol may increase the hypoglycemic activities of Glipizide.	#B1CFE5	17.2648621688504	1
Fluoxetine	Nortriptyline	0.392	2.594	Major	32 (24/8)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Nortriptyline.	#F6B6B6	4.38472690002549	0.000663991875482151
Disopyramide	Bisoprolol	0.418	1.585	Major	17 (11/6)	Disopyramide may increase the bradycardic activities of Bisoprolol.	#F8BABA	2.32938616563854	0.00105517010938849
Atenolol	Terbutaline	0.117	-1.048	Moderate	204 (107/97)	Atenolol may decrease the bronchodilatory activities of Terbutaline.	#B4D1E6	27.9526339876625	1
Chlorpromazine	Galantamine	0.198	3.459	Moderate	5 (4/1)	The metabolism of Galantamine can be decreased when combined with Chlorpromazine.	#F4B1B1	0.685113578128982	1
Indomethacin	Atenolol	0.142	-1.718	Moderate	261 (105/156)	Indomethacin may decrease the antihypertensive activities of Atenolol.	#B1CFE5	35.7629287783329	1
Fluconazole	Diazepam	0.251	2.098	Moderate	209 (148/61)	The metabolism of Diazepam can be decreased when combined with Fluconazole.	#F7B7B7	28.6377475657915	1
Paroxetine	Rasagiline	0.31	1.308	Major	98 (59/39)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rasagiline.	#F9BCBC	13.4282261313281	1
Propranolol	Phenobarbital	0.341	1.047	Moderate	42 (23/19)	The metabolism of Propranolol can be increased when combined with Phenobarbital.	#F9BCBC	5.75495405628345	0.0506114062492522
Phenytoin	Acenocoumarol	0.363	-2.024	None	110 (40/70)	Phenytoin may increase the anticoagulant activities of Acenocoumarol.	#AFCEE4	15.0724987188376	1
Propranolol	Ergotamine	0.217	3.243	Moderate	38 (30/8)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#F5B2B2	5.20686319378026	1
Biperiden	Donepezil	0.306	1.153	Moderate	28 (16/12)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Donepezil.	#F9BCBC	3.8366360375223	0.000280595621715528
Carbamazepine	Sertraline	0.331	2.075	Moderate	85 (60/25)	The metabolism of Carbamazepine can be decreased when combined with Sertraline.	#F7B7B7	11.6469308281927	1
Enalapril	Lithium cation	0.261	1.171	Moderate	153 (88/65)	The serum concentration of Lithium can be increased when it is combined with Enalapril.	#F9BCBC	20.9644754907469	1
Carbamazepine	Acenocoumarol	0.35	-1.362	None	135 (62/73)	The serum concentration of Acenocoumarol can be decreased when it is combined with Carbamazepine.	#B2D0E5	18.4980666094825	1
Colestipol	Ursodeoxycholic acid	0.365	3.459	None	10 (8/2)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Colestipol.	#F4B1B1	1.37022715625796	0.135863209402597
Atenolol	Insulin detemir	0.288	-1.171	Moderate	161 (80/81)		#B4D1E6	22.0606572157532	1
Rivastigmine	Clomipramine	0.326	2.965	Moderate	31 (24/7)		#F5B4B4	4.24770418439969	1
Levothyroxine	Cholestyramine	0.208	4.439	Moderate	92 (77/15)	The serum concentration of Levothyroxine can be decreased when it is combined with Cholestyramine.	#F2ACAC	12.6060898375733	1
Cloxacillin	Acenocoumarol	0.08	-1.91	None	289 (109/180)	Cloxacillin may decrease the anticoagulant activities of Acenocoumarol.	#B1CFE5	39.5995648158552	1
Ezetimibe	Cholestyramine	0.254	-1.071	Moderate	52 (27/25)	Cholestyramine can cause a decrease in the absorption of Ezetimibe resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	7.12518121254142	1
Lovastatin	Diltiazem	0.429	-1.316	Major	124 (58/66)	The serum concentration of Lovastatin can be increased when it is combined with Diltiazem.	#B4D1E6	16.9908167375988	1
Metoprolol	Prazosin	0.613	Inf	Moderate	2 (2/0)	Metoprolol may increase the orthostatic hypotensive activities of Prazosin.	#B32020	0.274045431251593	1
Phenytoin	Oxcarbazepine	0.426	-1.322	Moderate	15 (7/8)	The serum concentration of the active metabolites of Oxcarbazepine can be reduced when Oxcarbazepine is used in combination with Phenytoin resulting in a loss in efficacy.	#B4D1E6	2.05534073438695	0.00186654055382003
Oxycodone	Paroxetine	0.218	2.83	Moderate	94 (72/22)	The metabolism of Oxycodone can be decreased when combined with Paroxetine.	#F5B4B4	12.8801352688249	1
Fluoxetine	Ergotamine	0.311	7.999	Major	41 (37/4)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluoxetine.	#EA9B9B	5.61793134065765	1
Rifabutin	Tacrolimus	0.218	1.729	None	3 (2/1)	The serum concentration of Tacrolimus can be decreased when it is combined with Rifabutin.	#F7B9B9	0.411068146877389	1
Ergotamine	Rizatriptan	0.185	1.057	Major	20 (11/9)	Ergotamine may increase the vasoconstricting activities of Rizatriptan.	#F9BCBC	2.74045431251593	1.2921513273225e-07
Methotrexate	Flurbiprofen	0.241	3.026	Major	9 (7/2)	The serum concentration of Methotrexate can be increased when it is combined with Flurbiprofen.	#F5B2B2	1.23320444063217	0.798275927141824
Propranolol	Salmeterol	0.247	-1.86	Major	240 (92/148)		#B1CFE5	32.8854517501911	1
Fluoxetine	Oxycodone	0.201	3.15	Moderate	65 (51/14)	The metabolism of Oxycodone can be decreased when combined with Fluoxetine.	#F5B2B2	8.90647651567677	1
Carvedilol	Insulin glulisine	0.245	-2.718	Moderate	67 (20/47)		#ACCCE3	9.18052194692836	4.22160789853531e-06
Sucralfate	Levothyroxine	0.185	4.648	Minor	102 (86/16)	The serum concentration of Levothyroxine can be decreased when it is combined with Sucralfate.	#F1ABAB	13.9763169938312	1
Ziprasidone	Pimozide	0.458	-1.156	Major	2 (1/1)	The serum concentration of Pimozide can be increased when it is combined with Ziprasidone.	#B4D1E6	0.274045431251593	0.987626060954619
Spironolactone	Telmisartan	0.287	-1.626	Major	154 (64/90)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Telmisartan.	#B2D0E5	21.1014982063727	1
Simvastatin	Fusidic acid	0.067	1.06	None	138 (76/62)	The serum concentration of Simvastatin can be increased when it is combined with Fusidic Acid.	#F9BCBC	18.9091347563599	1
Sumatriptan	Paroxetine	0.221	8.431	Major	43 (39/4)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Paroxetine.	#E99999	5.89197677190925	1
Nabumetone	Acenocoumarol	0.116	1.022	None	96 (52/44)	Nabumetone may increase the anticoagulant activities of Acenocoumarol.	#F9BCBC	13.1541807000765	1
Duloxetine	Rasagiline	0.435	1.038	Major	55 (30/25)	Rasagiline may increase the orthostatic hypotensive activities of Duloxetine.	#F9BCBC	7.5362493594188	1
Ciprofloxacin	Rasagiline	0.079	-2.094	Major	163 (58/105)		#AFCEE4	22.3347026470048	1
Donepezil	Methotrimeprazine	0.281	3.747	Moderate	16 (13/3)	The metabolism of Donepezil can be decreased when combined with Methotrimeprazine.	#F3AFAF	2.19236345001274	1
Propranolol	Maprotiline	0.337	5.188	Minor	21 (18/3)		#F0A9A9	2.87747702814173	1
Azathioprine	Acenocoumarol	0.372	-1.413	None	80 (36/44)	Azathioprine may decrease the anticoagulant activities of Acenocoumarol.	#B2D0E5	10.9618172500637	1
Atenolol	Diltiazem	0.311	-1.443	Major	245 (109/136)	Diltiazem may increase the hypotensive activities of Atenolol.	#B2D0E5	33.5705653283201	1
Erythromycin	Acenocoumarol	0.082	-1.063	None	142 (74/68)	The serum concentration of Acenocoumarol can be increased when it is combined with Erythromycin.	#B4D1E6	19.4572256188631	1
Phenytoin	Quetiapine	0.421	-2.249	Major	53 (18/35)	The serum concentration of Quetiapine can be decreased when it is combined with Phenytoin.	#AFCEE4	7.26220392816721	1.21636810750669e-05
Duloxetine	Nortriptyline	0.27	4.612	Major	19 (16/3)	Duloxetine may increase the serotonergic activities of Nortriptyline.	#F2ACAC	2.60343159689013	0.260462626232439
Naproxen	Acenocoumarol	0.107	-1.48	None	636 (279/357)	Naproxen may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	87.1464471380065	1
Spironolactone	Perindopril	0.416	-1.322	Major	60 (28/32)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Perindopril.	#B4D1E6	8.22136293754779	1
Methylprednisolone	Clarithromycin	0.44	1.508	Major	118 (75/43)	The serum concentration of Methylprednisolone can be increased when it is combined with Clarithromycin.	#F8BABA	16.168680443844	1
Lidocaine	Atenolol	0.11	1.835	Moderate	128 (87/41)	The serum concentration of Lidocaine can be increased when it is combined with Atenolol.	#F7B9B9	17.5389076001019	1
Warfarin	Ranitidine	0.242	-1.521	Moderate	125 (54/71)	The serum concentration of Warfarin can be increased when it is combined with Ranitidine.	#B2D0E5	17.1278394532246	1
Fluconazole	Clonazepam	0.179	2.224	None	75 (54/21)	The metabolism of Clonazepam can be decreased when combined with Fluconazole.	#F7B7B7	10.2767036719347	1
Citalopram	Zolmitriptan	0.199	3.93	Major	61 (50/11)	The risk or severity of adverse effects can be increased when Citalopram is combined with Zolmitriptan.	#F3AFAF	8.35838565317358	1
Paroxetine	Propafenone	0.285	3.193	Moderate	61 (48/13)	The serum concentration of Propafenone can be increased when it is combined with Paroxetine.	#F5B2B2	8.35838565317358	1
Zolmitriptan	Dihydroergotamine	0.337	2.882	Major	13 (10/3)	Dihydroergotamine may increase the vasoconstricting activities of Zolmitriptan.	#F5B4B4	1.78129530313535	0.036059129480631
Fluconazole	Amitriptyline	0.182	3.049	Moderate	86 (67/19)	Amitriptyline may increase the QTc-prolonging activities of Fluconazole.	#F5B2B2	11.7839535438185	1
Pravastatin	Gemfibrozil	0.27	-1.704	Major	188 (76/112)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Pravastatin.	#B1CFE5	25.7602705376497	1
Zolmitriptan	Fluoxetine	0.313	3.675	Major	42 (34/8)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fluoxetine.	#F3AFAF	5.75495405628345	1
Cyclosporine	Simvastatin	0.351	-1.9	Major	148 (56/92)	The serum concentration of Simvastatin can be increased when it is combined with Cyclosporine.	#B1CFE5	20.2793619126179	1
Cyclosporine	Amiodarone	0.252	-1.998	Moderate	30 (11/19)	The serum concentration of Cyclosporine can be increased when it is combined with Amiodarone.	#AFCEE4	4.11068146877389	0.0502112027073351
Lovastatin	Clarithromycin	0.082	2.057	Major	98 (69/29)	The serum concentration of Lovastatin can be increased when it is combined with Clarithromycin.	#F7B7B7	13.4282261313281	1
Phenytoin	Diazepam	0.279	-1.638	Moderate	116 (48/68)	The serum concentration of Phenytoin can be increased when it is combined with Diazepam.	#B2D0E5	15.8946350125924	1
Omeprazole	Ketoconazole	0.127	-1.431	Moderate	132 (59/73)	The serum concentration of Ketoconazole can be decreased when it is combined with Omeprazole.	#B2D0E5	18.0869984626051	1
Clarithromycin	Solifenacin	0.116	1.104	Major	148 (83/65)	The metabolism of Solifenacin can be decreased when combined with Clarithromycin.	#F9BCBC	20.2793619126179	1
Atorvastatin	Itraconazole	0.103	-1.575	Major	222 (94/128)	The risk or severity of adverse effects can be increased when Itraconazole is combined with Atorvastatin.	#B2D0E5	30.4190428689268	1
Zolmitriptan	Escitalopram	0.335	3.706	Major	37 (30/7)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Escitalopram.	#F3AFAF	5.06984047815447	1
Digoxin	Rabeprazole	0.258	-1.191	Moderate	136 (67/69)		#B4D1E6	18.6350893251083	1
Cyclosporine	Tacrolimus	0.105	1.153	Major	14 (8/6)	Tacrolimus may increase the nephrotoxic activities of Cyclosporine.	#F9BCBC	1.91831801876115	1
Ziprasidone	Donepezil	0.327	-1.388	Moderate	11 (5/6)	The metabolism of Donepezil can be decreased when combined with Ziprasidone.	#B2D0E5	1.50724987188376	8.89281775134001e-05
Imipramine	Duloxetine	0.16	2.594	Major	24 (18/6)	Duloxetine may increase the serotonergic activities of Imipramine.	#F6B6B6	3.28854517501911	0.849230390987812
Paroxetine	Rizatriptan	0.262	4.432	Major	49 (41/8)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rizatriptan.	#F2ACAC	6.71411306566403	1
Piroxicam	Alendronic acid	0.15	19.024	None	46 (44/2)	The risk or severity of adverse effects can be increased when Piroxicam is combined with Alendronic acid.	#D26767	6.30304491878664	1
Fludrocortisone	Acetylsalicylic acid	0.324	-1.628	Moderate	65 (27/38)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fludrocortisone.	#B2D0E5	8.90647651567677	1
Acarbose	Digoxin	0.262	1.017	Moderate	37 (20/17)	The serum concentration of Digoxin can be decreased when it is combined with Acarbose.	#F9BCBC	5.06984047815447	1
Fluvoxamine	Tramadol	0.226	2.95	Major	75 (58/17)	Fluvoxamine may increase the neuroexcitatory activities of Tramadol.	#F5B4B4	10.2767036719347	1
Phenytoin	Clozapine	0.195	Inf	Moderate	1 (1/0)	The serum concentration of Clozapine can be decreased when it is combined with Phenytoin.	#B32020	0.137022715625796	1
Glyburide	Glucosamine	0.273	-1.156	None	156 (78/78)		#B4D1E6	21.3755436376242	1
Warfarin	Paroxetine	0.279	1.67	Moderate	85 (56/29)	Paroxetine may increase the anticoagulant activities of Warfarin.	#F7B9B9	11.6469308281927	1
Gentamicin	Ceftriaxone	1	Inf	Moderate	1 (1/0)		#B32020	0.137022715625796	1
Erythromycin	Citalopram	0.117	3.047	Major	95 (74/21)	The metabolism of Citalopram can be decreased when combined with Erythromycin.	#F5B2B2	13.0171579844507	1
Phenytoin	Megestrol acetate	0.284	-1.301	Moderate	17 (8/9)		#B4D1E6	2.32938616563854	1
Ciprofloxacin	Iron	0.289	-1.652	Moderate	255 (105/150)		#B2D0E5	34.9407924845781	1
Warfarin	Levofloxacin	0.128	-2.268	Major	154 (52/102)	Levofloxacin may increase the anticoagulant activities of Warfarin.	#AFCEE4	21.1014982063727	1
Cyclosporine	Ciprofloxacin	0.089	-1.897	Moderate	66 (25/41)		#B1CFE5	9.04349923130257	1
Fluoxetine	Lithium cation	0.317	1.297	Major	40 (24/16)	Lithium may increase the serotonergic activities of Fluoxetine.	#F9BCBC	5.48090862503186	1
Phenytoin	Ciprofloxacin	0.11	-2.441	Moderate	112 (36/76)	The therapeutic efficacy of Phenytoin can be decreased when used in combination with Ciprofloxacin.	#AECDE3	15.3465441500892	1
Levofloxacin	Iron	0.278	-1.577	Moderate	208 (88/120)	The serum concentration of Levofloxacin can be decreased when it is combined with Iron.	#B2D0E5	28.5007248501657	1
Betamethasone	Acetylsalicylic acid	0.089	-1.173	Moderate	139 (69/70)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Betamethasone.	#B4D1E6	19.0461574719857	1
Venlafaxine	Propafenone	0.348	4.324	Moderate	36 (30/6)	The serum concentration of Venlafaxine can be increased when it is combined with Propafenone.	#F2ACAC	4.93281776252867	1
Bisoprolol	Verapamil	0.237	-1.388	Major	176 (80/96)	The metabolism of Bisoprolol can be decreased when combined with Verapamil.	#B2D0E5	24.1159979501402	1
Almotriptan	Sertraline	0.283	3.335	Major	34 (27/7)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Sertraline.	#F4B1B1	4.65877233127708	1
Fluoxetine	Carbamazepine	0.388	1.391	Moderate	60 (37/23)	The metabolism of Carbamazepine can be decreased when combined with Fluoxetine.	#F8BABA	8.22136293754779	1
Repaglinide	Gemfibrozil	0.276	-2.155	Major	126 (44/82)	The serum concentration of Repaglinide can be increased when it is combined with Gemfibrozil.	#AFCEE4	17.2648621688504	1
Clozapine	Flurazepam	0.375	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Flurazepam is combined with Clozapine.	#B32020	0.137022715625796	1
Phenytoin	Dexamethasone	0.437	-2.402	Moderate	40 (13/27)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenytoin.	#AECDE3	5.48090862503186	0.03024870223908
Acetaminophen	Isoniazid	0.195	-1.38	Moderate	136 (62/74)	The risk or severity of adverse effects can be increased when Isoniazid is combined with Acetaminophen.	#B2D0E5	18.6350893251083	1
Oxycodone	Escitalopram	0.272	2.054	Moderate	54 (38/16)	Oxycodone may increase the serotonergic activities of Escitalopram.	#F7B7B7	7.39922664379301	1
Erythromycin	Lincomycin	0.583	4.324	Moderate	6 (5/1)	The therapeutic efficacy of Erythromycin can be decreased when used in combination with Lincomycin.	#F2ACAC	0.822136293754779	1
Disopyramide	Sotalol	0.04	Inf	Major	1 (1/0)	Disopyramide may increase the bradycardic activities of Sotalol.	#B32020	0.137022715625796	1
Imipramine	Fluoxetine	0.468	2.018	Major	30 (21/9)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Imipramine.	#F7B7B7	4.11068146877389	1
Biperiden	Rivastigmine	0.249	-1.156	Moderate	22 (11/11)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Rivastigmine.	#B4D1E6	3.01449974376752	0.0973806777931965
Disopyramide	Atenolol	0.457	1.297	Major	10 (6/4)	Disopyramide may increase the bradycardic activities of Atenolol.	#F9BCBC	1.37022715625796	0.0964143398296838
Haloperidol	Carbamazepine	0.351	-1.735	Moderate	35 (14/21)	The metabolism of Haloperidol can be increased when combined with Carbamazepine.	#B1CFE5	4.79579504690288	0.0782851880517492
Phenytoin	Amiodarone	0.369	-1.239	Moderate	29 (14/15)	The serum concentration of Phenytoin can be increased when it is combined with Amiodarone.	#B4D1E6	3.9736587531481	1
Paroxetine	Almotriptan	0.212	3.135	Major	37 (29/8)	The metabolism of Almotriptan can be decreased when combined with Paroxetine.	#F5B2B2	5.06984047815447	1
Warfarin	Ibuprofen	0.157	-1.482	Major	292 (128/164)	Ibuprofen may increase the anticoagulant activities of Warfarin.	#B2D0E5	40.0106329627326	1
Enalapril	Rifampicin	0.136	-1.995	None	139 (51/88)	The metabolism of Enalapril can be increased when combined with Rifampicin.	#AFCEE4	19.0461574719857	1
Gliclazide	Glucosamine	0.236	1.031	None	182 (99/83)		#F9BCBC	24.938134243895	1
Metoprolol	Glyburide	0.305	-1.217	Moderate	39 (19/20)	Metoprolol may increase the hypoglycemic activities of Glyburide.	#B4D1E6	5.34388590940606	1
Digoxin	Clarithromycin	0.111	1.181	Major	123 (71/52)	The metabolism of Digoxin can be decreased when combined with Clarithromycin.	#F9BCBC	16.853794021973	1
Fluoxetine	Rizatriptan	0.287	4.669	Major	32 (27/5)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rizatriptan.	#F1ABAB	4.38472690002549	1
Indomethacin	Carvedilol	0.144	-2.065	Moderate	117 (42/75)	Indomethacin may decrease the antihypertensive activities of Carvedilol.	#AFCEE4	16.0316577282182	1
Clozapine	Clonazepam	0.363	2.594	Moderate	4 (3/1)	The risk or severity of adverse effects can be increased when Clonazepam is combined with Clozapine.	#F6B6B6	0.548090862503186	1
Sotalol	Ibuprofen	0.136	1.072	Moderate	112 (62/50)	Ibuprofen may decrease the antihypertensive activities of Sotalol.	#F9BCBC	15.3465441500892	1
Duloxetine	Flecainide	0.347	3.747	Moderate	48 (39/9)	The metabolism of Flecainide can be decreased when combined with Duloxetine.	#F3AFAF	6.57709035003823	1
Lansoprazole	Itraconazole	0.159	1.297	Moderate	80 (48/32)	The serum concentration of Itraconazole can be decreased when it is combined with Lansoprazole.	#F9BCBC	10.9618172500637	1
Erythromycin	Sertraline	0.099	3.286	Moderate	72 (57/15)	The risk or severity of adverse effects can be increased when Erythromycin is combined with Sertraline.	#F5B2B2	9.86563552505734	1
Chlorthalidone	Digoxin	0.268	1.231	Moderate	63 (37/26)	The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Digoxin.	#F9BCBC	8.63243108442518	1
Ranolazine	Simvastatin	0.381	-2.98	Major	186 (52/134)	The serum concentration of Simvastatin can be increased when it is combined with Ranolazine.	#ACCCE3	25.4862251063981	1
Cyclosporine	Sirolimus	0.248	-5.782	Moderate	6 (1/5)	The risk or severity of adverse effects can be increased when Sirolimus is combined with Cyclosporine.	#9FC1DD	0.822136293754779	0.000169318452431045
Cyclosporine	Fluoxetine	0.346	4.324	Moderate	18 (15/3)	The metabolism of Fluoxetine can be decreased when combined with Cyclosporine.	#F2ACAC	2.46640888126434	1
Phenylephrine	Nortriptyline	0.333	Inf	Major	1 (1/0)	Nortriptyline may increase the vasopressor activities of Phenylephrine.	#B32020	0.137022715625796	1
Tizanidine	Ethinylestradiol	1	Inf	Major	1 (1/0)		#B32020	0.137022715625796	1
Glimepiride	Pregabalin	0.22	-1.771	None	162 (64/98)	The risk or severity of heart failure can be increased when Pregabalin is combined with Glimepiride.	#B1CFE5	22.197679931379	1
Metoprolol	Gliclazide	0.311	-1.48	None	57 (25/32)	Metoprolol may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	7.8102947906704	1
Imipramine	Galantamine	0.296	4.324	Moderate	6 (5/1)	The metabolism of Galantamine can be decreased when combined with Imipramine.	#F2ACAC	0.822136293754779	1
Cyclosporine	Ezetimibe	0.352	-1.735	Moderate	25 (10/15)	The serum concentration of Cyclosporine can be increased when it is combined with Ezetimibe.	#B1CFE5	3.42556789064491	1
Phenytoin	Vigabatrin	0.508	-1.156	Minor	2 (1/1)	The serum concentration of Phenytoin can be decreased when it is combined with Vigabatrin.	#B4D1E6	0.274045431251593	1
Phenytoin	Gabapentin	0.326	-1.81	Moderate	59 (23/36)	The risk or severity of adverse effects can be increased when Gabapentin is combined with Phenytoin.	#B1CFE5	8.08434022192199	1
Tobramycin	Cefonicid	1	Inf	Moderate	1 (1/0)		#B32020	0.137022715625796	1
Atenolol	Ergotamine	0.229	2.45	Moderate	46 (34/12)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F6B6B6	6.30304491878664	1
Diltiazem	Propranolol	0.294	1.235	Major	85 (50/35)	The metabolism of Propranolol can be decreased when combined with Diltiazem.	#F9BCBC	11.6469308281927	1
Phenobarbital	Acenocoumarol	0.323	-1.779	None	66 (26/40)	The metabolism of Acenocoumarol can be increased when combined with Phenobarbital.	#B1CFE5	9.04349923130257	1
Fluconazole	Acenocoumarol	0.085	-1.364	None	146 (67/79)	The serum concentration of Acenocoumarol can be increased when it is combined with Fluconazole.	#B2D0E5	20.0053164813663	1
Trospium	Tolterodine	0.21	1.189	Moderate	19 (11/8)	The risk or severity of adverse effects can be increased when Trospium is combined with Tolterodine.	#F9BCBC	2.60343159689013	1
Furosemide	Gentamicin	0.125	-1.503	Major	46 (20/26)	The serum concentration of Gentamicin can be increased when it is combined with Furosemide.	#B2D0E5	6.30304491878664	1
Pimozide	Escitalopram	0.289	5.188	Major	7 (6/1)	The risk or severity of QTc prolongation can be increased when Pimozide is combined with Escitalopram.	#F0A9A9	0.959159009380575	1
Pregabalin	Pioglitazone	0.237	1.261	Moderate	59 (35/24)	The risk or severity of heart failure can be increased when Pregabalin is combined with Pioglitazone.	#F9BCBC	8.08434022192199	1
Fenofibrate	Fluvastatin	0.418	-2.034	Major	80 (29/51)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Fluvastatin.	#AFCEE4	10.9618172500637	1
Fluvoxamine	Lithium cation	0.366	2.162	Major	7 (5/2)	Lithium may increase the serotonergic activities of Fluvoxamine.	#F7B7B7	0.959159009380575	1
Diazepam	Itraconazole	0.222	1.82	Moderate	118 (80/38)	The metabolism of Diazepam can be decreased when combined with Itraconazole.	#F7B9B9	16.168680443844	1
Fluconazole	Lovastatin	0.105	5.534	Major	37 (32/5)	The serum concentration of Lovastatin can be increased when it is combined with Fluconazole.	#F0A7A7	5.06984047815447	1
Warfarin	Fenofibrate	0.351	-2.062	Major	64 (23/41)	Fenofibrate may increase the anticoagulant activities of Warfarin.	#AFCEE4	8.76945380005097	1
Dihydroergotamine	Fluoxetine	0.25	2.965	Major	31 (24/7)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluoxetine.	#F5B4B4	4.24770418439969	1
Theophylline	Clarithromycin	0.376	-1.81	Moderate	59 (23/36)	The metabolism of Theophylline can be decreased when combined with Clarithromycin.	#B1CFE5	8.08434022192199	1
Ergotamine	Almotriptan	0.227	1.297	Major	10 (6/4)	Ergotamine may increase the vasoconstricting activities of Almotriptan.	#F9BCBC	1.37022715625796	0.0271414167935063
Terbutaline	Carvedilol	0.111	-1.631	Major	94 (39/55)	Carvedilol may decrease the vasoconstricting activities of Terbutaline.	#B2D0E5	12.8801352688249	1
Amitriptyline	Terbutaline	0.17	3.963	Moderate	67 (55/12)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Terbutaline.	#F3AFAF	9.18052194692836	1
Metronidazole	Acenocoumarol	0.095	-1.767	None	182 (72/110)	The serum concentration of Acenocoumarol can be increased when it is combined with Metronidazole.	#B1CFE5	24.938134243895	1
Hydrochlorothiazide	Lithium cation	0.218	1.351	Major	82 (50/32)	Hydrochlorothiazide may decrease the excretion rate of Lithium which could result in a higher serum level.	#F8BABA	11.2358626813153	1
Dihydroergotamine	Propranolol	0.208	7.782	Moderate	20 (18/2)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#EB9C9C	2.74045431251593	1
Indomethacin	Propranolol	0.177	1.017	Moderate	74 (40/34)	Indomethacin may decrease the antihypertensive activities of Propranolol.	#F9BCBC	10.1396809563089	1
Moclobemide	Clomipramine	0.521	Inf	None	2 (2/0)	Moclobemide may increase the serotonergic activities of Clomipramine.	#B32020	0.274045431251593	1
Donepezil	Oxybutynin	0.261	1.057	Moderate	20 (11/9)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Donepezil.	#F9BCBC	2.74045431251593	1
Ciprofloxacin	Warfarin	0.155	-3.025	Major	188 (52/136)		#ABCBE2	25.7602705376497	1
Cyclosporine	Pravastatin	0.523	-2.776	Major	51 (15/36)	The serum concentration of Pravastatin can be increased when it is combined with Cyclosporine.	#ACCCE3	6.98815849691562	0.324246708798005
Bisoprolol	Ergotamine	0.257	2.794	Moderate	55 (42/13)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F5B4B4	7.5362493594188	1
Cyclosporine	Metoclopramide	0.092	-1.349	Moderate	39 (18/21)	Metoclopramide can cause an increase in the absorption of Cyclosporine resulting in an increased serum concentration and potentially a worsening of adverse effects.	#B2D0E5	5.34388590940606	1
Amitriptyline	Rasagiline	0.219	1.424	Major	45 (28/17)	Rasagiline may increase the serotonergic activities of Amitriptyline.	#F8BABA	6.16602220316084	1
Alendronic acid	Ketoprofen	0.159	25.941	Moderate	31 (30/1)	The risk or severity of adverse effects can be increased when Ketoprofen is combined with Alendronic acid.	#C44545	4.24770418439969	1
Alendronic acid	Flurbiprofen	0.206	14.7	Moderate	18 (17/1)	The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Alendronic acid.	#DC7B7B	2.46640888126434	1
Omeprazole	Quazepam	0.278	2.335	Moderate	37 (27/10)	The metabolism of Quazepam can be decreased when combined with Omeprazole.	#F6B6B6	5.06984047815447	1
Celecoxib	Acenocoumarol	0.108	-1.019	None	205 (109/96)	Celecoxib may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	28.0896567032883	1
Sertraline	Propafenone	0.229	2.516	Moderate	43 (32/11)	Sertraline may increase the QTc-prolonging activities of Propafenone.	#F6B6B6	5.89197677190925	1
Salbutamol	Rasagiline	0.181	-2.159	Moderate	129 (45/84)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Salbutamol.	#AFCEE4	17.6759303157277	1
Fluoxetine	Sumatriptan	0.324	4.324	Major	24 (20/4)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Sumatriptan.	#F2ACAC	3.28854517501911	1
Fluoxetine	Warfarin	0.323	1.783	Moderate	49 (33/16)	The metabolism of Warfarin can be decreased when combined with Fluoxetine.	#F7B9B9	6.71411306566403	1
Erythromycin	Diazepam	0.19	2.044	Moderate	111 (78/33)	The metabolism of Diazepam can be decreased when combined with Erythromycin.	#F7B7B7	15.2095214344634	1
Disopyramide	Omeprazole	0.404	1.556	None	28 (18/10)		#F8BABA	3.8366360375223	1
Trazodone	Ginkgo biloba	0.26	1.729	Moderate	54 (36/18)		#F7B9B9	7.39922664379301	1
Imipramine	Salbutamol	0.188	2.09	Moderate	41 (29/12)	The risk or severity of adverse effects can be increased when Imipramine is combined with Salbutamol.	#F7B7B7	5.61793134065765	1
Simvastatin	Rifampicin	0.119	-1.855	Major	125 (48/77)	The metabolism of Simvastatin can be increased when combined with Rifampicin.	#B1CFE5	17.1278394532246	1
Rizatriptan	Escitalopram	0.195	2.594	Major	28 (21/7)	The risk or severity of adverse effects can be increased when Rizatriptan is combined with Escitalopram.	#F6B6B6	3.8366360375223	1
Ibuprofen	Nadolol	0.192	1.061	Moderate	98 (54/44)	Ibuprofen may decrease the antihypertensive activities of Nadolol.	#F9BCBC	13.4282261313281	1
Sulfasalazine	Azathioprine	0.762	Inf	Moderate	3 (3/0)		#B32020	0.411068146877389	1
Fludrocortisone	Phenobarbital	0.43	Inf	Moderate	2 (2/0)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenobarbital.	#B32020	0.274045431251593	1
Sucralfate	Ibandronate	0.141	4.54	Moderate	25 (21/4)		#F2ACAC	3.42556789064491	1
Phenytoin	Topiramate	0.655	-1.322	Moderate	15 (7/8)	The serum concentration of Phenytoin can be increased when it is combined with Topiramate.	#B4D1E6	2.05534073438695	0.935596284513337
Spironolactone	Lisinopril	0.285	-1.973	Major	184 (68/116)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Lisinopril.	#B1CFE5	25.2121796751465	1
Galantamine	Tolterodine	0.343	-2.217	Moderate	35 (12/23)	The therapeutic efficacy of Tolterodine can be decreased when used in combination with Galantamine.	#AFCEE4	4.79579504690288	0.0705203374244591
Megestrol acetate	Phenobarbital	0.185	1.297	Moderate	10 (6/4)		#F9BCBC	1.37022715625796	1
Ranitidine	Itraconazole	0.261	1.216	Moderate	77 (45/32)	The serum concentration of Itraconazole can be decreased when it is combined with Ranitidine.	#F9BCBC	10.5507491031863	1
Diclofenac	Warfarin	0.142	-1.962	Major	178 (66/112)	Diclofenac may increase the anticoagulant activities of Warfarin.	#B1CFE5	24.3900433813918	1
Dihydroergotamine	Almotriptan	0.325	2.162	Major	7 (5/2)	Dihydroergotamine may increase the vasoconstricting activities of Almotriptan.	#F7B7B7	0.959159009380575	1
Erythromycin	Fluoxetine	0.105	3.747	Moderate	48 (39/9)	The metabolism of Fluoxetine can be decreased when combined with Erythromycin.	#F3AFAF	6.57709035003823	1
Phenytoin	Mirtazapine	0.442	1.081	Moderate	27 (15/12)	Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.	#F9BCBC	3.6996133218965	1
Amitriptyline	Rivastigmine	0.227	1.489	Moderate	49 (31/18)		#F8BABA	6.71411306566403	1
Phenytoin	Fludrocortisone	0.323	1.729	Moderate	3 (2/1)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenytoin.	#F7B9B9	0.411068146877389	1
Simvastatin	Ketoconazole	0.106	1.09	Major	52 (29/23)	The serum concentration of Simvastatin can be increased when it is combined with Ketoconazole.	#F9BCBC	7.12518121254142	1
Fluconazole	Tolterodine	0.161	2.421	Moderate	38 (28/10)	The metabolism of Tolterodine can be decreased when combined with Fluconazole.	#F6B6B6	5.20686319378026	1
Ziprasidone	Chlorpromazine	1	Inf	Major	1 (1/0)	Chlorpromazine may increase the QTc-prolonging activities of Ziprasidone.	#B32020	0.137022715625796	1
Metoprolol	Escitalopram	0.413	1.47	Minor	27 (17/10)	The serum concentration of Metoprolol can be increased when it is combined with Escitalopram.	#F8BABA	3.6996133218965	1
Galantamine	Solifenacin	0.386	-2.891	Moderate	49 (14/35)	The therapeutic efficacy of Solifenacin can be decreased when used in combination with Galantamine.	#ACCCE3	6.71411306566403	0.567536082724861
Pantoprazole	Itraconazole	0.133	-1.226	Moderate	103 (50/53)	The serum concentration of Itraconazole can be decreased when it is combined with Pantoprazole.	#B4D1E6	14.113339709457	1
Venlafaxine	Almotriptan	0.313	13.835	Major	17 (16/1)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Almotriptan.	#DE8080	2.32938616563854	1
Prednisone	Phenobarbital	0.194	-1.528	Moderate	65 (28/37)	The serum concentration of Prednisone can be decreased when it is combined with Phenobarbital.	#B2D0E5	8.90647651567677	1
Phenytoin	Prednisone	0.151	-1.595	Moderate	69 (29/40)	The serum concentration of Prednisone can be decreased when it is combined with Phenytoin.	#B2D0E5	9.45456737817995	1
Repaglinide	Clarithromycin	0.089	-1.178	Moderate	109 (54/55)	The serum concentration of Repaglinide can be increased when it is combined with Clarithromycin.	#B4D1E6	14.9354760032118	1
Fluconazole	Haloperidol	0.657	-1.973	Major	46 (17/29)	The metabolism of Haloperidol can be decreased when combined with Fluconazole.	#B1CFE5	6.30304491878664	1
Metoclopramide	Levodopa	0.128	1.131	Moderate	90 (51/39)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Metoclopramide.	#F9BCBC	12.3320444063217	1
Amitriptyline	Donepezil	0.274	2.516	Moderate	43 (32/11)		#F6B6B6	5.89197677190925	1
Haloperidol	Propranolol	0.27	-1.267	Moderate	44 (21/23)	The metabolism of Propranolol can be decreased when combined with Haloperidol.	#B4D1E6	6.02899948753504	1
Lidocaine	Propranolol	0.194	2.45	Moderate	46 (34/12)	The serum concentration of Lidocaine can be increased when it is combined with Propranolol.	#F6B6B6	6.30304491878664	1
Almotriptan	Escitalopram	0.282	4.324	Major	18 (15/3)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Escitalopram.	#F2ACAC	2.46640888126434	1
Cyclosporine	Ibuprofen	0.112	-1.474	Moderate	91 (40/51)	Ibuprofen may increase the nephrotoxic activities of Cyclosporine.	#B2D0E5	12.4690671219475	1
Citalopram	Sumatriptan	0.177	11.241	Major	28 (26/2)	The risk or severity of adverse effects can be increased when Citalopram is combined with Sumatriptan.	#E38D8D	3.8366360375223	1
Atenolol	Verapamil	0.301	-1.028	Major	85 (45/40)	Verapamil may increase the hypotensive activities of Atenolol.	#B4D1E6	11.6469308281927	1
Clonazepam	Itraconazole	0.209	2.28	None	40 (29/11)	The metabolism of Clonazepam can be decreased when combined with Itraconazole.	#F7B7B7	5.48090862503186	1
Fluoxetine	Propafenone	0.348	3.978	Moderate	28 (23/5)	Propafenone may increase the QTc-prolonging activities of Fluoxetine.	#F2AEAE	3.8366360375223	1
Citalopram	Metoprolol	0.354	2.498	Moderate	35 (26/9)	The serum concentration of Metoprolol can be increased when it is combined with Citalopram.	#F6B6B6	4.79579504690288	1
Itraconazole	Budesonide	0.255	-1.248	Major	131 (63/68)	The serum concentration of Budesonide can be increased when it is combined with Itraconazole.	#B4D1E6	17.9499757469793	1
Naproxen	Lithium cation	0.093	1.892	Major	51 (35/16)	The serum concentration of Lithium can be increased when it is combined with Naproxen.	#F7B9B9	6.98815849691562	1
Phenytoin	Sertraline	0.409	-1.872	Moderate	55 (21/34)	The serum concentration of Phenytoin can be increased when it is combined with Sertraline.	#B1CFE5	7.5362493594188	1
Digoxin	Methotrexate	0.224	-1.334	Moderate	56 (26/30)	Digoxin may decrease the cardiotoxic activities of Methotrexate.	#B2D0E5	7.6732720750446	1
Theophylline	Carbamazepine	0.244	1.513	Moderate	11 (7/4)	The serum concentration of Theophylline can be decreased when it is combined with Carbamazepine.	#F8BABA	1.50724987188376	1
Pioglitazone	Gemfibrozil	0.279	-2.159	Major	43 (15/28)	The metabolism of Pioglitazone can be decreased when combined with Gemfibrozil.	#AFCEE4	5.89197677190925	1
Ciprofloxacin	Sevelamer	0.186	-3.036	Moderate	58 (16/42)		#ABCBE2	7.94731750629619	1
Carbamazepine	Aripiprazole	0.367	-1.156	Moderate	12 (6/6)	The serum concentration of Aripiprazole can be decreased when it is combined with Carbamazepine.	#B4D1E6	1.64427258750956	1
Doxycycline	Acenocoumarol	0.092	-1.156	None	62 (31/31)	The metabolism of Acenocoumarol can be decreased when combined with Doxycycline.	#B4D1E6	8.49540836879938	1
Fenofibrate	Ursodeoxycholic acid	0.341	1.153	None	35 (20/15)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Fenofibrate.	#F9BCBC	4.79579504690288	1
Acenocoumarol	Cholestyramine	0.18	-1.196	None	59 (29/30)	Cholestyramine can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	8.08434022192199	1
Metoprolol	Salbutamol	0.157	-1.515	Moderate	67 (29/38)	Metoprolol may decrease the bronchodilatory activities of Salbutamol.	#B2D0E5	9.18052194692836	1
Rosuvastatin	Gemfibrozil	0.258	-2.399	Major	83 (27/56)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Rosuvastatin.	#AECDE3	11.3728853969411	1
Doxycycline	Amoxicillin	0.435	-1.262	Moderate	161 (77/84)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Doxycycline.	#B4D1E6	22.0606572157532	1
Diltiazem	Tacrolimus	0.255	-2.024	Moderate	66 (24/42)	The metabolism of Tacrolimus can be decreased when combined with Diltiazem.	#AFCEE4	9.04349923130257	1
Methotrexate	Cloxacillin	0.058	2.075	Major	34 (24/10)	The serum concentration of Methotrexate can be increased when it is combined with Cloxacillin.	#F7B7B7	4.65877233127708	1
Tizanidine	Lisinopril	0.134	1.003	Major	54 (29/25)	Tizanidine may increase the hypotensive activities of Lisinopril.	#F9BCBC	7.39922664379301	1
Metoprolol	Paroxetine	0.302	1.421	Moderate	37 (23/14)	The serum concentration of Metoprolol can be increased when it is combined with Paroxetine.	#F8BABA	5.06984047815447	1
Atenolol	Glipizide	0.35	-1.765	Moderate	48 (19/29)	Atenolol may increase the hypoglycemic activities of Glipizide.	#B1CFE5	6.57709035003823	1
Propranolol	Hydralazine	0.354	1.853	Minor	22 (15/7)	Hydralazine may increase the hypotensive activities of Propranolol.	#F7B9B9	3.01449974376752	1
Atenolol	Piroxicam	0.173	2.882	Moderate	26 (20/6)	Piroxicam may decrease the antihypertensive activities of Atenolol.	#F5B4B4	3.56259060627071	1
Colestipol	Warfarin	0.304	1.729	Minor	6 (4/2)	Colestipol can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F7B9B9	0.822136293754779	1
Dihydroergotamine	Atenolol	0.23	1.887	Moderate	35 (24/11)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F7B9B9	4.79579504690288	1
Alprazolam	Ketoconazole	0.135	3.026	Major	18 (14/4)	The serum concentration of Alprazolam can be increased when it is combined with Ketoconazole.	#F5B2B2	2.46640888126434	1
Rifabutin	Warfarin	1	Inf	None	1 (1/0)	The metabolism of Warfarin can be increased when combined with Rifabutin.	#B32020	0.137022715625796	1
Sotalol	Gliclazide	0.286	-1.465	None	34 (15/19)	Sotalol may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	4.65877233127708	1
Atorvastatin	Fusidic acid	0.092	-1.295	None	53 (25/28)	The serum concentration of Atorvastatin can be increased when it is combined with Fusidic Acid.	#B4D1E6	7.26220392816721	1
Diazepam	Rifampicin	0.3	1.221	Minor	41 (24/17)	The metabolism of Diazepam can be increased when combined with Rifampicin.	#F9BCBC	5.61793134065765	1
Sotalol	Formoterol	0.174	-1.012	Major	30 (16/14)	Formoterol may increase the QTc-prolonging activities of Sotalol.	#B4D1E6	4.11068146877389	1
Propranolol	Glipizide	0.255	-1.051	Moderate	21 (11/10)	Propranolol may increase the hypoglycemic activities of Glipizide.	#B4D1E6	2.87747702814173	1
Trospium	Solifenacin	0.228	-1.388	Moderate	22 (10/12)	The risk or severity of adverse effects can be increased when Trospium is combined with Solifenacin.	#B2D0E5	3.01449974376752	1
Fluconazole	Tacrolimus	0.345	-1.156	Major	36 (18/18)	The serum concentration of Tacrolimus can be increased when it is combined with Fluconazole.	#B4D1E6	4.93281776252867	1
Fentanyl	Itraconazole	0.219	2.786	Major	38 (29/9)	The serum concentration of Fentanyl can be increased when it is combined with Itraconazole.	#F5B4B4	5.20686319378026	1
Norfloxacin	Iron	0.296	1.759	None	88 (59/29)	The serum concentration of Norfloxacin can be decreased when it is combined with Iron.	#F7B9B9	12.0579989750701	1
Erythromycin	Lovastatin	0.137	3.026	Major	27 (21/6)	The serum concentration of Lovastatin can be increased when it is combined with Erythromycin.	#F5B2B2	3.6996133218965	1
Erythromycin	Levofloxacin	0.539	1.199	Moderate	74 (43/31)	Erythromycin may increase the QTc-prolonging activities of Levofloxacin.	#F9BCBC	10.1396809563089	1
Celecoxib	Lithium cation	0.11	14.7	Major	18 (17/1)	The serum concentration of Lithium can be increased when it is combined with Celecoxib.	#DC7B7B	2.46640888126434	1
Warfarin	Fluvastatin	0.285	-1.487	Minor	32 (14/18)	The metabolism of Warfarin can be decreased when combined with Fluvastatin.	#B2D0E5	4.38472690002549	1
Clemastine	Galantamine	0.054	Inf	Moderate	2 (2/0)	The metabolism of Galantamine can be decreased when combined with Clemastine.	#B32020	0.274045431251593	1
Diclofenac	Lithium cation	0.156	1.783	Moderate	49 (33/16)	The serum concentration of Lithium can be increased when it is combined with Diclofenac.	#F7B9B9	6.71411306566403	1
Clozapine	Carbamazepine	0.194	Inf	Major	1 (1/0)	Carbamazepine may increase the myelosuppressive activities of Clozapine.	#B32020	0.137022715625796	1
Fluoxetine	Rasagiline	0.27	-1.156	Major	42 (21/21)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rasagiline.	#B4D1E6	5.75495405628345	1
Prednisone	Rifampicin	0.24	-1.33	Moderate	43 (20/23)	The serum concentration of Prednisone can be decreased when it is combined with Rifampicin.	#B4D1E6	5.89197677190925	1
Fentanyl	Rifampicin	0.266	-1.051	Major	21 (11/10)	The serum concentration of Fentanyl can be decreased when it is combined with Rifampicin.	#B4D1E6	2.87747702814173	1
Erythromycin	Zafirlukast	0.166	1.297	Moderate	5 (3/2)	The serum concentration of Zafirlukast can be decreased when it is combined with Erythromycin.	#F9BCBC	0.685113578128982	1
Fluvoxamine	Mirtazapine	0.354	-1.349	Major	26 (12/14)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Mirtazapine.	#B2D0E5	3.56259060627071	1
Dexamethasone	Acenocoumarol	0.168	-2.287	None	131 (44/87)		#AFCEE4	17.9499757469793	1
Valproic acid	Nimodipine	0.242	1.297	Minor	15 (9/6)		#F9BCBC	2.05534073438695	1
Spironolactone	Quinapril	0.358	-1.59	Major	38 (16/22)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Quinapril.	#B2D0E5	5.20686319378026	1
Prazosin	Verapamil	0.833	1.729	Moderate	3 (2/1)	The risk or severity of hypotension can be increased when Prazosin is combined with Verapamil.	#F7B9B9	0.411068146877389	1
Clomipramine	Rasagiline	0.349	1.729	Major	15 (10/5)	Rasagiline may increase the serotonergic activities of Clomipramine.	#F7B9B9	2.05534073438695	1
Fluoxetine	Doxepin	0.504	5.188	Major	7 (6/1)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Doxepin.	#F0A9A9	0.959159009380575	1
Digoxin	Indapamide	0.295	-1.606	Moderate	86 (36/50)	The risk or severity of adverse effects can be increased when Indapamide is combined with Digoxin.	#B2D0E5	11.7839535438185	1
Propranolol	Terbutaline	0.132	-1.041	Major	57 (30/27)		#B4D1E6	7.8102947906704	1
Metoprolol	Salmeterol	0.272	-1.446	Moderate	36 (16/20)	Metoprolol may decrease the bronchodilatory activities of Salmeterol.	#B2D0E5	4.93281776252867	1
Cyclosporine	Azithromycin	0.1	-1.701	Moderate	42 (17/25)	The metabolism of Cyclosporine can be decreased when combined with Azithromycin.	#B1CFE5	5.75495405628345	1
Trazodone	Itraconazole	0.196	2.594	Moderate	32 (24/8)	The metabolism of Trazodone can be decreased when combined with Itraconazole.	#F6B6B6	4.38472690002549	1
Citalopram	Almotriptan	0.207	17.294	Major	21 (20/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Almotriptan.	#D66F6F	2.87747702814173	1
Spironolactone	Eplerenone	0.135	-6.518	Major	73 (11/62)	Eplerenone may increase the hyperkalemic activities of Spironolactone.	#9CBFDB	10.0026582406831	1
Clonidine	Bisoprolol	0.471	1.441	Major	8 (5/3)	Clonidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F8BABA	1.09618172500637	1
Indomethacin	Acenocoumarol	0.142	-2.148	None	140 (49/91)	Indomethacin may increase the anticoagulant activities of Acenocoumarol.	#AFCEE4	19.1831801876115	1
Rosuvastatin	Colchicine	0.176	-2.58	Moderate	42 (13/29)	Colchicine may increase the myopathic rhabdomyolysis activities of Rosuvastatin.	#AECDE3	5.75495405628345	1
Trospium	Rivastigmine	0.237	-1.619	Moderate	12 (5/7)	The therapeutic efficacy of Trospium can be decreased when used in combination with Rivastigmine.	#B2D0E5	1.64427258750956	0.492060593602807
Nabumetone	Warfarin	0.141	1.946	Major	13 (9/4)	Nabumetone may increase the anticoagulant activities of Warfarin.	#F7B9B9	1.78129530313535	1
Metoprolol	Propafenone	0.384	2.162	Moderate	7 (5/2)	The serum concentration of Metoprolol can be increased when it is combined with Propafenone.	#F7B7B7	0.959159009380575	1
Phenytoin	Hydrocortisone	0.257	-1.998	Moderate	30 (11/19)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenytoin.	#AFCEE4	4.11068146877389	1
Fluvoxamine	Acenocoumarol	0.338	1.415	None	29 (18/11)	The metabolism of Acenocoumarol can be decreased when combined with Fluvoxamine.	#F8BABA	3.9736587531481	1
Citalopram	Josamycin	0.073	7.782	None	20 (18/2)		#EB9C9C	2.74045431251593	1
Fluoxetine	Moclobemide	0.116	2.594	None	4 (3/1)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Moclobemide.	#F6B6B6	0.548090862503186	1
Fluvoxamine	Duloxetine	0.198	1.902	Major	16 (11/5)	The serum concentration of Duloxetine can be increased when it is combined with Fluvoxamine.	#F7B9B9	2.19236345001274	1
Levofloxacin	Methotrimeprazine	0.207	-2.371	Moderate	61 (20/41)	Methotrimeprazine may increase the QTc-prolonging activities of Levofloxacin.	#AECDE3	8.35838565317358	1
Warfarin	Norfloxacin	0.098	1.976	Major	46 (32/14)	Norfloxacin may increase the anticoagulant activities of Warfarin.	#F7B9B9	6.30304491878664	1
Metoprolol	Fluoxetine	0.222	1.853	Moderate	22 (15/7)	The serum concentration of Metoprolol can be increased when it is combined with Fluoxetine.	#F7B9B9	3.01449974376752	1
Labetalol	Ibuprofen	0.153	4.035	Moderate	17 (14/3)	Ibuprofen may decrease the antihypertensive activities of Labetalol.	#F2AEAE	2.32938616563854	1
Erythromycin	Amiodarone	0.09	1.494	Major	30 (19/11)	Erythromycin may increase the QTc-prolonging activities of Amiodarone.	#F8BABA	4.11068146877389	1
Bupropion	Rasagiline	0.457	-3.007	Major	18 (5/13)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Bupropion.	#ABCBE2	2.46640888126434	0.0252946628935428
Tenoxicam	Alendronic acid	0.273	6.918	None	18 (16/2)	The risk or severity of adverse effects can be increased when Tenoxicam is combined with Alendronic acid.	#EDA1A1	2.46640888126434	1
Esomeprazole	Itraconazole	0.173	1.513	Moderate	44 (28/16)	The serum concentration of Itraconazole can be decreased when it is combined with Esomeprazole.	#F8BABA	6.02899948753504	1
Hydroxyzine	Donepezil	0.161	1.816	Moderate	31 (21/10)		#F7B9B9	4.24770418439969	1
Atorvastatin	Bezafibrate	0.345	-2.212	None	67 (23/44)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Atorvastatin.	#AFCEE4	9.18052194692836	1
Digoxin	Hydroxychloroquine	0.293	1.513	Moderate	22 (14/8)	The serum concentration of Digoxin can be increased when it is combined with Hydroxychloroquine.	#F8BABA	3.01449974376752	1
Colestipol	Levothyroxine	0.285	2.306	Moderate	22 (16/6)	The serum concentration of Levothyroxine can be decreased when it is combined with Colestipol.	#F7B7B7	3.01449974376752	1
Fluconazole	Rifampicin	0.759	1.009	Major	13 (7/6)	The metabolism of Rifampicin can be decreased when combined with Fluconazole.	#F9BCBC	1.78129530313535	1
Diclofenac	Rifampicin	0.351	-1.301	Moderate	51 (24/27)	The serum concentration of Diclofenac can be decreased when it is combined with Rifampicin.	#B4D1E6	6.98815849691562	1
Ropinirole	Ciprofloxacin	0.119	-1.86	Moderate	60 (23/37)	The serum concentration of Ropinirole can be increased when it is combined with Ciprofloxacin.	#B1CFE5	8.22136293754779	1
Cyclosporine	Methotrexate	0.263	-1.156	Moderate	10 (5/5)	The serum concentration of Methotrexate can be increased when it is combined with Cyclosporine.	#B4D1E6	1.37022715625796	1
Galantamine	Clomipramine	0.301	1.513	Moderate	11 (7/4)	The metabolism of Galantamine can be decreased when combined with Clomipramine.	#F8BABA	1.50724987188376	1
Itraconazole	Solifenacin	0.141	-1.051	Major	42 (22/20)	The metabolism of Solifenacin can be decreased when combined with Itraconazole.	#B4D1E6	5.75495405628345	1
Eletriptan	Venlafaxine	0.205	Inf	Major	5 (5/0)	The serum concentration of Eletriptan can be increased when it is combined with Venlafaxine.	#B32020	0.685113578128982	1
Ibandronate	Iron	0.132	4.179	Moderate	35 (29/6)		#F2AEAE	4.79579504690288	1
Fluconazole	Everolimus	0.279	1.297	Major	5 (3/2)	The serum concentration of Everolimus can be increased when it is combined with Fluconazole.	#F9BCBC	0.685113578128982	1
Trazodone	Warfarin	0.285	-1.522	Minor	44 (19/25)	Trazodone may decrease the anticoagulant activities of Warfarin.	#B2D0E5	6.02899948753504	1
Pyridostigmine	Fludrocortisone	0.275	-4.626	Moderate	5 (1/4)	The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Pyridostigmine.	#A5C6DF	0.685113578128982	0.0125284019759368
Repaglinide	Glipizide	0.246	-2.313	None	27 (9/18)	Repaglinide may increase the hypoglycemic activities of Glipizide.	#AFCEE4	3.6996133218965	1
Primidone	Acenocoumarol	0.23	-1.927	None	32 (12/20)	The metabolism of Acenocoumarol can be increased when combined with Primidone.	#B1CFE5	4.38472690002549	1
Amiodarone	Clarithromycin	0.14	-1.844	Major	96 (37/59)	Clarithromycin may increase the QTc-prolonging activities of Amiodarone.	#B1CFE5	13.1541807000765	1
Moxifloxacin	Amiodarone	0.19	-2.914	Major	88 (25/63)	Moxifloxacin may increase the QTc-prolonging activities of Amiodarone.	#ACCCE3	12.0579989750701	1
Fluvoxamine	Rizatriptan	0.067	3.459	Major	5 (4/1)	The metabolism of Rizatriptan can be decreased when combined with Fluvoxamine.	#F4B1B1	0.685113578128982	1
Fluoxetine	Almotriptan	0.22	2.248	Major	18 (13/5)	The metabolism of Almotriptan can be decreased when combined with Fluoxetine.	#F7B7B7	2.46640888126434	1
Carbamazepine	Verapamil	0.293	2.378	Major	15 (11/4)	The serum concentration of Carbamazepine can be increased when it is combined with Verapamil.	#F6B6B6	2.05534073438695	1
Losartan	Lithium cation	0.304	-1.203	Moderate	51 (25/26)	The serum concentration of Lithium can be increased when it is combined with Losartan.	#B4D1E6	6.98815849691562	1
Cyclosporine	Fluvastatin	0.506	1.081	Moderate	9 (5/4)	The serum concentration of Fluvastatin can be increased when it is combined with Cyclosporine.	#F9BCBC	1.23320444063217	1
Bisoprolol	Epinephrine	0.096	-1.33	Moderate	43 (20/23)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#B4D1E6	5.89197677190925	1
Midazolam	Itraconazole	0.214	6.053	Major	8 (7/1)	The serum concentration of Midazolam can be increased when it is combined with Itraconazole.	#EEA4A4	1.09618172500637	1
Theophylline	Ciprofloxacin	0.201	-5.099	Major	119 (22/97)		#A2C4DE	16.3057031594698	1
Primidone	Methylprednisolone	0.406	1.297	Moderate	10 (6/4)	The serum concentration of Methylprednisolone can be decreased when it is combined with Primidone.	#F9BCBC	1.37022715625796	1
Doxycycline	Methotrexate	0.15	2.162	Moderate	14 (10/4)		#F7B7B7	1.91831801876115	1
Clozapine	Donepezil	0.211	Inf	Moderate	1 (1/0)	The metabolism of Donepezil can be decreased when combined with Clozapine.	#B32020	0.137022715625796	1
Rabeprazole	Itraconazole	0.155	2.162	Moderate	35 (25/10)	The serum concentration of Itraconazole can be decreased when it is combined with Rabeprazole.	#F7B7B7	4.79579504690288	1
Metoprolol	Repaglinide	0.349	-1.619	Moderate	24 (10/14)		#B2D0E5	3.28854517501911	1
Clonidine	Carvedilol	0.581	1.729	Major	3 (2/1)	Clonidine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#F7B9B9	0.411068146877389	1
Ramipril	Lithium cation	0.264	1.249	Moderate	22 (13/9)	The serum concentration of Lithium can be increased when it is combined with Ramipril.	#F9BCBC	3.01449974376752	1
Lidocaine	Carvedilol	0.114	-1.203	Moderate	51 (25/26)	The serum concentration of Lidocaine can be increased when it is combined with Carvedilol.	#B4D1E6	6.98815849691562	1
Atorvastatin	Josamycin	0.079	1.211	None	36 (21/15)	The risk or severity of adverse effects can be increased when Josamycin is combined with Atorvastatin.	#F9BCBC	4.93281776252867	1
Cyclosporine	Norfloxacin	0.2	1.153	Moderate	21 (12/9)	The metabolism of Cyclosporine can be decreased when combined with Norfloxacin.	#F9BCBC	2.87747702814173	1
Fluvoxamine	Almotriptan	0.158	Inf	Major	3 (3/0)	The metabolism of Almotriptan can be decreased when combined with Fluvoxamine.	#B32020	0.411068146877389	1
Dihydroergotamine	Sumatriptan	0.523	3.459	Major	5 (4/1)	Dihydroergotamine may increase the vasoconstricting activities of Sumatriptan.	#F4B1B1	0.685113578128982	1
Losartan	Rifampicin	0.123	-2.13	Moderate	54 (19/35)	The serum concentration of Losartan can be decreased when it is combined with Rifampicin.	#AFCEE4	7.39922664379301	1
Estradiol	Phenobarbital	0.031	Inf	Moderate	2 (2/0)	The metabolism of Estradiol can be increased when combined with Phenobarbital.	#B32020	0.274045431251593	1
Glyburide	Oxprenolol	0.403	2.594	None	4 (3/1)	Oxprenolol may increase the hypoglycemic activities of Glyburide.	#F6B6B6	0.548090862503186	1
Eletriptan	Sertraline	0.258	5.188	Major	7 (6/1)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Sertraline.	#F0A9A9	0.959159009380575	1
Diltiazem	Cilostazol	0.251	-7.372	Major	59 (8/51)	The serum concentration of Cilostazol can be increased when it is combined with Diltiazem.	#97BCD9	8.08434022192199	1
Paroxetine	Selegiline	0.347	-1.446	Major	18 (8/10)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Selegiline.	#B2D0E5	2.46640888126434	1
Warfarin	Hydrocortisone	0.14	1.131	Moderate	30 (17/13)	Hydrocortisone may increase the anticoagulant activities of Warfarin.	#F9BCBC	4.11068146877389	1
Citalopram	Pimozide	0.318	1.297	Major	10 (6/4)	The risk or severity of QTc prolongation can be increased when Citalopram is combined with Pimozide.	#F9BCBC	1.37022715625796	1
Ramipril	Tizanidine	0.15	1.197	Major	31 (18/13)	The risk or severity of hypotension can be increased when Tizanidine is combined with Ramipril.	#F9BCBC	4.24770418439969	1
Bisoprolol	Chlorpropamide	0.22	3.459	Moderate	5 (4/1)	Bisoprolol may increase the hypoglycemic activities of Chlorpropamide.	#F4B1B1	0.685113578128982	1
Alprazolam	Josamycin	0.081	4.107	None	23 (19/4)	The serum concentration of Alprazolam can be increased when it is combined with Josamycin.	#F2AEAE	3.15152245939332	1
Ergotamine	Carvedilol	0.256	5.188	Moderate	14 (12/2)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#F0A9A9	1.91831801876115	1
Ibuprofen	Oxprenolol	0.122	5.188	None	14 (12/2)	Ibuprofen may decrease the antihypertensive activities of Oxprenolol.	#F0A9A9	1.91831801876115	1
Rifampicin	Atorvastatin	0.135	-3.348	Major	74 (19/55)	The metabolism of Atorvastatin can be increased when combined with Rifampicin.	#A9C9E1	10.1396809563089	1
Acenocoumarol	Etoricoxib	0.108	-1.26	None	140 (67/73)	Etoricoxib may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	19.1831801876115	1
Moxifloxacin	Josamycin	0.625	Inf	None	8 (8/0)		#B32020	1.09618172500637	1
Fluvastatin	Gemfibrozil	0.348	-2.184	Major	52 (18/34)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Fluvastatin.	#AFCEE4	7.12518121254142	1
Diltiazem	Midazolam	0.372	-1.619	Moderate	24 (10/14)	The metabolism of Midazolam can be decreased when combined with Diltiazem.	#B2D0E5	3.28854517501911	1
Metoprolol	Formoterol	0.212	-1.229	Moderate	33 (16/17)	The metabolism of Formoterol can be decreased when combined with Metoprolol.	#B4D1E6	4.52174961565128	1
Phenytoin	Levodopa	0.368	-3.965	Moderate	31 (7/24)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Phenytoin.	#A8C8E1	4.24770418439969	1
Trospium	Amitriptyline	0.323	9.512	Moderate	12 (11/1)		#E79494	1.64427258750956	1
Imipramine	Rasagiline	0.434	Inf	Major	4 (4/0)	Rasagiline may increase the serotonergic activities of Imipramine.	#B32020	0.548090862503186	1
Ofloxacin	Acenocoumarol	0.087	-1.787	None	28 (11/17)		#B1CFE5	3.8366360375223	1
Phenytoin	Sucralfate	0.349	2.162	Moderate	7 (5/2)		#F7B7B7	0.959159009380575	1
Azithromycin	Warfarin	0.097	-1.703	Moderate	89 (36/53)	The metabolism of Warfarin can be decreased when combined with Azithromycin.	#B1CFE5	12.1950216906959	1
Sumatriptan	Escitalopram	0.253	2.075	Major	17 (12/5)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Escitalopram.	#F7B7B7	2.32938616563854	1
Disopyramide	Propranolol	0.565	1.729	Major	3 (2/1)	Disopyramide may increase the bradycardic activities of Propranolol.	#F7B9B9	0.411068146877389	1
Gemfibrozil	Ursodeoxycholic acid	0.33	-1.542	None	35 (15/20)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Gemfibrozil.	#B2D0E5	4.79579504690288	1
Rifabutin	Clarithromycin	0.491	1.729	Moderate	3 (2/1)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifabutin.	#F7B9B9	0.411068146877389	1
Conjugated estrogens	Ursodeoxycholic acid	0.161	Inf	None	1 (1/0)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Conjugated estrogens.	#B32020	0.137022715625796	1
Trospium	Quetiapine	0.193	-1.487	Moderate	16 (7/9)		#B2D0E5	2.19236345001274	1
Perphenazine	Rivastigmine	0.472	2.594	Moderate	4 (3/1)		#F6B6B6	0.548090862503186	1
Warfarin	Gemfibrozil	0.288	-1.735	Major	35 (14/21)	The metabolism of Warfarin can be decreased when combined with Gemfibrozil.	#B1CFE5	4.79579504690288	1
Galantamine	Pimozide	1	Inf	Moderate	1 (1/0)	Galantamine may increase the QTc-prolonging activities of Pimozide.	#B32020	0.137022715625796	1
Verapamil	Phenobarbital	0.392	1.297	Moderate	10 (6/4)	The metabolism of Verapamil can be increased when combined with Phenobarbital.	#F9BCBC	1.37022715625796	1
Terbinafine	Acenocoumarol	0.119	-1.569	None	66 (28/38)		#B2D0E5	9.04349923130257	1
Cyclosporine	Flurbiprofen	0.467	Inf	Moderate	1 (1/0)	Flurbiprofen may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.137022715625796	1
Hydrocortisone	Phenobarbital	0.196	-1.799	Moderate	23 (9/14)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenobarbital.	#B1CFE5	3.15152245939332	1
Fluconazole	Carbamazepine	0.072	5.188	Moderate	14 (12/2)	The serum concentration of Carbamazepine can be increased when it is combined with Fluconazole.	#F0A9A9	1.91831801876115	1
Spironolactone	Eprosartan	0.303	-2.056	Major	50 (18/32)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Eprosartan.	#AFCEE4	6.85113578128982	1
Carbamazepine	Oxybutynin	0.451	-1.156	None	12 (6/6)	The metabolism of Oxybutynin can be increased when combined with Carbamazepine.	#B4D1E6	1.64427258750956	1
Colestipol	Raloxifene	0.412	4.324	Moderate	6 (5/1)	Colestipol can cause a decrease in the absorption of Raloxifene resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F2ACAC	0.822136293754779	1
Cyclosporine	Repaglinide	0.352	-2.313	Major	18 (6/12)	The serum concentration of Repaglinide can be increased when it is combined with Cyclosporine.	#AFCEE4	2.46640888126434	1
Repaglinide	Glucosamine	0.236	-1.19	None	69 (34/35)		#B4D1E6	9.45456737817995	1
Verapamil	Colchicine	0.177	-4.754	Major	46 (9/37)	The serum concentration of Colchicine can be increased when it is combined with Verapamil.	#A3C5DF	6.30304491878664	1
Theophylline	Pentoxifylline	0.362	-3.614	Moderate	33 (8/25)	The serum concentration of Theophylline can be increased when it is combined with Pentoxifylline.	#A9C9E1	4.52174961565128	1
Pseudoephedrine	Bromocriptine	0.214	Inf	Moderate	1 (1/0)	Bromocriptine may increase the hypertensive and vasoconstricting activities of Pseudoephedrine.	#B32020	0.137022715625796	1
Fluvoxamine	Frovatriptan	0.077	Inf	Major	1 (1/0)	The metabolism of Frovatriptan can be decreased when combined with Fluvoxamine.	#B32020	0.137022715625796	1
Atenolol	Insulin glulisine	0.306	-1.234	Moderate	31 (15/16)		#B4D1E6	4.24770418439969	1
Erythromycin	Digoxin	0.132	1.264	Moderate	32 (19/13)	The metabolism of Digoxin can be decreased when combined with Erythromycin.	#F9BCBC	4.38472690002549	1
Venlafaxine	Frovatriptan	0.281	3.459	Major	5 (4/1)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Frovatriptan.	#F4B1B1	0.685113578128982	1
Nabumetone	Methotrexate	0.213	1.946	Major	13 (9/4)	The serum concentration of Methotrexate can be increased when it is combined with Nabumetone.	#F7B9B9	1.78129530313535	1
Dihydroergotamine	Nadolol	0.157	Inf	Moderate	3 (3/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#B32020	0.411068146877389	1
Glipizide	Carvedilol	0.341	-2.747	Moderate	27 (8/19)	Carvedilol may increase the hypoglycemic activities of Glipizide.	#ACCCE3	3.6996133218965	1
Metoprolol	Piroxicam	0.553	Inf	Moderate	3 (3/0)	Piroxicam may decrease the antihypertensive activities of Metoprolol.	#B32020	0.411068146877389	1
Dextromethorphan	Memantine	0.221	2.224	Minor	25 (18/7)	The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Memantine.	#F7B7B7	3.42556789064491	1
Sucralfate	Ciprofloxacin	0.458	-1.515	Moderate	67 (29/38)		#B2D0E5	9.18052194692836	1
Lovastatin	Tacrolimus	0.103	-1.074	Moderate	27 (14/13)	The serum concentration of Lovastatin can be increased when it is combined with Tacrolimus.	#B4D1E6	3.6996133218965	1
Trimipramine	Donepezil	0.5	Inf	Moderate	1 (1/0)		#B32020	0.137022715625796	1
Lovastatin	Gemfibrozil	0.347	-1.272	Major	42 (20/22)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Lovastatin.	#B4D1E6	5.75495405628345	1
Salbutamol	Doxepin	0.263	1.729	Moderate	12 (8/4)	The risk or severity of adverse effects can be increased when Doxepin is combined with Salbutamol.	#F7B9B9	1.64427258750956	1
Cyclosporine	Colchicine	0.108	-3.469	Major	12 (3/9)	The serum concentration of Colchicine can be increased when it is combined with Cyclosporine.	#A9C9E1	1.64427258750956	1
Metoprolol	Indomethacin	0.229	-1.879	Moderate	21 (8/13)	Indomethacin may decrease the antihypertensive activities of Metoprolol.	#B1CFE5	2.87747702814173	1
Sotalol	Levofloxacin	0.085	-1.69	Major	32 (13/19)	Levofloxacin may increase the QTc-prolonging activities of Sotalol.	#B1CFE5	4.38472690002549	1
Atenolol	Prazosin	0.297	1.729	Moderate	6 (4/2)	Atenolol may increase the orthostatic hypotensive activities of Prazosin.	#F7B9B9	0.822136293754779	1
Pravastatin	Colchicine	0.163	-7.06	Major	135 (19/116)	Colchicine may increase the myopathic rhabdomyolysis activities of Pravastatin.	#99BDDA	18.4980666094825	1
Salbutamol	Nadolol	0.156	-1.156	Major	34 (17/17)		#B4D1E6	4.65877233127708	1
Citalopram	Naratriptan	0.321	3.459	Major	5 (4/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Naratriptan.	#F4B1B1	0.685113578128982	1
Leflunomide	Acenocoumarol	0.34	-1.301	None	34 (16/18)	Leflunomide may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	4.65877233127708	1
Frovatriptan	Sertraline	0.129	Inf	Major	5 (5/0)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Sertraline.	#B32020	0.685113578128982	1
Cyclosporine	Clindamycin	0.124	5.188	Moderate	7 (6/1)	The metabolism of Clindamycin can be decreased when combined with Cyclosporine.	#F0A9A9	0.959159009380575	1
Phenytoin	Methotrexate	0.175	1.038	Moderate	11 (6/5)	The serum concentration of Phenytoin can be decreased when it is combined with Methotrexate.	#F9BCBC	1.50724987188376	1
Nifedipine	Phenobarbital	0.2	1.297	Major	10 (6/4)	The serum concentration of Nifedipine can be decreased when it is combined with Phenobarbital.	#F9BCBC	1.37022715625796	1
Phenytoin	Estriol	0.169	4.324	None	6 (5/1)		#F2ACAC	0.822136293754779	1
Triamcinolone	Acenocoumarol	0.166	-1.633	None	82 (34/48)		#B2D0E5	11.2358626813153	1
Ticlopidine	Carbamazepine	0.406	-1.735	Moderate	5 (2/3)	The metabolism of Ticlopidine can be increased when combined with Carbamazepine.	#B1CFE5	0.685113578128982	1
Paroxetine	Pimozide	0.312	4.324	Major	6 (5/1)	The serum concentration of Pimozide can be increased when it is combined with Paroxetine.	#F2ACAC	0.822136293754779	1
Nortriptyline	Rasagiline	0.343	2.594	Major	4 (3/1)	Rasagiline may increase the serotonergic activities of Nortriptyline.	#F6B6B6	0.548090862503186	1
Tolterodine	Itraconazole	0.101	1.441	Moderate	24 (15/9)	The serum concentration of Tolterodine can be increased when it is combined with Itraconazole.	#F8BABA	3.28854517501911	1
Metoprolol	Primidone	0.326	-1.156	Moderate	4 (2/2)	The serum concentration of Metoprolol can be decreased when it is combined with Primidone.	#B4D1E6	0.548090862503186	1
Verapamil	Carvedilol	0.265	-1.565	Major	40 (17/23)	The metabolism of Carvedilol can be decreased when combined with Verapamil.	#B2D0E5	5.48090862503186	1
Torasemide	Gentamicin	0.167	1.153	Major	14 (8/6)	The serum concentration of Gentamicin can be increased when it is combined with Torasemide.	#F9BCBC	1.91831801876115	1
Trospium	Loratadine	0.194	2.248	None	18 (13/5)		#F7B7B7	2.46640888126434	1
Dihydroergotamine	Rizatriptan	0.423	1.729	Major	6 (4/2)	Dihydroergotamine may increase the vasoconstricting activities of Rizatriptan.	#F7B9B9	0.822136293754779	1
Fluconazole	Cyclophosphamide	0.4	1.297	None	5 (3/2)	The metabolism of Cyclophosphamide can be decreased when combined with Fluconazole.	#F9BCBC	0.685113578128982	1
Theophylline	Lithium cation	0.365	-1.156	Moderate	6 (3/3)	The serum concentration of Lithium can be decreased when it is combined with Theophylline.	#B4D1E6	0.822136293754779	1
Warfarin	Pentoxifylline	0.272	-5.204	Moderate	66 (12/54)	Pentoxifylline may increase the anticoagulant activities of Warfarin.	#A2C4DE	9.04349923130257	1
Chlorpropamide	Acetylsalicylic acid	0.382	-1.156	None	10 (5/5)	Acetylsalicylic acid may increase the hypoglycemic activities of Chlorpropamide.	#B4D1E6	1.37022715625796	1
Trospium	Maprotiline	0.115	Inf	Moderate	2 (2/0)		#B32020	0.274045431251593	1
Trospium	Zuclopenthixol	0.3	Inf	None	1 (1/0)		#B32020	0.137022715625796	1
Lovastatin	Warfarin	0.264	-1.735	Moderate	30 (12/18)	The metabolism of Warfarin can be decreased when combined with Lovastatin.	#B1CFE5	4.11068146877389	1
Triamcinolone	Phenobarbital	0.05	2.594	Moderate	8 (6/2)	The metabolism of Triamcinolone can be increased when combined with Phenobarbital.	#F6B6B6	1.09618172500637	1
Citalopram	Eletriptan	0.486	2.594	Major	8 (6/2)	The risk or severity of adverse effects can be increased when Citalopram is combined with Eletriptan.	#F6B6B6	1.09618172500637	1
Lovastatin	Carbamazepine	0.36	-1.367	None	24 (11/13)	The metabolism of Lovastatin can be increased when combined with Carbamazepine.	#B2D0E5	3.28854517501911	1
Prednisone	Itraconazole	0.417	-1.532	Moderate	86 (37/49)	The serum concentration of Prednisone can be increased when it is combined with Itraconazole.	#B2D0E5	11.7839535438185	1
Phenytoin	Fluoxetine	0.367	-1.787	Moderate	28 (11/17)	The serum concentration of Phenytoin can be increased when it is combined with Fluoxetine.	#B1CFE5	3.8366360375223	1
Acetylsalicylic acid	Paramethasone	0.067	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Paramethasone.	#B32020	0.137022715625796	1
Galantamine	Methotrimeprazine	0.217	-3.855	Moderate	13 (3/10)	The metabolism of Galantamine can be decreased when combined with Methotrimeprazine.	#A8C8E1	1.78129530313535	0.025936118884128
Ergotamine	Itraconazole	0.104	1.513	Major	11 (7/4)	The serum concentration of Ergotamine can be increased when it is combined with Itraconazole.	#F8BABA	1.50724987188376	1
Valsartan	Lithium cation	0.198	-1.807	Moderate	41 (16/25)	The serum concentration of Lithium can be increased when it is combined with Valsartan.	#B1CFE5	5.61793134065765	1
Lithium cation	Etoricoxib	0.116	2.378	None	15 (11/4)	The serum concentration of Lithium can be increased when it is combined with Etoricoxib.	#F6B6B6	2.05534073438695	1
Phenytoin	Tacrolimus	0.332	1.081	Major	9 (5/4)	The serum concentration of Tacrolimus can be decreased when it is combined with Phenytoin.	#F9BCBC	1.23320444063217	1
Bumetanide	Ibuprofen	0.084	10.377	Moderate	13 (12/1)	The therapeutic efficacy of Bumetanide can be decreased when used in combination with Ibuprofen.	#E59090	1.78129530313535	1
Raloxifene	Cholestyramine	0.266	Inf	Moderate	10 (10/0)	Cholestyramine can cause a decrease in the absorption of Raloxifene resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	1.37022715625796	1
Sucralfate	Levofloxacin	0.36	-1.577	Moderate	52 (22/30)	The serum concentration of Levofloxacin can be decreased when it is combined with Sucralfate.	#B2D0E5	7.12518121254142	1
Tizanidine	Captopril	0.273	2.594	Major	12 (9/3)	The risk or severity of hypotension can be increased when Tizanidine is combined with Captopril.	#F6B6B6	1.64427258750956	1
Metoprolol	Lidocaine	0.15	Inf	Moderate	7 (7/0)	The serum concentration of Metoprolol can be increased when it is combined with Lidocaine.	#B32020	0.959159009380575	1
Propranolol	Isoprenaline	1	Inf	Moderate	1 (1/0)		#B32020	0.137022715625796	1
Paroxetine	Frovatriptan	0.559	2.162	None	7 (5/2)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Frovatriptan.	#F7B7B7	0.959159009380575	1
Fluvoxamine	Carbamazepine	0.416	-1.156	Moderate	8 (4/4)	The metabolism of Carbamazepine can be decreased when combined with Fluvoxamine.	#B4D1E6	1.09618172500637	1
Hydroxyzine	Galantamine	0.133	1.297	Moderate	15 (9/6)		#F9BCBC	2.05534073438695	1
Fluoxetine	Trimipramine	0.226	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Trimipramine.	#B32020	0.274045431251593	1
Fluoxetine	Josamycin	0.182	1.946	None	13 (9/4)		#F7B9B9	1.78129530313535	1
Glimepiride	Glucosamine	0.234	-1.06	None	46 (24/22)		#B4D1E6	6.30304491878664	1
Diltiazem	Buspirone	0.125	Inf	Moderate	1 (1/0)	The metabolism of Buspirone can be decreased when combined with Diltiazem.	#B32020	0.137022715625796	1
Ampicillin	Acenocoumarol	0.054	-1.927	None	16 (6/10)	Ampicillin may increase the anticoagulant activities of Acenocoumarol.	#B1CFE5	2.19236345001274	1
Erythromycin	Felodipine	0.287	4.324	Moderate	6 (5/1)	The metabolism of Felodipine can be decreased when combined with Erythromycin.	#F2ACAC	0.822136293754779	1
Fluconazole	Ergotamine	0.274	3.459	Moderate	10 (8/2)	The metabolism of Ergotamine can be decreased when combined with Fluconazole.	#F4B1B1	1.37022715625796	1
Meloxicam	Acenocoumarol	0.193	1.427	None	53 (33/20)	Meloxicam may increase the anticoagulant activities of Acenocoumarol.	#F8BABA	7.26220392816721	1
Midazolam	Clarithromycin	0.142	1.359	Moderate	18 (11/7)	The serum concentration of Midazolam can be increased when it is combined with Clarithromycin.	#F8BABA	2.46640888126434	1
Metoprolol	Sertraline	0.351	1.606	Moderate	20 (13/7)	The serum concentration of Metoprolol can be increased when it is combined with Sertraline.	#F8BABA	2.74045431251593	1
Hydroxyzine	Rivastigmine	0.203	1.101	Moderate	25 (14/11)		#F9BCBC	3.42556789064491	1
Dihydroergotamine	Bisoprolol	0.126	1.922	Moderate	29 (20/9)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F7B9B9	3.9736587531481	1
Nortriptyline	Carbamazepine	0.369	-1.156	Moderate	6 (3/3)	The metabolism of Nortriptyline can be increased when combined with Carbamazepine.	#B4D1E6	0.822136293754779	1
Nortriptyline	Terbutaline	0.176	1.081	Moderate	9 (5/4)	The risk or severity of adverse effects can be increased when Nortriptyline is combined with Terbutaline.	#F9BCBC	1.23320444063217	1
Carbamazepine	Midazolam	0.421	-1.156	Moderate	8 (4/4)	The metabolism of Midazolam can be increased when combined with Carbamazepine.	#B4D1E6	1.09618172500637	1
Fluvoxamine	Amitriptyline	0.264	4.324	Major	12 (10/2)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Amitriptyline.	#F2ACAC	1.64427258750956	1
Rifampicin	Amiodarone	0.308	-2.313	Major	15 (5/10)	The serum concentration of Amiodarone can be decreased when it is combined with Rifampicin.	#AFCEE4	2.05534073438695	1
Prednisone	Primidone	0.157	-2.208	Moderate	32 (11/21)	The serum concentration of Prednisone can be decreased when it is combined with Primidone.	#AFCEE4	4.38472690002549	1
Midazolam	Rifampicin	0.52	Inf	Minor	2 (2/0)	The metabolism of Midazolam can be increased when combined with Rifampicin.	#B32020	0.274045431251593	1
Fluconazole	Fluvastatin	0.116	1.124	Moderate	23 (13/10)	The serum concentration of Fluvastatin can be increased when it is combined with Fluconazole.	#F9BCBC	3.15152245939332	1
Sotalol	Clarithromycin	0.058	1.112	Major	16 (9/7)	Clarithromycin may increase the QTc-prolonging activities of Sotalol.	#F9BCBC	2.19236345001274	1
Medroxyprogesterone acetate	Acenocoumarol	0.119	3.459	None	5 (4/1)	Medroxyprogesterone acetate may decrease the anticoagulant activities of Acenocoumarol.	#F4B1B1	0.685113578128982	1
Itraconazole	Acenocoumarol	0.084	-2.002	None	71 (26/45)	The serum concentration of Acenocoumarol can be increased when it is combined with Itraconazole.	#AFCEE4	9.72861280943155	1
Repaglinide	Nadolol	0.277	1.038	Moderate	11 (6/5)		#F9BCBC	1.50724987188376	1
Warfarin	Phenobarbital	0.307	-1.446	Major	9 (4/5)	The metabolism of Warfarin can be increased when combined with Phenobarbital.	#B2D0E5	1.23320444063217	1
Verapamil	Midazolam	0.487	1.441	Moderate	8 (5/3)	The metabolism of Midazolam can be decreased when combined with Verapamil.	#F8BABA	1.09618172500637	1
Propranolol	Propafenone	0.244	-1.272	Moderate	21 (10/11)	The serum concentration of Propranolol can be increased when it is combined with Propafenone.	#B4D1E6	2.87747702814173	1
Diltiazem	Carbamazepine	0.404	-1.446	Major	27 (12/15)	The serum concentration of Carbamazepine can be increased when it is combined with Diltiazem.	#B2D0E5	3.6996133218965	1
Cyclosporine	Digoxin	0.184	-3.007	Moderate	18 (5/13)	The serum concentration of Digoxin can be increased when it is combined with Cyclosporine.	#ABCBE2	2.46640888126434	1
Pregabalin	Rosiglitazone	0.27	1.189	Moderate	19 (11/8)	The risk or severity of heart failure can be increased when Pregabalin is combined with Rosiglitazone.	#F9BCBC	2.60343159689013	1
Moxifloxacin	Warfarin	0.114	-3.373	Major	47 (12/35)		#A9C9E1	6.44006763441243	1
Risperidone	Itraconazole	0.113	1.189	None	19 (11/8)	The metabolism of Risperidone can be decreased when combined with Itraconazole.	#F9BCBC	2.60343159689013	1
Irbesartan	Lithium cation	0.326	1.153	Moderate	14 (8/6)	The serum concentration of Lithium can be increased when it is combined with Irbesartan.	#F9BCBC	1.91831801876115	1
Amitriptyline	Clonidine	0.75	Inf	Major	2 (2/0)	Amitriptyline may decrease the antihypertensive activities of Clonidine.	#B32020	0.274045431251593	1
Rifampicin	Leflunomide	0.152	-1.156	Major	4 (2/2)	The serum concentration of the active metabolites of Leflunomide can be increased when Leflunomide is used in combination with Rifampicin.	#B4D1E6	0.548090862503186	1
Duloxetine	Propafenone	0.253	8.647	Moderate	11 (10/1)	The serum concentration of Duloxetine can be increased when it is combined with Propafenone.	#E89898	1.50724987188376	1
Trospium	Clemastine	0.059	Inf	Moderate	1 (1/0)		#B32020	0.137022715625796	1
Digoxin	Josamycin	0.122	1.297	None	10 (6/4)	The serum concentration of Digoxin can be increased when it is combined with Josamycin.	#F9BCBC	1.37022715625796	1
Theophylline	Norfloxacin	0.296	1.249	Moderate	22 (13/9)	The metabolism of Theophylline can be decreased when combined with Norfloxacin.	#F9BCBC	3.01449974376752	1
Fluorouracil	Acenocoumarol	0.092	-1.487	None	16 (7/9)	The serum concentration of Acenocoumarol can be increased when it is combined with Fluorouracil.	#B2D0E5	2.19236345001274	1
Theophylline	Verapamil	0.331	-3.469	Moderate	20 (5/15)	The metabolism of Theophylline can be decreased when combined with Verapamil.	#A9C9E1	2.74045431251593	1
Cyclosporine	Sevelamer	0.368	-3.469	Moderate	4 (1/3)	The serum concentration of Cyclosporine can be decreased when it is combined with Sevelamer.	#A9C9E1	0.548090862503186	1
Naratriptan	Escitalopram	0.537	-1.156	Major	4 (2/2)	The risk or severity of adverse effects can be increased when Naratriptan is combined with Escitalopram.	#B4D1E6	0.548090862503186	1
Fluconazole	Celecoxib	0.262	1.801	Moderate	37 (25/12)	The metabolism of Celecoxib can be decreased when combined with Fluconazole.	#F7B9B9	5.06984047815447	1
Amitriptyline	Moclobemide	0.891	Inf	None	2 (2/0)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Moclobemide.	#B32020	0.274045431251593	1
Fluvoxamine	Selegiline	0.353	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Selegiline.	#B32020	0.137022715625796	1
Chlorpromazine	Levofloxacin	0.339	-1.927	Moderate	16 (6/10)	Chlorpromazine may increase the QTc-prolonging activities of Levofloxacin.	#B1CFE5	2.19236345001274	1
Cyclosporine	Diltiazem	0.348	-2.544	Moderate	16 (5/11)	The metabolism of Cyclosporine can be decreased when combined with Diltiazem.	#AECDE3	2.19236345001274	1
Clarithromycin	Quetiapine	0.164	-1.285	Major	57 (27/30)	The serum concentration of Quetiapine can be increased when it is combined with Clarithromycin.	#B4D1E6	7.8102947906704	1
Erythromycin	Methylprednisolone	0.49	-1.156	Moderate	26 (13/13)	The metabolism of Methylprednisolone can be decreased when combined with Erythromycin.	#B4D1E6	3.56259060627071	1
Pravastatin	Bezafibrate	0.475	-1.67	None	22 (9/13)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Pravastatin.	#B1CFE5	3.01449974376752	1
Digoxin	Telithromycin	0.578	1.729	Moderate	3 (2/1)	The metabolism of Digoxin can be decreased when combined with Telithromycin.	#F7B9B9	0.411068146877389	1
Fluvoxamine	Oxycodone	0.096	3.459	Moderate	5 (4/1)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Oxycodone.	#F4B1B1	0.685113578128982	1
Erythromycin	Verapamil	0.052	1.235	Major	17 (10/7)	The metabolism of Verapamil can be decreased when combined with Erythromycin.	#F9BCBC	2.32938616563854	1
Citalopram	Selegiline	0.369	-1.156	Major	12 (6/6)	The risk or severity of adverse effects can be increased when Citalopram is combined with Selegiline.	#B4D1E6	1.64427258750956	1
Pseudoephedrine	Clomipramine	0.06	Inf	None	8 (8/0)	Clomipramine may decrease the antihypertensive activities of Pseudoephedrine.	#B32020	1.09618172500637	1
Phenobarbital	Dexamethasone	0.231	-1.85	Moderate	13 (5/8)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenobarbital.	#B1CFE5	1.78129530313535	1
Erythromycin	Repaglinide	0.093	-1.156	Moderate	28 (14/14)	The serum concentration of Repaglinide can be increased when it is combined with Erythromycin.	#B4D1E6	3.8366360375223	1
Warfarin	Azathioprine	0.198	-2.024	Moderate	11 (4/7)	Azathioprine may decrease the anticoagulant activities of Warfarin.	#AFCEE4	1.50724987188376	1
Eletriptan	Dihydroergotamine	0.125	-1.156	Major	2 (1/1)	The serum concentration of Eletriptan can be increased when it is combined with Dihydroergotamine.	#B4D1E6	0.274045431251593	1
Colestipol	Acenocoumarol	0.167	-1.652	None	17 (7/10)	Colestipol can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B2D0E5	2.32938616563854	1
Ketoconazole	Tolterodine	0.093	2.594	Moderate	4 (3/1)	The serum concentration of Tolterodine can be increased when it is combined with Ketoconazole.	#F6B6B6	0.548090862503186	1
Piroxicam	Bisoprolol	0.154	1.441	Moderate	24 (15/9)	Piroxicam may decrease the antihypertensive activities of Bisoprolol.	#F8BABA	3.28854517501911	1
Carbamazepine	Metronidazole	0.247	-1.619	Moderate	24 (10/14)	The metabolism of Metronidazole can be increased when combined with Carbamazepine.	#B2D0E5	3.28854517501911	1
Metoprolol	Ergotamine	0.402	Inf	Moderate	3 (3/0)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#B32020	0.411068146877389	1
Ergotamine	Frovatriptan	0.5	Inf	Major	1 (1/0)	Ergotamine may increase the vasoconstricting activities of Frovatriptan.	#B32020	0.137022715625796	1
Dihydroergotamine	Nitroglycerin	0.195	1.359	Moderate	18 (11/7)	The bioavailability of Dihydroergotamine can be increased when combined with Nitroglycerin.	#F8BABA	2.46640888126434	1
Galantamine	Zuclopenthixol	0.15	Inf	None	1 (1/0)	Galantamine may increase the QTc-prolonging activities of Zuclopenthixol.	#B32020	0.137022715625796	1
Telmisartan	Lithium cation	0.27	-1.487	Moderate	16 (7/9)	The serum concentration of Lithium can be increased when it is combined with Telmisartan.	#B2D0E5	2.19236345001274	1
Lansoprazole	Ketoconazole	0.131	Inf	Moderate	5 (5/0)	The serum concentration of Ketoconazole can be decreased when it is combined with Lansoprazole.	#B32020	0.685113578128982	1
Venlafaxine	Naratriptan	0.149	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Naratriptan.	#B32020	0.274045431251593	1
Doxycycline	Cloxacillin	0.756	1.556	Moderate	14 (9/5)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Doxycycline.	#F8BABA	1.91831801876115	1
Salmeterol	Nadolol	0.277	-2.168	Major	23 (8/15)		#AFCEE4	3.15152245939332	1
Erythromycin	Ergotamine	0.285	1.297	Major	10 (6/4)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Erythromycin.	#F9BCBC	1.37022715625796	1
Clemastine	Donepezil	0.235	-1.156	Moderate	4 (2/2)	The metabolism of Donepezil can be decreased when combined with Clemastine.	#B4D1E6	0.548090862503186	1
Ergotamine	Clarithromycin	0.266	2.075	Major	17 (12/5)	The serum concentration of Ergotamine can be increased when it is combined with Clarithromycin.	#F7B7B7	2.32938616563854	1
Warfarin	Cholestyramine	0.226	-1.156	Moderate	10 (5/5)	Cholestyramine can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	1.37022715625796	1
Warfarin	Naproxen	0.144	1.441	Major	48 (30/18)	Naproxen may increase the anticoagulant activities of Warfarin.	#F8BABA	6.57709035003823	1
Ticlopidine	Theophylline	0.154	Inf	Moderate	1 (1/0)	The metabolism of Theophylline can be decreased when combined with Ticlopidine.	#B32020	0.137022715625796	1
Nortriptyline	Salbutamol	0.184	1.585	Moderate	17 (11/6)	The risk or severity of adverse effects can be increased when Nortriptyline is combined with Salbutamol.	#F8BABA	2.32938616563854	1
Methotrexate	Cholestyramine	0.195	1.038	None	11 (6/5)	Cholestyramine can cause a decrease in the absorption of Methotrexate resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F9BCBC	1.50724987188376	1
Morphine	Cimetidine	0.056	Inf	Moderate	1 (1/0)	The metabolism of Morphine can be decreased when combined with Cimetidine.	#B32020	0.137022715625796	1
Cyclosporine	Primidone	0.105	Inf	Moderate	1 (1/0)	The metabolism of Cyclosporine can be increased when combined with Primidone.	#B32020	0.137022715625796	1
Fluoxetine	Frovatriptan	0.173	Inf	Major	3 (3/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Frovatriptan.	#B32020	0.411068146877389	1
Prednisone	Estradiol	0.35	3.891	Moderate	11 (9/2)	The serum concentration of Prednisone can be increased when it is combined with Estradiol.	#F3AFAF	1.50724987188376	1
Theophylline	Propafenone	0.388	-1.927	Moderate	8 (3/5)	The serum concentration of Theophylline can be increased when it is combined with Propafenone.	#B1CFE5	1.09618172500637	1
Metronidazole	Lithium cation	0.052	2.594	Moderate	8 (6/2)		#F6B6B6	1.09618172500637	1
Cyclosporine	Verapamil	0.672	-1.156	Moderate	6 (3/3)	The metabolism of Cyclosporine can be decreased when combined with Verapamil.	#B4D1E6	0.822136293754779	1
Moxifloxacin	Iron	0.273	1.197	Moderate	31 (18/13)		#F9BCBC	4.24770418439969	1
Erythromycin	Cabergoline	0.131	1.729	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Cabergoline is combined with Erythromycin.	#F7B9B9	0.411068146877389	1
Thiethylperazine	Bromocriptine	0.125	Inf	Moderate	1 (1/0)		#B32020	0.137022715625796	1
Eletriptan	Ergotamine	0.21	-4.626	Major	5 (1/4)	Ergotamine may increase the vasoconstricting activities of Eletriptan.	#A5C6DF	0.685113578128982	0.0209283291629511
Imipramine	Ketoconazole	0.333	Inf	Moderate	1 (1/0)	The metabolism of Imipramine can be decreased when combined with Ketoconazole.	#B32020	0.137022715625796	1
Glyburide	Nadolol	0.348	-2.506	Moderate	19 (6/13)	Nadolol may increase the hypoglycemic activities of Glyburide.	#AECDE3	2.60343159689013	1
Amitriptyline	Galantamine	0.384	1.297	Moderate	15 (9/6)		#F9BCBC	2.05534073438695	1
Theophylline	Disulfiram	0.022	Inf	Moderate	1 (1/0)	The serum concentration of Theophylline can be increased when it is combined with Disulfiram.	#B32020	0.137022715625796	1
Prednisone	Estriol	0.215	20.753	None	25 (24/1)	The serum concentration of Prednisone can be increased when it is combined with Estriol.	#CF5F5F	3.42556789064491	1
Maprotiline	Rivastigmine	0.494	2.594	Moderate	4 (3/1)		#F6B6B6	0.548090862503186	1
Cimetidine	Propranolol	0.043	Inf	Moderate	2 (2/0)	The metabolism of Propranolol can be decreased when combined with Cimetidine.	#B32020	0.274045431251593	1
Erythromycin	Moxifloxacin	0.506	-1.245	Major	27 (13/14)	Erythromycin may increase the QTc-prolonging activities of Moxifloxacin.	#B4D1E6	3.6996133218965	1
Captopril	Lithium cation	0.172	1.081	Moderate	9 (5/4)	The serum concentration of Lithium can be increased when it is combined with Captopril.	#F9BCBC	1.23320444063217	1
Donepezil	Flavoxate	0.75	Inf	Moderate	1 (1/0)		#B32020	0.137022715625796	1
Imipramine	Carbamazepine	0.577	-1.156	Moderate	6 (3/3)	The metabolism of Imipramine can be increased when combined with Carbamazepine.	#B4D1E6	0.822136293754779	1
Quinapril	Lithium cation	0.229	-1.156	Moderate	6 (3/3)	The serum concentration of Lithium can be increased when it is combined with Quinapril.	#B4D1E6	0.822136293754779	1
Gliclazide	Nadolol	0.231	-1.879	None	21 (8/13)	Nadolol may increase the hypoglycemic activities of Gliclazide.	#B1CFE5	2.87747702814173	1
Citalopram	Clozapine	0.367	1.729	Major	3 (2/1)	The serum concentration of Clozapine can be increased when it is combined with Citalopram.	#F7B9B9	0.411068146877389	1
Trospium	Biperiden	0.355	-1.156	Moderate	4 (2/2)	The risk or severity of adverse effects can be increased when Biperiden is combined with Trospium.	#B4D1E6	0.548090862503186	1
Sucralfate	Norfloxacin	0.341	2.45	Moderate	23 (17/6)	The serum concentration of Norfloxacin can be decreased when it is combined with Sucralfate.	#F6B6B6	3.15152245939332	1
Warfarin	Clarithromycin	0.158	-1.465	Major	34 (15/19)	The metabolism of Warfarin can be decreased when combined with Clarithromycin.	#B2D0E5	4.65877233127708	1
Allopurinol	Mercaptopurine	0.248	-4.048	Major	9 (2/7)	The serum concentration of Mercaptopurine can be increased when it is combined with Allopurinol.	#A6C7E0	1.23320444063217	1
Minocycline	Acenocoumarol	0.101	-1.927	None	24 (9/15)	Minocycline may increase the anticoagulant activities of Acenocoumarol.	#B1CFE5	3.28854517501911	1
Dihydroergotamine	Isosorbide dinitrate	0.324	Inf	Moderate	1 (1/0)	The metabolism of Isosorbide Dinitrate can be decreased when combined with Dihydroergotamine.	#B32020	0.137022715625796	1
Levofloxacin	Josamycin	0.597	-1.413	None	20 (9/11)		#B2D0E5	2.74045431251593	1
Trospium	Donepezil	0.392	1.297	Moderate	5 (3/2)	The therapeutic efficacy of Trospium can be decreased when used in combination with Donepezil.	#F9BCBC	0.685113578128982	1
Propranolol	Rifampicin	0.286	-1.85	Moderate	13 (5/8)	The metabolism of Propranolol can be increased when combined with Rifampicin.	#B1CFE5	1.78129530313535	1
Rifampicin	Clarithromycin	0.686	-3.304	Moderate	27 (7/20)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifampicin.	#ABCBE2	3.6996133218965	1
Digoxin	Bumetanide	0.298	-2.313	Moderate	6 (2/4)	The risk or severity of adverse effects can be increased when Bumetanide is combined with Digoxin.	#AFCEE4	0.822136293754779	1
Atomoxetine	Fluoxetine	0.286	Inf	Major	1 (1/0)	The serum concentration of Atomoxetine can be increased when it is combined with Fluoxetine.	#B32020	0.137022715625796	1
Alprazolam	Telithromycin	0.161	1.729	Moderate	6 (4/2)	The serum concentration of Alprazolam can be increased when it is combined with Telithromycin.	#F7B9B9	0.822136293754779	1
Methotrexate	Sulfamethoxazole	0.245	-1.446	Moderate	18 (8/10)	The risk or severity of adverse effects can be increased when Sulfamethoxazole is combined with Methotrexate.	#B2D0E5	2.46640888126434	1
Piroxicam	Methotrexate	0.101	Inf	Major	4 (4/0)	The serum concentration of Methotrexate can be increased when it is combined with Piroxicam.	#B32020	0.548090862503186	1
Telithromycin	Acenocoumarol	0.278	Inf	None	3 (3/0)	The metabolism of Acenocoumarol can be decreased when combined with Telithromycin.	#B32020	0.411068146877389	1
Phenytoin	Midazolam	0.278	-2.891	Moderate	7 (2/5)	The serum concentration of Phenytoin can be increased when it is combined with Midazolam.	#ACCCE3	0.959159009380575	1
Minocycline	Amoxicillin	0.288	-1.735	Moderate	55 (22/33)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Minocycline.	#B1CFE5	7.5362493594188	1
Trimethoprim	Methotrexate	0.234	-1.285	Major	19 (9/10)	The risk or severity of adverse effects can be increased when Trimethoprim is combined with Methotrexate.	#B4D1E6	2.60343159689013	1
Methylprednisolone	Phenobarbital	0.131	1.441	Moderate	8 (5/3)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenobarbital.	#F8BABA	1.09618172500637	1
Theophylline	Phenobarbital	0.433	-2.891	Moderate	7 (2/5)	The metabolism of Theophylline can be increased when combined with Phenobarbital.	#ACCCE3	0.959159009380575	1
Fluvoxamine	Theophylline	0.176	1.729	Major	3 (2/1)	The metabolism of Theophylline can be decreased when combined with Fluvoxamine.	#F7B9B9	0.411068146877389	1
Warfarin	Isoniazid	0.182	1.729	Moderate	3 (2/1)	The metabolism of Warfarin can be decreased when combined with Isoniazid.	#F7B9B9	0.411068146877389	1
Terbutaline	Clomipramine	0.098	1.729	Moderate	15 (10/5)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Terbutaline.	#F7B9B9	2.05534073438695	1
Verapamil	Eplerenone	0.446	-3.758	Moderate	17 (4/13)	The serum concentration of Eplerenone can be increased when it is combined with Verapamil.	#A8C8E1	2.32938616563854	1
Tacrolimus	Metronidazole	0.2	-1.735	Moderate	25 (10/15)		#B1CFE5	3.42556789064491	1
Isoniazid	Acenocoumarol	0.227	-3.662	None	25 (6/19)	The metabolism of Acenocoumarol can be decreased when combined with Isoniazid.	#A8C8E1	3.42556789064491	1
Rivastigmine	Oxybutynin	0.323	-1.735	Moderate	10 (4/6)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Rivastigmine.	#B1CFE5	1.37022715625796	1
Miglitol	Glucosamine	0.227	-1.735	None	10 (4/6)		#B1CFE5	1.37022715625796	1
Spironolactone	Benazepril	0.571	-1.156	Major	4 (2/2)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Benazepril.	#B4D1E6	0.548090862503186	1
Erythromycin	Warfarin	0.133	1.009	Major	13 (7/6)	The serum concentration of Warfarin can be increased when it is combined with Erythromycin.	#F9BCBC	1.78129530313535	1
Trospium	Oxybutynin	0.344	-2.313	Moderate	6 (2/4)	The risk or severity of adverse effects can be increased when Trospium is combined with Oxybutynin.	#AFCEE4	0.822136293754779	1
Chlorpropamide	Repaglinide	0.315	-1.156	None	2 (1/1)	Chlorpropamide may increase the hypoglycemic activities of Repaglinide.	#B4D1E6	0.274045431251593	1
Phenytoin	Flurazepam	0.395	1.729	Moderate	3 (2/1)	The serum concentration of Phenytoin can be increased when it is combined with Flurazepam.	#F7B9B9	0.411068146877389	1
Donepezil	Perphenazine	0.176	Inf	Moderate	2 (2/0)		#B32020	0.274045431251593	1
Rifampicin	Acenocoumarol	0.222	-2.313	None	24 (8/16)	The metabolism of Acenocoumarol can be increased when combined with Rifampicin.	#AFCEE4	3.28854517501911	1
Propranolol	Verapamil	0.295	-1.446	Major	27 (12/15)	The metabolism of Propranolol can be decreased when combined with Verapamil.	#B2D0E5	3.6996133218965	1
Prednisolone	Acetylsalicylic acid	0.107	-1.156	Moderate	14 (7/7)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisolone.	#B4D1E6	1.91831801876115	1
Ergotamine	Nitroglycerin	0.18	1.235	Moderate	17 (10/7)	The bioavailability of Ergotamine can be increased when combined with Nitroglycerin.	#F9BCBC	2.32938616563854	1
Warfarin	Metronidazole	0.194	-1.285	Major	19 (9/10)	The serum concentration of Warfarin can be increased when it is combined with Metronidazole.	#B4D1E6	2.60343159689013	1
Phenytoin	Methylprednisolone	0.108	-1.388	Moderate	11 (5/6)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenytoin.	#B2D0E5	1.50724987188376	1
Omeprazole	Chlordiazepoxide	0.112	4.324	Moderate	6 (5/1)		#F2ACAC	0.822136293754779	1
Atenolol	Clonidine	0.332	-1.156	Major	4 (2/2)	Clonidine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#B4D1E6	0.548090862503186	1
Phenytoin	Theophylline	0.515	-2.313	Moderate	6 (2/4)	The serum concentration of Theophylline can be decreased when it is combined with Phenytoin.	#AFCEE4	0.822136293754779	1
Pioglitazone	Glucosamine	0.157	1.729	None	15 (10/5)		#F7B9B9	2.05534073438695	1
Trospium	Ipratropium	0.264	1.556	Moderate	14 (9/5)	The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Trospium.	#F8BABA	1.91831801876115	1
Methylprednisolone	Rifampicin	0.448	-2.024	Moderate	11 (4/7)	The serum concentration of Methylprednisolone can be decreased when it is combined with Rifampicin.	#AFCEE4	1.50724987188376	1
Fluoxetine	Cilostazol	0.252	-1.927	Moderate	16 (6/10)	The serum concentration of Cilostazol can be increased when it is combined with Fluoxetine.	#B1CFE5	2.19236345001274	1
Indomethacin	Lithium cation	0.203	2.162	Major	7 (5/2)	The serum concentration of Lithium can be increased when it is combined with Indomethacin.	#F7B7B7	0.959159009380575	1
Amitriptyline	Pseudoephedrine	0.121	3.026	None	18 (14/4)	Amitriptyline may decrease the antihypertensive activities of Pseudoephedrine.	#F5B2B2	2.46640888126434	1
Sucralfate	Ofloxacin	0.061	Inf	Moderate	2 (2/0)		#B32020	0.274045431251593	1
Galantamine	Ketoconazole	0.045	Inf	Moderate	1 (1/0)	The metabolism of Galantamine can be decreased when combined with Ketoconazole.	#B32020	0.137022715625796	1
Metronidazole	Phenobarbital	0.074	-1.85	Moderate	13 (5/8)	The serum concentration of Metronidazole can be decreased when it is combined with Phenobarbital.	#B1CFE5	1.78129530313535	1
Cyclobenzaprine	Rasagiline	0.132	1.384	Major	13 (8/5)	Cyclobenzaprine may increase the serotonergic activities of Rasagiline.	#F8BABA	1.78129530313535	1
Cyclosporine	Diclofenac	0.118	-1.787	Moderate	28 (11/17)	Diclofenac may increase the nephrotoxic activities of Cyclosporine.	#B1CFE5	3.8366360375223	1
Amitriptyline	Ketoconazole	0.144	3.459	Moderate	5 (4/1)	The metabolism of Amitriptyline can be decreased when combined with Ketoconazole.	#F4B1B1	0.685113578128982	1
Propranolol	Epinephrine	0.106	-1.156	Major	10 (5/5)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#B4D1E6	1.37022715625796	1
Ticlopidine	Acetylsalicylic acid	0.179	-3.758	Moderate	34 (8/26)	The risk or severity of adverse effects can be increased when Ticlopidine is combined with Acetylsalicylic acid.	#A8C8E1	4.65877233127708	1
Lovastatin	Josamycin	0.078	-1.156	None	8 (4/4)	The serum concentration of Lovastatin can be increased when it is combined with Josamycin.	#B4D1E6	1.09618172500637	1
Dextromethorphan	Rasagiline	0.057	-1.041	Major	19 (10/9)	Rasagiline may increase the serotonergic activities of Dextromethorphan.	#B4D1E6	2.60343159689013	1
Bisoprolol	Rifampicin	0.163	-4.626	Moderate	50 (10/40)	The metabolism of Bisoprolol can be increased when combined with Rifampicin.	#A5C6DF	6.85113578128982	1
Ergotamine	Nadolol	0.048	-2.313	Moderate	6 (2/4)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#AFCEE4	0.822136293754779	1
Erythromycin	Itraconazole	0.29	1.729	Major	12 (8/4)	The metabolism of Erythromycin can be decreased when combined with Itraconazole.	#F7B9B9	1.64427258750956	1
Trihexyphenidyl	Galantamine	0.241	-1.156	Moderate	2 (1/1)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Galantamine.	#B4D1E6	0.274045431251593	1
Fluvoxamine	Warfarin	0.122	2.594	Moderate	4 (3/1)	The metabolism of Warfarin can be decreased when combined with Fluvoxamine.	#F6B6B6	0.548090862503186	1
Rifabutin	Atorvastatin	0.198	1.729	Moderate	3 (2/1)	The metabolism of Atorvastatin can be increased when combined with Rifabutin.	#F7B9B9	0.411068146877389	1
Phenytoin	Trimethoprim	0.258	-1.735	Moderate	10 (4/6)	The serum concentration of Phenytoin can be increased when it is combined with Trimethoprim.	#B1CFE5	1.37022715625796	1
Methylphenidate	Rasagiline	0.33	-6.361	Moderate	13 (2/11)	Rasagiline may increase the hypertensive activities of Methylphenidate.	#9CBFDB	1.78129530313535	0.0608260001256486
Cyclosporine	Methylphenidate	0.92	Inf	Minor	1 (1/0)		#B32020	0.137022715625796	1
Cyclosporine	Rifampicin	0.037	Inf	Major	1 (1/0)	The metabolism of Cyclosporine can be increased when combined with Rifampicin.	#B32020	0.137022715625796	1
Cyclophosphamide	Acenocoumarol	0.2	-2.024	None	11 (4/7)		#AFCEE4	1.50724987188376	1
Ciprofloxacin	Tizanidine	0.184	-2.313	Major	48 (16/32)	Tizanidine may increase the QTc-prolonging activities of Ciprofloxacin.	#AFCEE4	6.57709035003823	1
Lovastatin	Bezafibrate	0.173	3.459	None	5 (4/1)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Lovastatin.	#F4B1B1	0.685113578128982	1
Lovastatin	Fenofibrate	0.285	-2.217	Major	35 (12/23)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Lovastatin.	#AFCEE4	4.79579504690288	1
Cyclosporine	Rosuvastatin	0.15	-2.698	Major	10 (3/7)	The serum concentration of Rosuvastatin can be increased when it is combined with Cyclosporine.	#ACCCE3	1.37022715625796	1
Pyridostigmine	Methylprednisolone	0.405	Inf	Moderate	3 (3/0)	The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Pyridostigmine.	#B32020	0.411068146877389	1
Celecoxib	Warfarin	0.138	3.747	Moderate	16 (13/3)	Celecoxib may increase the anticoagulant activities of Warfarin.	#F3AFAF	2.19236345001274	1
Verapamil	Oxprenolol	0.091	Inf	None	1 (1/0)	Verapamil may increase the hypotensive activities of Oxprenolol.	#B32020	0.137022715625796	1
Phenytoin	Warfarin	0.349	-3.084	Moderate	11 (3/8)	Phenytoin may increase the anticoagulant activities of Warfarin.	#ABCBE2	1.50724987188376	1
Terbutaline	Nadolol	0.247	3.459	Major	5 (4/1)		#F4B1B1	0.685113578128982	1
Ziprasidone	Amiodarone	0.046	Inf	Major	2 (2/0)	The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Amiodarone.	#B32020	0.274045431251593	1
Ketoconazole	Clonazepam	0.157	Inf	None	3 (3/0)	The metabolism of Clonazepam can be decreased when combined with Ketoconazole.	#B32020	0.411068146877389	1
Tacrolimus	Felodipine	0.091	-1.542	Moderate	7 (3/4)	The serum concentration of Tacrolimus can be increased when it is combined with Felodipine.	#B2D0E5	0.959159009380575	1
Cyclosporine	Glyburide	0.192	-1.735	Moderate	10 (4/6)	The therapeutic efficacy of Glyburide can be decreased when used in combination with Cyclosporine.	#B1CFE5	1.37022715625796	1
Piroxicam	Carvedilol	0.091	Inf	Moderate	5 (5/0)	Piroxicam may decrease the antihypertensive activities of Carvedilol.	#B32020	0.685113578128982	1
Pantoprazole	Ketoconazole	0.285	-2.313	Moderate	15 (5/10)	The serum concentration of Ketoconazole can be decreased when it is combined with Pantoprazole.	#AFCEE4	2.05534073438695	1
Cyclosporine	Fluconazole	0.281	-2.698	Moderate	10 (3/7)	The serum concentration of Cyclosporine can be increased when it is combined with Fluconazole.	#ACCCE3	1.37022715625796	1
Naratriptan	Sertraline	0.166	1.729	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Naratriptan is combined with Sertraline.	#F7B9B9	0.411068146877389	1
Doxycycline	Rifampicin	1	-1.735	Moderate	5 (2/3)	The serum concentration of Doxycycline can be decreased when it is combined with Rifampicin.	#B1CFE5	0.685113578128982	1
Donepezil	Clomipramine	0.354	-1.542	Moderate	14 (6/8)	The metabolism of Donepezil can be decreased when combined with Clomipramine.	#B2D0E5	1.91831801876115	1
Warfarin	Methimazole	0.321	-3.758	Moderate	17 (4/13)	Methimazole may decrease the anticoagulant activities of Warfarin.	#A8C8E1	2.32938616563854	1
Warfarin	Itraconazole	0.092	1.297	Moderate	10 (6/4)	The serum concentration of Warfarin can be increased when it is combined with Itraconazole.	#F9BCBC	1.37022715625796	1
Dextromethorphan	Selegiline	0.194	-1.156	Major	6 (3/3)	Selegiline may increase the serotonergic activities of Dextromethorphan.	#B4D1E6	0.822136293754779	1
Hydrocortisone	Cholestyramine	0.228	1.009	Moderate	13 (7/6)	Cholestyramine can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F9BCBC	1.78129530313535	1
Torasemide	Tobramycin	0.533	Inf	Major	2 (2/0)	The serum concentration of Tobramycin can be increased when it is combined with Torasemide.	#B32020	0.274045431251593	1
Trospium	Tiotropium	0.272	-2.891	Moderate	14 (4/10)	Trospium may increase the anticholinergic activities of Tiotropium.	#ACCCE3	1.91831801876115	1
Rosiglitazone	Gemfibrozil	0.268	-5.493	Moderate	23 (4/19)	The metabolism of Rosiglitazone can be decreased when combined with Gemfibrozil.	#A0C3DD	3.15152245939332	1
Piroxicam	Propranolol	0.281	1.081	Moderate	9 (5/4)	Piroxicam may decrease the antihypertensive activities of Propranolol.	#F9BCBC	1.23320444063217	1
Trospium	Desloratadine	0.14	Inf	None	4 (4/0)	The risk or severity of adverse effects can be increased when Trospium is combined with Desloratadine.	#B32020	0.548090862503186	1
Fluoxetine	Selegiline	0.384	-1.156	Major	6 (3/3)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Selegiline.	#B4D1E6	0.822136293754779	1
Colestipol	Hydrocortisone	0.187	-1.542	Moderate	7 (3/4)	Colestipol can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B2D0E5	0.959159009380575	1
Galantamine	Biperiden	0.195	-3.469	Moderate	8 (2/6)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Galantamine.	#A9C9E1	1.09618172500637	1
Galantamine	Perphenazine	0.333	Inf	Moderate	1 (1/0)		#B32020	0.137022715625796	1
Amitriptyline	Epinephrine	0.194	5.188	Major	7 (6/1)	Amitriptyline may decrease the antihypertensive activities of Epinephrine.	#F0A9A9	0.959159009380575	1
Morphine	Rifampicin	0.5	-1.735	Moderate	5 (2/3)	The serum concentration of Morphine can be decreased when it is combined with Rifampicin.	#B1CFE5	0.685113578128982	1
Rifampicin	Dexamethasone	0.365	-1.542	Moderate	7 (3/4)	The serum concentration of Dexamethasone can be decreased when it is combined with Rifampicin.	#B2D0E5	0.959159009380575	1
Spironolactone	Fosinopril	0.281	-1.388	Major	11 (5/6)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Fosinopril.	#B2D0E5	1.50724987188376	1
Dextropropoxyphene	Acenocoumarol	0.295	Inf	None	2 (2/0)		#B32020	0.274045431251593	1
Trospium	Cetirizine	0.21	6.918	None	9 (8/1)		#EDA1A1	1.23320444063217	1
Moxifloxacin	Sotalol	0.042	1.729	Major	6 (4/2)	Moxifloxacin may increase the QTc-prolonging activities of Sotalol.	#F7B9B9	0.822136293754779	1
Lovastatin	Colchicine	0.258	-3.469	Major	24 (6/18)	The serum concentration of Colchicine can be increased when it is combined with Lovastatin.	#A9C9E1	3.28854517501911	1
Carbamazepine	Clarithromycin	0.082	-1.472	Major	25 (11/14)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Carbamazepine.	#B2D0E5	3.42556789064491	1
Itraconazole	Quazepam	0.039	Inf	None	1 (1/0)	The metabolism of Quazepam can be decreased when combined with Itraconazole.	#B32020	0.137022715625796	1
Trospium	Risperidone	0.307	-1.927	Moderate	8 (3/5)		#B1CFE5	1.09618172500637	1
Nortriptyline	Rivastigmine	0.325	-1.156	Moderate	4 (2/2)		#B4D1E6	0.548090862503186	1
Felodipine	Itraconazole	0.033	-1.156	Major	6 (3/3)	The serum concentration of Felodipine can be increased when it is combined with Itraconazole.	#B4D1E6	0.822136293754779	1
Diltiazem	Rifampicin	0.284	-2.602	Major	13 (4/9)	The serum concentration of Diltiazem can be decreased when it is combined with Rifampicin.	#AECDE3	1.78129530313535	1
Lisinopril	Lithium cation	0.203	-1.446	Moderate	18 (8/10)	The serum concentration of Lithium can be increased when it is combined with Lisinopril.	#B2D0E5	2.46640888126434	1
Methylphenidate	Carbamazepine	0.251	-1.735	None	5 (2/3)		#B1CFE5	0.685113578128982	1
Dihydroergotamine	Clarithromycin	0.266	-1.301	Major	17 (8/9)	The serum concentration of Dihydroergotamine can be increased when it is combined with Clarithromycin.	#B4D1E6	2.32938616563854	1
Digoxin	Minocycline	0.086	-1.156	Moderate	8 (4/4)		#B4D1E6	1.09618172500637	1
Cyclosporine	Glipizide	0.722	-1.156	Moderate	2 (1/1)	The metabolism of Glipizide can be decreased when combined with Cyclosporine.	#B4D1E6	0.274045431251593	1
Metoprolol	Hydralazine	0.136	1.729	Minor	3 (2/1)	Hydralazine may increase the hypotensive activities of Metoprolol.	#F7B9B9	0.411068146877389	1
Phenytoin	Estradiol	0.1	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Estradiol can be decreased when used in combination with Phenytoin.	#B32020	0.137022715625796	1
Ranolazine	Amiodarone	0.272	-9.252	Major	27 (3/24)	The serum concentration of Ranolazine can be increased when it is combined with Amiodarone.	#90B6D6	3.6996133218965	1
Tacrolimus	Itraconazole	0.246	1.297	Major	10 (6/4)	The serum concentration of Tacrolimus can be increased when it is combined with Itraconazole.	#F9BCBC	1.37022715625796	1
Clozapine	Diazepam	0.25	1.729	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Diazepam is combined with Clozapine.	#F7B9B9	0.411068146877389	1
Tetracycline	Acenocoumarol	0.15	1.729	None	12 (8/4)		#F7B9B9	1.64427258750956	1
Cyclobenzaprine	Rivastigmine	0.21	3.459	Moderate	10 (8/2)		#F4B1B1	1.37022715625796	1
Mefenamic acid	Acenocoumarol	0.293	1.729	None	3 (2/1)	Mefenamic acid may increase the anticoagulant activities of Acenocoumarol.	#F7B9B9	0.411068146877389	1
Epinephrine	Carvedilol	0.088	-1.446	Major	9 (4/5)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#B2D0E5	1.23320444063217	1
Atenolol	Epinephrine	0.155	1.009	Moderate	13 (7/6)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F9BCBC	1.78129530313535	1
Ranolazine	Sotalol	0.191	-1.156	Major	2 (1/1)	Ranolazine may increase the QTc-prolonging activities of Sotalol.	#B4D1E6	0.274045431251593	1
Sertraline	Cilostazol	0.319	-5.204	Moderate	33 (6/27)	The serum concentration of Cilostazol can be increased when it is combined with Sertraline.	#A2C4DE	4.52174961565128	1
Metoprolol	Diltiazem	0.428	-2.082	Major	14 (5/9)	The serum concentration of Metoprolol can be increased when it is combined with Diltiazem.	#AFCEE4	1.91831801876115	1
Lovastatin	Itraconazole	0.131	-1.012	Major	15 (8/7)	The serum concentration of Lovastatin can be increased when it is combined with Itraconazole.	#B4D1E6	2.05534073438695	1
Lovastatin	Ketoconazole	0.084	-1.156	Major	4 (2/2)	The serum concentration of Lovastatin can be increased when it is combined with Ketoconazole.	#B4D1E6	0.548090862503186	1
Trospium	Haloperidol	0.26	Inf	Moderate	2 (2/0)		#B32020	0.274045431251593	1
Diazepam	Ketoconazole	0.221	1.297	Moderate	10 (6/4)	The metabolism of Diazepam can be decreased when combined with Ketoconazole.	#F9BCBC	1.37022715625796	1
Cimetidine	Nifedipine	0.2	Inf	Moderate	1 (1/0)	The serum concentration of Nifedipine can be increased when it is combined with Cimetidine.	#B32020	0.137022715625796	1
Digoxin	Cholestyramine	0.259	-1.927	Moderate	16 (6/10)	Cholestyramine can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B1CFE5	2.19236345001274	1
Cyclosporine	Phenobarbital	0.209	-2.313	Moderate	3 (1/2)	The metabolism of Cyclosporine can be increased when combined with Phenobarbital.	#AFCEE4	0.411068146877389	1
Ethinylestradiol	Acenocoumarol	0.036	Inf	None	1 (1/0)	Ethinyl Estradiol may decrease the anticoagulant activities of Acenocoumarol.	#B32020	0.137022715625796	1
Trospium	Fexofenadine	0.083	Inf	None	1 (1/0)		#B32020	0.137022715625796	1
Erythromycin	Carbamazepine	0.295	4.324	Major	6 (5/1)	The metabolism of Carbamazepine can be decreased when combined with Erythromycin.	#F2ACAC	0.822136293754779	1
Atomoxetine	Paroxetine	1	Inf	Major	1 (1/0)	The serum concentration of Atomoxetine can be increased when it is combined with Paroxetine.	#B32020	0.137022715625796	1
Prednisone	Ketoconazole	0.291	-6.014	Moderate	31 (5/26)	The serum concentration of Prednisone can be increased when it is combined with Ketoconazole.	#9DC0DC	4.24770418439969	1
Verapamil	Primidone	0.245	-1.735	Moderate	5 (2/3)	The metabolism of Verapamil can be increased when combined with Primidone.	#B1CFE5	0.685113578128982	1
Eletriptan	Escitalopram	0.311	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Escitalopram.	#B32020	0.274045431251593	1
Doxycycline	Phenobarbital	0.236	1.729	Moderate	3 (2/1)	The serum concentration of Doxycycline can be decreased when it is combined with Phenobarbital.	#F7B9B9	0.411068146877389	1
Folic acid	Primidone	0.223	-3.084	Moderate	11 (3/8)	The serum concentration of Primidone can be decreased when it is combined with Folic Acid.	#ABCBE2	1.50724987188376	1
Cyclosporine	Phenytoin	0.348	Inf	Moderate	1 (1/0)	The metabolism of Cyclosporine can be increased when combined with Phenytoin.	#B32020	0.137022715625796	1
Dextromethorphan	Terbinafine	0.396	2.882	Major	13 (10/3)	The metabolism of Dextromethorphan can be decreased when combined with Terbinafine.	#F5B4B4	1.78129530313535	1
Celecoxib	Rifampicin	0.106	4.324	Moderate	6 (5/1)	The metabolism of Celecoxib can be increased when combined with Rifampicin.	#F2ACAC	0.822136293754779	1
Ketoconazole	Pioglitazone	0.528	-1.156	Moderate	2 (1/1)	The metabolism of Pioglitazone can be decreased when combined with Ketoconazole.	#B4D1E6	0.274045431251593	1
Doxycycline	Insulin glulisine	0.194	1.729	Moderate	3 (2/1)		#F7B9B9	0.411068146877389	1
Salbutamol	Moclobemide	0.086	1.729	None	3 (2/1)	The risk or severity of adverse effects can be increased when Moclobemide is combined with Salbutamol.	#F7B9B9	0.411068146877389	1
Cilazapril	Lithium cation	0.087	Inf	None	1 (1/0)	The serum concentration of Lithium can be increased when it is combined with Cilazapril.	#B32020	0.137022715625796	1
Metoprolol	Verapamil	0.312	2.594	Major	4 (3/1)	The serum concentration of Metoprolol can be increased when it is combined with Verapamil.	#F6B6B6	0.548090862503186	1
Alprazolam	Cimetidine	0.286	2.594	Moderate	4 (3/1)		#F6B6B6	0.548090862503186	1
Terbinafine	Rifampicin	0.681	1.729	Minor	3 (2/1)	The serum concentration of Terbinafine can be decreased when it is combined with Rifampicin.	#F7B9B9	0.411068146877389	1
Doxycycline	Digoxin	0.107	-1.156	Moderate	12 (6/6)	The metabolism of Digoxin can be decreased when combined with Doxycycline.	#B4D1E6	1.64427258750956	1
Flurazepam	Itraconazole	0.069	1.297	None	5 (3/2)	The metabolism of Flurazepam can be decreased when combined with Itraconazole.	#F9BCBC	0.685113578128982	1
Chlorpropamide	Glucosamine	0.032	Inf	None	1 (1/0)		#B32020	0.137022715625796	1
Donepezil	Doxepin	0.059	Inf	Moderate	1 (1/0)		#B32020	0.137022715625796	1
Erythromycin	Eplerenone	0.047	-2.698	Moderate	10 (3/7)	The serum concentration of Eplerenone can be increased when it is combined with Erythromycin.	#ACCCE3	1.37022715625796	1
Mercaptopurine	Acenocoumarol	0.396	-2.891	None	7 (2/5)	Mercaptopurine may decrease the anticoagulant activities of Acenocoumarol.	#ACCCE3	0.959159009380575	1
Indomethacin	Oxprenolol	0.091	Inf	None	1 (1/0)	Indomethacin may decrease the antihypertensive activities of Oxprenolol.	#B32020	0.137022715625796	1
Carbamazepine	Felodipine	0.383	-1.156	Moderate	4 (2/2)	The metabolism of Felodipine can be increased when combined with Carbamazepine.	#B4D1E6	0.548090862503186	1
Fluvoxamine	Nortriptyline	0.17	-1.156	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Nortriptyline.	#B4D1E6	0.274045431251593	1
Terbutaline	Rasagiline	0.155	-2.313	Moderate	15 (5/10)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Terbutaline.	#AFCEE4	2.05534073438695	1
Cyclophosphamide	Warfarin	0.4	Inf	Moderate	1 (1/0)		#B32020	0.137022715625796	1
Indomethacin	Warfarin	0.17	-2.313	Major	18 (6/12)	Indomethacin may increase the anticoagulant activities of Warfarin.	#AFCEE4	2.46640888126434	1
Ketoconazole	Budesonide	0.408	-1.388	Major	11 (5/6)	The serum concentration of Budesonide can be increased when it is combined with Ketoconazole.	#B2D0E5	1.50724987188376	1
Cyclosporine	Clarithromycin	0.166	-2.024	Major	11 (4/7)	The metabolism of Cyclosporine can be decreased when combined with Clarithromycin.	#AFCEE4	1.50724987188376	1
Trandolapril	Tizanidine	0.258	-1.156	Major	4 (2/2)	The risk or severity of hypotension can be increased when Tizanidine is combined with Trandolapril.	#B4D1E6	0.548090862503186	1
Phenytoin	Triamcinolone	0.072	-1.156	Moderate	6 (3/3)	The metabolism of Triamcinolone can be increased when combined with Phenytoin.	#B4D1E6	0.822136293754779	1
Doxycycline	Carbamazepine	0.156	1.297	Moderate	5 (3/2)	The serum concentration of Doxycycline can be decreased when it is combined with Carbamazepine.	#F9BCBC	0.685113578128982	1
Ranolazine	Digoxin	0.261	-2.698	Moderate	10 (3/7)	The serum concentration of Digoxin can be increased when it is combined with Ranolazine.	#ACCCE3	1.37022715625796	1
Fluconazole	Imipramine	0.106	2.594	Moderate	4 (3/1)	The metabolism of Imipramine can be decreased when combined with Fluconazole.	#F6B6B6	0.548090862503186	1
Imipramine	Rivastigmine	0.123	Inf	Moderate	2 (2/0)		#B32020	0.274045431251593	1
Ketoconazole	Atorvastatin	0.135	-2.313	Major	15 (5/10)	The serum concentration of Atorvastatin can be increased when it is combined with Ketoconazole.	#AFCEE4	2.05534073438695	1
Prednisolone	Itraconazole	0.111	Inf	Moderate	1 (1/0)	The serum concentration of Prednisolone can be increased when it is combined with Itraconazole.	#B32020	0.137022715625796	1
Indomethacin	Labetalol	0.158	-2.313	Moderate	3 (1/2)	Indomethacin may decrease the antihypertensive activities of Labetalol.	#AFCEE4	0.411068146877389	1
Donepezil	Zuclopenthixol	0.18	Inf	None	1 (1/0)		#B32020	0.137022715625796	1
Capecitabine	Acenocoumarol	0.19	1.153	None	7 (4/3)	The serum concentration of Acenocoumarol can be increased when it is combined with Capecitabine.	#F9BCBC	0.959159009380575	1
Triamcinolone	Warfarin	0.177	-2.544	Moderate	16 (5/11)	Triamcinolone may increase the anticoagulant activities of Warfarin.	#AECDE3	2.19236345001274	1
Methylprednisolone	Itraconazole	0.361	-1.322	Major	15 (7/8)	The serum concentration of Methylprednisolone can be increased when it is combined with Itraconazole.	#B4D1E6	2.05534073438695	1
Moxifloxacin	Sucralfate	0.466	-1.542	Moderate	14 (6/8)		#B2D0E5	1.91831801876115	1
Prazosin	Carvedilol	0.044	-1.156	Moderate	2 (1/1)	Prazosin may increase the antihypertensive activities of Carvedilol.	#B4D1E6	0.274045431251593	1
Labetalol	Terbutaline	0.021	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Labetalol is combined with Terbutaline.	#B32020	0.137022715625796	1
Ranolazine	Verapamil	0.619	-1.156	Major	4 (2/2)	The serum concentration of Ranolazine can be increased when it is combined with Verapamil.	#B4D1E6	0.548090862503186	1
Fluvastatin	Colchicine	0.184	-6.071	Major	25 (4/21)	Colchicine may increase the myopathic rhabdomyolysis activities of Fluvastatin.	#9DC0DC	3.42556789064491	1
Chlorthalidone	Lithium cation	0.153	-1.156	Major	6 (3/3)	Chlorthalidone may decrease the excretion rate of Lithium which could result in a higher serum level.	#B4D1E6	0.822136293754779	1
Pimozide	Sertraline	0.212	-2.313	Major	6 (2/4)	Sertraline may increase the QTc-prolonging activities of Pimozide.	#AFCEE4	0.822136293754779	1
Fludrocortisone	Acenocoumarol	0.223	-3.855	None	13 (3/10)		#A8C8E1	1.78129530313535	1
Donepezil	Cyclobenzaprine	0.066	1.513	Moderate	11 (7/4)		#F8BABA	1.50724987188376	1
Felodipine	Josamycin	0.018	Inf	None	1 (1/0)		#B32020	0.137022715625796	1
Cyclosporine	Naproxen	0.134	-1.817	Moderate	18 (7/11)	Naproxen may increase the nephrotoxic activities of Cyclosporine.	#B1CFE5	2.46640888126434	1
Eletriptan	Clarithromycin	0.056	Inf	Major	2 (2/0)	The serum concentration of Eletriptan can be increased when it is combined with Clarithromycin.	#B32020	0.274045431251593	1
Warfarin	Cloxacillin	0.121	-1.735	Moderate	15 (6/9)	Cloxacillin may decrease the anticoagulant activities of Warfarin.	#B1CFE5	2.05534073438695	1
Sotalol	Repaglinide	0.311	-2.698	Moderate	10 (3/7)		#ACCCE3	1.37022715625796	1
Rifampicin	Etoricoxib	0.221	3.459	None	5 (4/1)	The metabolism of Etoricoxib can be increased when combined with Rifampicin.	#F4B1B1	0.685113578128982	1
Carbamazepine	Itraconazole	0.146	1.153	Moderate	7 (4/3)	The serum concentration of Itraconazole can be decreased when it is combined with Carbamazepine.	#F9BCBC	0.959159009380575	1
Trospium	Clomipramine	0.125	-1.156	Moderate	4 (2/2)		#B4D1E6	0.548090862503186	1
Cyclosporine	Glimepiride	0.172	-1.156	Moderate	4 (2/2)	The metabolism of Glimepiride can be decreased when combined with Cyclosporine.	#B4D1E6	0.548090862503186	1
Thiethylperazine	Levofloxacin	0.52	-1.446	None	36 (16/20)		#B2D0E5	4.93281776252867	1
Clozapine	Lisinopril	0.077	-1.156	Moderate	2 (1/1)	The risk or severity of adverse effects can be increased when Clozapine is combined with Lisinopril.	#B4D1E6	0.274045431251593	1
Clozapine	Sertraline	0.489	-2.313	Major	3 (1/2)	The serum concentration of Clozapine can be increased when it is combined with Sertraline.	#AFCEE4	0.411068146877389	1
Erythromycin	Quetiapine	0.074	-1.487	Major	16 (7/9)	The metabolism of Quetiapine can be decreased when combined with Erythromycin.	#B2D0E5	2.19236345001274	1
Chlorpromazine	Rivastigmine	0.152	-2.313	Moderate	3 (1/2)		#AFCEE4	0.411068146877389	1
Phenobarbital	Estriol	0.542	Inf	None	2 (2/0)		#B32020	0.274045431251593	1
Bisoprolol	Isoprenaline	0.45	Inf	Moderate	1 (1/0)	Bisoprolol may decrease the bronchodilatory activities of Isoprenaline.	#B32020	0.137022715625796	1
Diltiazem	Sirolimus	0.297	Inf	Moderate	1 (1/0)	The metabolism of Sirolimus can be decreased when combined with Diltiazem.	#B32020	0.137022715625796	1
Labetalol	Repaglinide	0.706	Inf	Moderate	1 (1/0)		#B32020	0.137022715625796	1
Lorazepam	Clozapine	0.41	-2.313	Major	6 (2/4)	The risk or severity of adverse effects can be increased when Lorazepam is combined with Clozapine.	#AFCEE4	0.822136293754779	1
Phenytoin	Clarithromycin	0.073	-3.932	Moderate	22 (5/17)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Phenytoin.	#A8C8E1	3.01449974376752	1
Haloperidol	Glycopyrronium	0.189	-2.891	Moderate	7 (2/5)	The serum concentration of Haloperidol can be decreased when it is combined with Glycopyrronium.	#ACCCE3	0.959159009380575	1
Clozapine	Norfloxacin	0.1	Inf	Major	1 (1/0)	Norfloxacin may increase the QTc-prolonging activities of Clozapine.	#B32020	0.137022715625796	1
Cyclosporine	Lovastatin	0.155	1.729	Major	3 (2/1)	The serum concentration of Lovastatin can be increased when it is combined with Cyclosporine.	#F7B9B9	0.411068146877389	1
Trihexyphenidyl	Rivastigmine	0.215	-5.782	Moderate	6 (1/5)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Rivastigmine.	#9FC1DD	0.822136293754779	1
Fluvoxamine	Imipramine	0.938	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Imipramine.	#B32020	0.137022715625796	1
Oxcarbazepine	Felodipine	0.056	Inf	Moderate	1 (1/0)		#B32020	0.137022715625796	1
Glyburide	Rifampicin	0.265	-2.698	Moderate	10 (3/7)	The serum concentration of Glyburide can be decreased when it is combined with Rifampicin.	#ACCCE3	1.37022715625796	1
Chlorpromazine	Donepezil	0.135	-2.313	Moderate	3 (1/2)	The metabolism of Donepezil can be decreased when combined with Chlorpromazine.	#AFCEE4	0.411068146877389	1
Galantamine	Maprotiline	0.031	-1.156	Moderate	2 (1/1)		#B4D1E6	0.274045431251593	1
Raloxifene	Estradiol	0.068	Inf	Moderate	2 (2/0)		#B32020	0.274045431251593	1
Prazosin	Bisoprolol	0.42	-2.313	Moderate	6 (2/4)	Bisoprolol may increase the orthostatic hypotensive activities of Prazosin.	#AFCEE4	0.822136293754779	1
Betamethasone	Acenocoumarol	0.119	1.009	None	13 (7/6)		#F9BCBC	1.78129530313535	1
Disopyramide	Clarithromycin	0.028	Inf	Major	1 (1/0)	Clarithromycin may increase the QTc-prolonging activities of Disopyramide.	#B32020	0.137022715625796	1
Warfarin	Leflunomide	0.324	1.729	Moderate	3 (2/1)	Leflunomide may increase the anticoagulant activities of Warfarin.	#F7B9B9	0.411068146877389	1
Cyclosporine	Indomethacin	0.238	-3.469	Moderate	8 (2/6)	Indomethacin may increase the nephrotoxic activities of Cyclosporine.	#A9C9E1	1.09618172500637	1
Theophylline	Josamycin	0.513	-1.156	None	2 (1/1)	The metabolism of Theophylline can be decreased when combined with Josamycin.	#B4D1E6	0.274045431251593	1
Clarithromycin	Colchicine	0.181	-2.313	Major	21 (7/14)	The serum concentration of Colchicine can be increased when it is combined with Clarithromycin.	#AFCEE4	2.87747702814173	1
Rifampicin	Gliclazide	0.165	-2.602	None	13 (4/9)	The serum concentration of Gliclazide can be decreased when it is combined with Rifampicin.	#AECDE3	1.78129530313535	1
Phenytoin	Felodipine	0.029	Inf	Major	1 (1/0)	The metabolism of Felodipine can be increased when combined with Phenytoin.	#B32020	0.137022715625796	1
Metoprolol	Terbutaline	0.037	-1.156	Moderate	6 (3/3)	Metoprolol may decrease the bronchodilatory activities of Terbutaline.	#B4D1E6	0.822136293754779	1
Verapamil	Triazolam	0.625	-1.156	Moderate	2 (1/1)	The metabolism of Triazolam can be decreased when combined with Verapamil.	#B4D1E6	0.274045431251593	1
Itraconazole	Aripiprazole	0.04	1.729	Moderate	3 (2/1)	The serum concentration of Aripiprazole can be increased when it is combined with Itraconazole.	#F7B9B9	0.411068146877389	1
Triazolam	Itraconazole	0.125	Inf	Major	1 (1/0)	The serum concentration of Triazolam can be increased when it is combined with Itraconazole.	#B32020	0.137022715625796	1
Trospium	Hydroxyzine	0.223	1.297	Moderate	5 (3/2)		#F9BCBC	0.685113578128982	1
Sotalol	Glyburide	0.424	-4.626	Moderate	15 (3/12)	Sotalol may increase the hypoglycemic activities of Glyburide.	#A5C6DF	2.05534073438695	1
Salbutamol	Oxprenolol	0.337	-1.735	None	5 (2/3)	Oxprenolol may decrease the bronchodilatory activities of Salbutamol.	#B1CFE5	0.685113578128982	1
Fluoxetine	Naratriptan	0.095	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Naratriptan.	#B32020	0.137022715625796	1
Atenolol	Chlorpropamide	0.398	-2.313	Moderate	3 (1/2)	Atenolol may increase the hypoglycemic activities of Chlorpropamide.	#AFCEE4	0.411068146877389	1
Trihexyphenidyl	Donepezil	0.083	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Donepezil.	#B32020	0.137022715625796	1
Glimepiride	Rifampicin	0.152	-1.156	Moderate	4 (2/2)	The serum concentration of Glimepiride can be decreased when it is combined with Rifampicin.	#B4D1E6	0.548090862503186	1
Cyproheptadine	Fluoxetine	0.333	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Cyproheptadine.	#B32020	0.137022715625796	1
Fluvastatin	Cholestyramine	0.198	-2.313	Moderate	9 (3/6)	The serum concentration of Fluvastatin can be decreased when it is combined with Cholestyramine.	#AFCEE4	1.23320444063217	1
Metoprolol	Glipizide	0.833	-1.156	Moderate	2 (1/1)	Metoprolol may increase the hypoglycemic activities of Glipizide.	#B4D1E6	0.274045431251593	1
Sulindac	Furosemide	0.111	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Sulindac.	#B32020	0.137022715625796	1
Cyclosporine	Nicardipine	0.293	-2.313	Moderate	3 (1/2)	The metabolism of Nicardipine can be decreased when combined with Cyclosporine.	#AFCEE4	0.411068146877389	1
Labetalol	Glyburide	0.095	Inf	Moderate	1 (1/0)	Labetalol may increase the hypoglycemic activities of Glyburide.	#B32020	0.137022715625796	1
Erythromycin	Triazolam	0.053	-1.156	Moderate	2 (1/1)	The serum concentration of Triazolam can be increased when it is combined with Erythromycin.	#B4D1E6	0.274045431251593	1
Metformin	Cimetidine	0.246	-3.855	Moderate	13 (3/10)	The serum concentration of Metformin can be increased when it is combined with Cimetidine.	#A8C8E1	1.78129530313535	1
Naltrexone	Fentanyl	0.018	Inf	Major	1 (1/0)	The therapeutic efficacy of Fentanyl can be decreased when used in combination with Naltrexone.	#B32020	0.137022715625796	1
Triazolam	Clarithromycin	0.108	Inf	Moderate	2 (2/0)	The serum concentration of Triazolam can be increased when it is combined with Clarithromycin.	#B32020	0.274045431251593	1
Itraconazole	Clarithromycin	0.478	-1.285	Moderate	19 (9/10)	The metabolism of Clarithromycin can be decreased when combined with Itraconazole.	#B4D1E6	2.60343159689013	1
Doxycycline	Insulin detemir	0.035	2.594	Moderate	4 (3/1)		#F6B6B6	0.548090862503186	1
Itraconazole	Phenobarbital	0.18	-1.156	Moderate	4 (2/2)	The serum concentration of Itraconazole can be decreased when it is combined with Phenobarbital.	#B4D1E6	0.548090862503186	1
Pyridostigmine	Hydrocortisone	0.174	-1.156	Moderate	4 (2/2)	The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Pyridostigmine.	#B4D1E6	0.548090862503186	1
Dihydroergotamine	Sotalol	0.3	Inf	Moderate	1 (1/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Sotalol.	#B32020	0.137022715625796	1
Metoprolol	Phenobarbital	0.202	-1.156	Moderate	2 (1/1)	The serum concentration of Metoprolol can be decreased when it is combined with Phenobarbital.	#B4D1E6	0.274045431251593	1
Eprosartan	Lithium cation	0.268	-1.735	Moderate	5 (2/3)	The serum concentration of Lithium can be increased when it is combined with Eprosartan.	#B1CFE5	0.685113578128982	1
Cyclosporine	Nabumetone	0.062	-1.156	Moderate	2 (1/1)	Nabumetone may increase the nephrotoxic activities of Cyclosporine.	#B4D1E6	0.274045431251593	1
Methotrexate	Tetracycline	0.035	Inf	Moderate	2 (2/0)		#B32020	0.274045431251593	1
Citalopram	Frovatriptan	0.268	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Citalopram is combined with Frovatriptan.	#B32020	0.274045431251593	1
Tizanidine	Perindopril	0.36	-1.735	Major	5 (2/3)	The risk or severity of hypotension can be increased when Tizanidine is combined with Perindopril.	#B1CFE5	0.685113578128982	1
Cimetidine	Clonazepam	0.333	Inf	Moderate	1 (1/0)		#B32020	0.137022715625796	1
Clozapine	Ciprofloxacin	0.147	-1.156	Major	2 (1/1)	Ciprofloxacin may increase the QTc-prolonging activities of Clozapine.	#B4D1E6	0.274045431251593	1
Tramadol	Moclobemide	0.087	Inf	None	2 (2/0)	Tramadol may increase the neuroexcitatory activities of Moclobemide.	#B32020	0.274045431251593	1
Hydrocortisone	Primidone	0.279	Inf	Moderate	2 (2/0)	The serum concentration of Hydrocortisone can be decreased when it is combined with Primidone.	#B32020	0.274045431251593	1
Trospium	Potassium chloride	0.229	-1.156	Major	2 (1/1)	Trospium may increase the ulcerogenic activities of Potassium Chloride.	#B4D1E6	0.274045431251593	1
Erythromycin	Colchicine	0.164	1.297	Major	5 (3/2)	The serum concentration of Colchicine can be increased when it is combined with Erythromycin.	#F9BCBC	0.685113578128982	1
Sumatriptan	Lithium cation	0.094	-1.156	None	2 (1/1)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Lithium.	#B4D1E6	0.274045431251593	1
Fluconazole	Warfarin	0.093	-2.024	Major	11 (4/7)	The serum concentration of Warfarin can be increased when it is combined with Fluconazole.	#AFCEE4	1.50724987188376	1
Dihydroergotamine	Isosorbide mononitrate	0.213	-1.735	Moderate	5 (2/3)	The metabolism of Isosorbide Mononitrate can be decreased when combined with Dihydroergotamine.	#B1CFE5	0.685113578128982	1
Tetracycline	Amoxicillin	0.477	1.482	Moderate	19 (12/7)		#F8BABA	2.60343159689013	1
Telithromycin	Atorvastatin	0.203	1.729	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Telithromycin is combined with Atorvastatin.	#F7B9B9	0.411068146877389	1
Theophylline	Propranolol	0.35	-2.313	Major	9 (3/6)	The metabolism of Propranolol can be decreased when combined with Theophylline.	#AFCEE4	1.23320444063217	1
Ketoprofen	Acenocoumarol	0.089	-1.446	None	9 (4/5)	Ketoprofen may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	1.23320444063217	1
Diazepam	Josamycin	0.201	-1.349	None	13 (6/7)		#B2D0E5	1.78129530313535	1
Testosterone	Acenocoumarol	0.255	-54.354	None	48 (1/47)	Testosterone may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	6.57709035003823	1
Ranolazine	Clarithromycin	0.185	-1.542	Major	7 (3/4)	The serum concentration of Ranolazine can be increased when it is combined with Clarithromycin.	#B2D0E5	0.959159009380575	1
Cyclosporine	Carbamazepine	0.083	-3.469	Major	4 (1/3)	The serum concentration of Cyclosporine can be decreased when it is combined with Carbamazepine.	#A9C9E1	0.548090862503186	1
Lidocaine	Nadolol	0.035	1.729	Moderate	3 (2/1)	The serum concentration of Lidocaine can be increased when it is combined with Nadolol.	#F7B9B9	0.411068146877389	1
Amitriptyline	Rifampicin	0.125	-1.156	Minor	6 (3/3)	The metabolism of Amitriptyline can be increased when combined with Rifampicin.	#B4D1E6	0.822136293754779	1
Erythromycin	Theophylline	0.13	-2.313	Moderate	6 (2/4)	The metabolism of Theophylline can be decreased when combined with Erythromycin.	#AFCEE4	0.822136293754779	1
Danazol	Acenocoumarol	0.229	-3.469	None	4 (1/3)	Danazol may increase the anticoagulant activities of Acenocoumarol.	#A9C9E1	0.548090862503186	1
Fluconazole	Triazolam	0.053	Inf	Major	1 (1/0)	The metabolism of Triazolam can be decreased when combined with Fluconazole.	#B32020	0.137022715625796	1
Fluvoxamine	Dihydroergotamine	0.136	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluvoxamine.	#B32020	0.137022715625796	1
Paroxetine	Moclobemide	0.148	-1.156	None	2 (1/1)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Moclobemide.	#B4D1E6	0.274045431251593	1
Clozapine	Alprazolam	0.1	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Alprazolam is combined with Clozapine.	#B32020	0.137022715625796	1
Warfarin	Ofloxacin	0.206	-2.313	Major	3 (1/2)		#AFCEE4	0.411068146877389	1
Ergotamine	Isosorbide mononitrate	0.072	1.729	Moderate	3 (2/1)		#F7B9B9	0.411068146877389	1
Tamoxifen	Rifampicin	0.067	Inf	Moderate	1 (1/0)	The metabolism of Tamoxifen can be increased when combined with Rifampicin.	#B32020	0.137022715625796	1
Estradiol	Ursodeoxycholic acid	0.258	-1.156	None	2 (1/1)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Estradiol.	#B4D1E6	0.274045431251593	1
Warfarin	Primidone	0.448	-2.313	Major	3 (1/2)	The metabolism of Warfarin can be increased when combined with Primidone.	#AFCEE4	0.411068146877389	1
Etidronic acid	Iron	0.556	-1.156	None	2 (1/1)		#B4D1E6	0.274045431251593	1
Sirolimus	Clarithromycin	0.054	-2.313	Major	3 (1/2)	The metabolism of Sirolimus can be decreased when combined with Clarithromycin.	#AFCEE4	0.411068146877389	1
Salmeterol	Oxprenolol	0.527	-1.156	None	2 (1/1)	Oxprenolol may decrease the bronchodilatory activities of Salmeterol.	#B4D1E6	0.274045431251593	1
Theophylline	Acyclovir	0.131	-1.156	Minor	4 (2/2)		#B4D1E6	0.548090862503186	1
Glimepiride	Ketoconazole	1	Inf	None	1 (1/0)	The metabolism of Glimepiride can be decreased when combined with Ketoconazole.	#B32020	0.137022715625796	1
Doxycycline	Warfarin	0.138	1.729	Moderate	3 (2/1)	The metabolism of Warfarin can be decreased when combined with Doxycycline.	#F7B9B9	0.411068146877389	1
Metoprolol	Dihydroergotamine	0.166	-2.313	Moderate	3 (1/2)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#AFCEE4	0.411068146877389	1
Cyclosporine	Terbinafine	1	Inf	Minor	1 (1/0)	The metabolism of Cyclosporine can be decreased when combined with Terbinafine.	#B32020	0.137022715625796	1
Digoxin	Itraconazole	0.217	-2.313	Major	15 (5/10)	The serum concentration of Digoxin can be increased when it is combined with Itraconazole.	#AFCEE4	2.05534073438695	1
Repaglinide	Josamycin	0.043	1.729	None	3 (2/1)	The serum concentration of Repaglinide can be increased when it is combined with Josamycin.	#F7B9B9	0.411068146877389	1
Labetalol	Salmeterol	0.405	-4.626	Major	5 (1/4)	Labetalol may decrease the vasoconstricting activities of Salmeterol.	#A5C6DF	0.685113578128982	1
Hydrocortisone	Rifampicin	0.191	-1.156	Moderate	4 (2/2)	The serum concentration of Hydrocortisone can be decreased when it is combined with Rifampicin.	#B4D1E6	0.548090862503186	1
Colestipol	Fluvastatin	0.069	-1.156	Moderate	2 (1/1)	Colestipol can cause a decrease in the absorption of Fluvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	0.274045431251593	1
Fluconazole	Midazolam	0.25	-2.313	Major	6 (2/4)	The metabolism of Midazolam can be decreased when combined with Fluconazole.	#AFCEE4	0.822136293754779	1
Fluconazole	Eplerenone	0.203	-5.782	Moderate	12 (2/10)	The serum concentration of Eplerenone can be increased when it is combined with Fluconazole.	#9FC1DD	1.64427258750956	1
Fluvoxamine	Zolmitriptan	0.076	-1.156	Moderate	2 (1/1)	The metabolism of Zolmitriptan can be decreased when combined with Fluvoxamine.	#B4D1E6	0.274045431251593	1
Piroxicam	Acenocoumarol	0.236	-1.156	None	8 (4/4)	Piroxicam may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	1.09618172500637	1
Haloperidol	Rifampicin	0.442	-3.469	Major	4 (1/3)	The metabolism of Haloperidol can be increased when combined with Rifampicin.	#A9C9E1	0.548090862503186	1
Meloxicam	Lithium cation	0.229	Inf	Major	2 (2/0)	The serum concentration of Lithium can be increased when it is combined with Meloxicam.	#B32020	0.274045431251593	1
Paroxetine	Naratriptan	0.086	-1.156	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Naratriptan.	#B4D1E6	0.274045431251593	1
Digoxin	Cyclophosphamide	0.16	-4.626	Moderate	5 (1/4)	Digoxin may decrease the cardiotoxic activities of Cyclophosphamide.	#A5C6DF	0.685113578128982	1
Galantamine	Oxybutynin	0.473	-6.939	Moderate	7 (1/6)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Galantamine.	#9ABEDB	0.959159009380575	1
Frovatriptan	Escitalopram	0.068	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Escitalopram.	#B32020	0.137022715625796	1
Tizanidine	Donepezil	0.295	-1.156	Moderate	4 (2/2)	Tizanidine may increase the bradycardic activities of Donepezil.	#B4D1E6	0.548090862503186	1
Trospium	Cyclobenzaprine	0.096	Inf	Moderate	2 (2/0)		#B32020	0.274045431251593	1
Labetalol	Gliclazide	0.328	-2.313	None	3 (1/2)	Labetalol may increase the hypoglycemic activities of Gliclazide.	#AFCEE4	0.411068146877389	1
Erythromycin	Tacrolimus	0.308	-1.542	Major	7 (3/4)	The serum concentration of Tacrolimus can be increased when it is combined with Erythromycin.	#B2D0E5	0.959159009380575	1
Nortriptyline	Terbinafine	0.048	Inf	Moderate	1 (1/0)	The metabolism of Nortriptyline can be decreased when combined with Terbinafine.	#B32020	0.137022715625796	1
Fluvoxamine	Rasagiline	0.556	Inf	Major	1 (1/0)	The serum concentration of Rasagiline can be increased when it is combined with Fluvoxamine.	#B32020	0.137022715625796	1
Ketoconazole	Acenocoumarol	0.065	-1.156	None	4 (2/2)	The serum concentration of Acenocoumarol can be increased when it is combined with Ketoconazole.	#B4D1E6	0.548090862503186	1
Nortriptyline	Donepezil	0.355	Inf	Moderate	1 (1/0)		#B32020	0.137022715625796	1
Formoterol	Oxprenolol	0.08	Inf	None	1 (1/0)	Oxprenolol may decrease the bronchodilatory activities of Formoterol.	#B32020	0.137022715625796	1
Carbamazepine	Warfarin	0.235	-2.891	Moderate	7 (2/5)	The serum concentration of Warfarin can be decreased when it is combined with Carbamazepine.	#ACCCE3	0.959159009380575	1
Warfarin	Rifampicin	0.333	-1.156	Major	2 (1/1)	The metabolism of Warfarin can be increased when combined with Rifampicin.	#B4D1E6	0.274045431251593	1
Doxycycline	Iron	0.351	-3.084	Moderate	11 (3/8)	Doxycycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#ABCBE2	1.50724987188376	1
Formoterol	Nadolol	0.349	-3.084	Major	11 (3/8)		#ABCBE2	1.50724987188376	1
Azithromycin	Disopyramide	0.031	Inf	Major	1 (1/0)	Azithromycin may increase the QTc-prolonging activities of Disopyramide.	#B32020	0.137022715625796	1
Fluvoxamine	Tizanidine	0.059	Inf	Major	1 (1/0)	The serum concentration of Tizanidine can be increased when it is combined with Fluvoxamine.	#B32020	0.137022715625796	1
Tetracycline	Iron	0.426	1.729	Moderate	3 (2/1)		#F7B9B9	0.411068146877389	1
Phenytoin	Doxycycline	0.025	-1.156	Moderate	2 (1/1)	The serum concentration of Doxycycline can be decreased when it is combined with Phenytoin.	#B4D1E6	0.274045431251593	1
Perindopril	Lithium cation	0.333	Inf	Moderate	1 (1/0)	The serum concentration of Lithium can be increased when it is combined with Perindopril.	#B32020	0.137022715625796	1
Ceftriaxone	Acenocoumarol	0.134	-1.156	None	2 (1/1)	Ceftriaxone may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	0.274045431251593	1
Warfarin	Minocycline	0.059	Inf	Moderate	1 (1/0)	Minocycline may increase the anticoagulant activities of Warfarin.	#B32020	0.137022715625796	1
Eplerenone	Clarithromycin	0.149	-8.481	Major	25 (3/22)	The serum concentration of Eplerenone can be increased when it is combined with Clarithromycin.	#93B8D7	3.42556789064491	1
Fluconazole	Dihydroergotamine	0.349	Inf	Moderate	2 (2/0)	The metabolism of Dihydroergotamine can be decreased when combined with Fluconazole.	#B32020	0.274045431251593	1
Pyridostigmine	Triamcinolone	0.023	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Triamcinolone is combined with Pyridostigmine.	#B32020	0.137022715625796	1
Fosinopril	Tizanidine	0.057	-2.313	Major	3 (1/2)	The risk or severity of hypotension can be increased when Tizanidine is combined with Fosinopril.	#AFCEE4	0.411068146877389	1
Cyclosporine	Erythromycin	0.111	Inf	Major	1 (1/0)	The metabolism of Cyclosporine can be decreased when combined with Erythromycin.	#B32020	0.137022715625796	1
Clarithromycin	Everolimus	0.028	-2.313	Major	3 (1/2)	The serum concentration of Everolimus can be increased when it is combined with Clarithromycin.	#AFCEE4	0.411068146877389	1
Tacrolimus	Rifampicin	0.153	-2.313	Major	3 (1/2)	The serum concentration of Tacrolimus can be decreased when it is combined with Rifampicin.	#AFCEE4	0.411068146877389	1
Warfarin	Terbinafine	0.24	-3.469	Moderate	8 (2/6)		#A9C9E1	1.09618172500637	1
Triamcinolone	Primidone	0.171	-1.156	Moderate	2 (1/1)	The metabolism of Triamcinolone can be increased when combined with Primidone.	#B4D1E6	0.274045431251593	1
Primidone	Dexamethasone	0.129	-2.313	Moderate	3 (1/2)	The serum concentration of Dexamethasone can be decreased when it is combined with Primidone.	#AFCEE4	0.411068146877389	1
Donepezil	Maprotiline	0.689	-2.313	Moderate	3 (1/2)		#AFCEE4	0.411068146877389	1
Ketoconazole	Solifenacin	0.343	-2.313	Major	3 (1/2)	The metabolism of Solifenacin can be decreased when combined with Ketoconazole.	#AFCEE4	0.411068146877389	1
Fluorouracil	Metronidazole	0.333	Inf	Moderate	1 (1/0)	The serum concentration of Fluorouracil can be increased when it is combined with Metronidazole.	#B32020	0.137022715625796	1
Griseofulvin	Acetylsalicylic acid	0.037	-4.626	Minor	5 (1/4)		#A5C6DF	0.685113578128982	1
Cimetidine	Acenocoumarol	0.1	Inf	None	1 (1/0)	Cimetidine may increase the anticoagulant activities of Acenocoumarol.	#B32020	0.137022715625796	1
Tacrolimus	Clarithromycin	0.366	-3.007	Major	18 (5/13)	The serum concentration of Tacrolimus can be increased when it is combined with Clarithromycin.	#ABCBE2	2.46640888126434	1
Cilostazol	Itraconazole	0.087	-2.313	Major	3 (1/2)	The serum concentration of Cilostazol can be increased when it is combined with Itraconazole.	#AFCEE4	0.411068146877389	1
Carbamazepine	Bupropion	0.387	-2.313	Moderate	3 (1/2)	The metabolism of Bupropion can be increased when combined with Carbamazepine.	#AFCEE4	0.411068146877389	1
Haloperidol	Itraconazole	0.57	-2.891	Moderate	7 (2/5)	The metabolism of Haloperidol can be decreased when combined with Itraconazole.	#ACCCE3	0.959159009380575	1
Erythromycin	Ranolazine	0.034	Inf	Major	1 (1/0)	The serum concentration of Ranolazine can be increased when it is combined with Erythromycin.	#B32020	0.137022715625796	1
Sucralfate	Itraconazole	0.333	1.729	None	3 (2/1)	Sucralfate can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F7B9B9	0.411068146877389	1
Tobramycin	Furosemide	0.204	-11.565	Major	11 (1/10)	The serum concentration of Tobramycin can be increased when it is combined with Furosemide.	#85AED1	1.50724987188376	1
Verapamil	Rifampicin	0.25	-1.156	Moderate	2 (1/1)	The metabolism of Verapamil can be increased when combined with Rifampicin.	#B4D1E6	0.274045431251593	1
Rifampicin	Itraconazole	0.045	Inf	Major	1 (1/0)	The serum concentration of Itraconazole can be decreased when it is combined with Rifampicin.	#B32020	0.137022715625796	1
Phenoxymethylpenicillin	Methotrexate	0.021	Inf	Major	1 (1/0)	The serum concentration of Methotrexate can be increased when it is combined with Phenoxymethylpenicillin.	#B32020	0.137022715625796	1
Warfarin	Tetracycline	0.143	-2.313	Moderate	3 (1/2)		#AFCEE4	0.411068146877389	1
Erythromycin	Cilostazol	0.074	-2.313	Major	3 (1/2)	The serum concentration of Cilostazol can be increased when it is combined with Erythromycin.	#AFCEE4	0.411068146877389	1
Epinephrine	Clomipramine	0.036	-1.156	Major	2 (1/1)	Clomipramine may decrease the antihypertensive activities of Epinephrine.	#B4D1E6	0.274045431251593	1
Rifampicin	Fluvastatin	0.111	-2.313	Moderate	3 (1/2)	The metabolism of Fluvastatin can be increased when combined with Rifampicin.	#AFCEE4	0.411068146877389	1
Erythromycin	Rifampicin	0.167	Inf	Moderate	1 (1/0)	The metabolism of Erythromycin can be increased when combined with Rifampicin.	#B32020	0.137022715625796	1
Methotrexate	Ketoprofen	0.067	Inf	Major	1 (1/0)	The serum concentration of Methotrexate can be increased when it is combined with Ketoprofen.	#B32020	0.137022715625796	1
Rifampicin	Nifedipine	0.116	-6.939	Major	7 (1/6)	The serum concentration of Nifedipine can be decreased when it is combined with Rifampicin.	#9ABEDB	0.959159009380575	1
Halazepam	Itraconazole	0.111	Inf	None	1 (1/0)		#B32020	0.137022715625796	1
Verapamil	Nadolol	0.419	-1.156	Major	2 (1/1)	Verapamil may increase the hypotensive activities of Nadolol.	#B4D1E6	0.274045431251593	1
Itraconazole	Josamycin	0.333	Inf	None	1 (1/0)		#B32020	0.137022715625796	1
Colestipol	Digoxin	0.296	-3.469	Moderate	4 (1/3)	Colestipol can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#A9C9E1	0.548090862503186	1
Allopurinol	Azathioprine	0.306	-10.408	Major	20 (2/18)	The serum concentration of the active metabolites of Azathioprine can be increased when Azathioprine is used in combination with Allopurinol.	#89B1D3	2.74045431251593	1
Erythromycin	Sotalol	0.032	Inf	Major	1 (1/0)	Erythromycin may increase the QTc-prolonging activities of Sotalol.	#B32020	0.137022715625796	1
Glycopyrronium	Rivastigmine	0.24	-9.252	None	9 (1/8)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Rivastigmine.	#90B6D6	1.23320444063217	1
Theophylline	Terbinafine	0.516	-1.156	Moderate	2 (1/1)	The metabolism of Theophylline can be decreased when combined with Terbinafine.	#B4D1E6	0.274045431251593	1
Ketoconazole	Rabeprazole	0.184	-5.782	Moderate	6 (1/5)	The serum concentration of Ketoconazole can be decreased when it is combined with Rabeprazole.	#9FC1DD	0.822136293754779	1
Digoxin	Sulfasalazine	0.146	-5.782	Moderate	6 (1/5)	The serum concentration of Digoxin can be increased when it is combined with Sulfasalazine.	#9FC1DD	0.822136293754779	1
Rifabutin	Simvastatin	0.088	-3.469	None	4 (1/3)	The metabolism of Simvastatin can be increased when combined with Rifabutin.	#A9C9E1	0.548090862503186	1
Prednisolone	Acenocoumarol	0.038	Inf	None	1 (1/0)		#B32020	0.137022715625796	1
Fluconazole	Cilostazol	0.092	-9.252	Major	9 (1/8)	The serum concentration of Cilostazol can be increased when it is combined with Fluconazole.	#90B6D6	1.23320444063217	1
Doxycycline	Insulin aspart	0.064	-4.048	Moderate	9 (2/7)		#A6C7E0	1.23320444063217	1
Donepezil	Glycopyrronium	0.248	-4.626	None	5 (1/4)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Donepezil.	#A5C6DF	0.685113578128982	1
Labetalol	Salbutamol	0.5	-2.313	Major	3 (1/2)	Labetalol may decrease the vasoconstricting activities of Salbutamol.	#AFCEE4	0.411068146877389	1
Esomeprazole	Ketoconazole	0.226	-4.626	Moderate	5 (1/4)	The serum concentration of Ketoconazole can be decreased when it is combined with Esomeprazole.	#A5C6DF	0.685113578128982	1
Tetracycline	Insulin detemir	0.08	-1.156	Moderate	2 (1/1)		#B4D1E6	0.274045431251593	1
Lovastatin	Rifampicin	0.152	-3.469	Major	4 (1/3)	The metabolism of Lovastatin can be increased when combined with Rifampicin.	#A9C9E1	0.548090862503186	1
Eletriptan	Paroxetine	0.244	-3.469	Major	4 (1/3)	The metabolism of Eletriptan can be decreased when combined with Paroxetine.	#A9C9E1	0.548090862503186	1
Phenytoin	Itraconazole	0.126	-4.626	Moderate	5 (1/4)	The serum concentration of Itraconazole can be decreased when it is combined with Phenytoin.	#A5C6DF	0.685113578128982	1
Tizanidine	Quinapril	0.243	-3.469	Major	4 (1/3)	The risk or severity of hypotension can be increased when Tizanidine is combined with Quinapril.	#A9C9E1	0.548090862503186	1
Verapamil	Lithium cation	0.365	-4.626	Moderate	5 (1/4)	Verapamil may increase the neurotoxic activities of Lithium.	#A5C6DF	0.685113578128982	1
Spironolactone	Cilazapril	0.351	-2.313	None	3 (1/2)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Cilazapril.	#AFCEE4	0.411068146877389	1
Erythromycin	Midazolam	0.053	-1.156	Moderate	2 (1/1)	The serum concentration of Midazolam can be increased when it is combined with Erythromycin.	#B4D1E6	0.274045431251593	1
Indomethacin	Sotalol	0.116	-4.626	Moderate	5 (1/4)	Indomethacin may decrease the antihypertensive activities of Sotalol.	#A5C6DF	0.685113578128982	1
Indomethacin	Nadolol	0.2	-1.156	Moderate	2 (1/1)	Indomethacin may decrease the antihypertensive activities of Nadolol.	#B4D1E6	0.274045431251593	1
Repaglinide	Rifampicin	0.087	-5.782	Moderate	6 (1/5)	The serum concentration of Repaglinide can be decreased when it is combined with Rifampicin.	#9FC1DD	0.822136293754779	1
Atenolol	Ampicillin	0.085	-3.469	Moderate	4 (1/3)	The bioavailability of Atenolol can be decreased when combined with Ampicillin.	#A9C9E1	0.548090862503186	1
Disulfiram	Acenocoumarol	0.243	-13.878	None	13 (1/12)	The serum concentration of Acenocoumarol can be increased when it is combined with Disulfiram.	#7AA6CD	1.78129530313535	1
Cimetidine	Diazepam	0.56	-4.626	Moderate	5 (1/4)	The metabolism of Diazepam can be decreased when combined with Cimetidine.	#A5C6DF	0.685113578128982	1
Dihydroergotamine	Itraconazole	0.09	-1.156	Major	2 (1/1)	The serum concentration of Dihydroergotamine can be increased when it is combined with Itraconazole.	#B4D1E6	0.274045431251593	1
Minocycline	Cloxacillin	0.833	-2.313	Moderate	3 (1/2)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Minocycline.	#AFCEE4	0.411068146877389	1
Imipramine	Terbutaline	0.222	-4.626	Moderate	5 (1/4)	The risk or severity of adverse effects can be increased when Imipramine is combined with Terbutaline.	#A5C6DF	0.685113578128982	1
Flurbiprofen	Acenocoumarol	0.092	-1.156	None	2 (1/1)	Flurbiprofen may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	0.274045431251593	1
Minocycline	Iron	0.298	-2.313	Moderate	3 (1/2)	Minocycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#AFCEE4	0.411068146877389	1
Pseudoephedrine	Rasagiline	0.019	Inf	Moderate	1 (1/0)	Rasagiline may increase the hypertensive activities of Pseudoephedrine.	#B32020	0.137022715625796	1
Fluconazole	Phenytoin	0.052	-2.313	Moderate	3 (1/2)	The serum concentration of Phenytoin can be increased when it is combined with Fluconazole.	#AFCEE4	0.411068146877389	1
Ranitidine	Ketoconazole	0.242	-6.939	Moderate	7 (1/6)	The serum concentration of Ketoconazole can be decreased when it is combined with Ranitidine.	#9ABEDB	0.959159009380575	1
Erythromycin	Dihydroergotamine	0.625	-1.156	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Erythromycin.	#B4D1E6	0.274045431251593	1
Fluconazole	Flurazepam	0.156	-4.626	None	5 (1/4)	The metabolism of Flurazepam can be decreased when combined with Fluconazole.	#A5C6DF	0.685113578128982	1
Tetracycline	Insulin aspart	0.181	-3.469	Moderate	4 (1/3)		#A9C9E1	0.548090862503186	1
Digoxin	Tetracycline	0.04	-1.156	Moderate	2 (1/1)		#B4D1E6	0.274045431251593	1
Perphenazine	Levofloxacin	0.04	Inf	Moderate	1 (1/0)		#B32020	0.137022715625796	1
Tenoxicam	Acenocoumarol	0.226	-4.626	None	5 (1/4)	Tenoxicam may increase the anticoagulant activities of Acenocoumarol.	#A5C6DF	0.685113578128982	1
Galantamine	Cyclobenzaprine	0.065	-1.156	Moderate	2 (1/1)		#B4D1E6	0.274045431251593	1
Indapamide	Lithium cation	0.378	-4.626	Major	5 (1/4)	Indapamide may decrease the excretion rate of Lithium which could result in a higher serum level.	#A5C6DF	0.685113578128982	1
Dihydroergotamine	Carvedilol	0.106	-3.469	Moderate	4 (1/3)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#A9C9E1	0.548090862503186	1
Simvastatin	Telithromycin	0.1	-3.469	Major	4 (1/3)	The serum concentration of Simvastatin can be increased when it is combined with Telithromycin.	#A9C9E1	0.548090862503186	1
Warfarin	Dexamethasone	0.084	-12.721	Moderate	12 (1/11)	Dexamethasone may increase the anticoagulant activities of Warfarin.	#7FA9CF	1.64427258750956	1
Warfarin	Meloxicam	0.043	Inf	Major	1 (1/0)	Meloxicam may increase the anticoagulant activities of Warfarin.	#B32020	0.137022715625796	1
Warfarin	Etoricoxib	0.206	-4.626	None	5 (1/4)	Etoricoxib may increase the anticoagulant activities of Warfarin.	#A5C6DF	0.685113578128982	1
Clonidine	Labetalol	0.176	-Inf	Major	1 (0/1)	Clonidine may increase the atrioventricular blocking (AV block) activities of Labetalol.	#1E61A5	0.137022715625796	1
Amikacin	Ceftriaxone	1	-Inf	Moderate	1 (0/1)		#1E61A5	0.137022715625796	1
Procainamide	Amiodarone	0.185	-Inf	Major	3 (0/3)	Amiodarone may increase the QTc-prolonging activities of Procainamide.	#1E61A5	0.411068146877389	0.0994581532633842
Atropine	Donepezil	0.143	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Atropine can be decreased when used in combination with Donepezil.	#1E61A5	0.137022715625796	1
Ergotamine	Naratriptan	0.109	-Inf	Major	1 (0/1)	Ergotamine may increase the vasoconstricting activities of Naratriptan.	#1E61A5	0.137022715625796	1
Selegiline	Escitalopram	0.274	-Inf	Major	10 (0/10)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Selegiline.	#1E61A5	1.37022715625796	1
Eplerenone	Tolevamer	0.193	-Inf	None	17 (0/17)		#1E61A5	2.32938616563854	1
Dihydroergotamine	Oxprenolol	0.567	-Inf	None	1 (0/1)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Oxprenolol.	#1E61A5	0.137022715625796	1
Irbesartan	Drospirenone	0.048	-Inf	Moderate	1 (0/1)	Irbesartan may increase the hyperkalemic activities of Drospirenone.	#1E61A5	0.137022715625796	1
Donepezil	Pimozide	0.571	-Inf	Moderate	2 (0/2)		#1E61A5	0.274045431251593	1
Doxycycline	Isotretinoin	0.064	-Inf	Major	2 (0/2)	The risk or severity of adverse effects can be increased when Doxycycline is combined with Isotretinoin.	#1E61A5	0.274045431251593	1
Clozapine	Rivastigmine	0.091	-Inf	Moderate	1 (0/1)		#1E61A5	0.137022715625796	1
Gentamicin	Bumetanide	0.125	-Inf	Major	1 (0/1)	The serum concentration of Gentamicin can be increased when it is combined with Bumetanide.	#1E61A5	0.137022715625796	1
Ticlopidine	Phenytoin	0.568	-Inf	Moderate	4 (0/4)	The serum concentration of Phenytoin can be increased when it is combined with Ticlopidine.	#1E61A5	0.548090862503186	1
Carteolol	Glyburide	0.111	-Inf	Moderate	1 (0/1)	Carteolol may increase the hypoglycemic activities of Glyburide.	#1E61A5	0.137022715625796	1
Acitretin	Methotrexate	0.18	-Inf	Major	4 (0/4)	Acitretin may increase the hepatotoxic activities of Methotrexate.	#1E61A5	0.548090862503186	1
Cyclosporine	Danazol	0.5	-Inf	Moderate	1 (0/1)	Danazol may increase the hepatotoxic activities of Cyclosporine.	#1E61A5	0.137022715625796	1
Cyclosporine	Ketoprofen	0.038	-Inf	Moderate	2 (0/2)	Ketoprofen may increase the nephrotoxic activities of Cyclosporine.	#1E61A5	0.274045431251593	1
Prazosin	Propranolol	0.364	-Inf	Moderate	3 (0/3)	Propranolol may increase the orthostatic hypotensive activities of Prazosin.	#1E61A5	0.411068146877389	1
Ziprasidone	Carbamazepine	0.532	-Inf	Minor	2 (0/2)	The serum concentration of Ziprasidone can be decreased when it is combined with Carbamazepine.	#1E61A5	0.274045431251593	1
Alfuzosin	Itraconazole	0.116	-Inf	Major	17 (0/17)	The serum concentration of Alfuzosin can be increased when it is combined with Itraconazole.	#1E61A5	2.32938616563854	1
Clozapine	Fluoxetine	0.059	-Inf	Moderate	1 (0/1)	The serum concentration of Clozapine can be increased when it is combined with Fluoxetine.	#1E61A5	0.137022715625796	1
Cyclosporine	Oxcarbazepine	0.441	-Inf	Moderate	3 (0/3)		#1E61A5	0.411068146877389	1
Methotrexate	Phenylbutazone	0.267	-Inf	Major	1 (0/1)	The serum concentration of Methotrexate can be increased when it is combined with Phenylbutazone.	#1E61A5	0.137022715625796	1
Primidone	Nifedipine	0.13	-Inf	Major	6 (0/6)	The serum concentration of Nifedipine can be decreased when it is combined with Primidone.	#1E61A5	0.822136293754779	1
Almotriptan	Itraconazole	0.447	-Inf	Moderate	3 (0/3)	The serum concentration of Almotriptan can be increased when it is combined with Itraconazole.	#1E61A5	0.411068146877389	1
Cimetidine	Nitrendipine	0.5	-Inf	None	1 (0/1)	The serum concentration of Nitrendipine can be increased when it is combined with Cimetidine.	#1E61A5	0.137022715625796	1
Cyproheptadine	Rivastigmine	0.333	-Inf	Moderate	1 (0/1)		#1E61A5	0.137022715625796	1
Chlorpropamide	Carvedilol	0.499	-Inf	Moderate	2 (0/2)	Carvedilol may increase the hypoglycemic activities of Chlorpropamide.	#1E61A5	0.274045431251593	1
Amitriptyline	Isoprenaline	0.077	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Isoprenaline.	#1E61A5	0.137022715625796	1
Trospium	Imipramine	0.167	-Inf	Moderate	1 (0/1)		#1E61A5	0.137022715625796	1
Rivastigmine	Pimozide	0.19	-Inf	Moderate	1 (0/1)		#1E61A5	0.137022715625796	1
Rivastigmine	Doxepin	0.067	-Inf	Moderate	1 (0/1)		#1E61A5	0.137022715625796	1
Ziprasidone	Galantamine	0.667	-Inf	Moderate	1 (0/1)	Galantamine may increase the QTc-prolonging activities of Ziprasidone.	#1E61A5	0.137022715625796	1
Theophylline	Nadolol	0.282	-Inf	Major	3 (0/3)		#1E61A5	0.411068146877389	1
Epinephrine	Rasagiline	0.089	-Inf	Moderate	3 (0/3)	Rasagiline may increase the hypertensive activities of Epinephrine.	#1E61A5	0.411068146877389	1
Amikacin	Furosemide	0.143	-Inf	Major	3 (0/3)	The serum concentration of Amikacin can be increased when it is combined with Furosemide.	#1E61A5	0.411068146877389	1
Gliclazide	Oxprenolol	0.488	-Inf	None	3 (0/3)	Oxprenolol may increase the hypoglycemic activities of Gliclazide.	#1E61A5	0.411068146877389	1
Gentamicin	Cefuroxime	0.648	-Inf	Moderate	6 (0/6)		#1E61A5	0.822136293754779	1
Fentanyl	Ketoconazole	0.175	-Inf	Major	4 (0/4)	The serum concentration of Fentanyl can be increased when it is combined with Ketoconazole.	#1E61A5	0.548090862503186	1
Fluphenazine	Levofloxacin	0.139	-Inf	Moderate	6 (0/6)		#1E61A5	0.822136293754779	1
Ketoconazole	Aripiprazole	0.067	-Inf	Moderate	1 (0/1)	The serum concentration of Aripiprazole can be increased when it is combined with Ketoconazole.	#1E61A5	0.137022715625796	1
Fluconazole	Halazepam	0.238	-Inf	None	3 (0/3)		#1E61A5	0.411068146877389	1
Cimetidine	Rivastigmine	0.034	-Inf	Moderate	1 (0/1)		#1E61A5	0.137022715625796	1
Imipramine	Donepezil	0.083	-Inf	Moderate	2 (0/2)	The metabolism of Donepezil can be decreased when combined with Imipramine.	#1E61A5	0.274045431251593	1
Trospium	Olanzapine	0.097	-Inf	Moderate	2 (0/2)		#1E61A5	0.274045431251593	1
Fludrocortisone	Rifampicin	0.333	-Inf	Moderate	1 (0/1)	The serum concentration of Fludrocortisone can be decreased when it is combined with Rifampicin.	#1E61A5	0.137022715625796	1
Eletriptan	Itraconazole	0.333	-Inf	Major	1 (0/1)	The serum concentration of Eletriptan can be increased when it is combined with Itraconazole.	#1E61A5	0.137022715625796	1
Betamethasone	Phenobarbital	0.032	-Inf	Moderate	2 (0/2)	The serum concentration of Betamethasone can be decreased when it is combined with Phenobarbital.	#1E61A5	0.274045431251593	1
Theophylline	Rifampicin	0.135	-Inf	Moderate	3 (0/3)	The metabolism of Theophylline can be increased when combined with Rifampicin.	#1E61A5	0.411068146877389	1
Cyclosporine	Ketoconazole	0.018	-Inf	Major	1 (0/1)	The metabolism of Cyclosporine can be decreased when combined with Ketoconazole.	#1E61A5	0.137022715625796	1
Lamotrigine	Rifampicin	0.04	-Inf	Moderate	2 (0/2)	The metabolism of Lamotrigine can be increased when combined with Rifampicin.	#1E61A5	0.274045431251593	1
Rifabutin	Acenocoumarol	0.107	-Inf	None	2 (0/2)	The metabolism of Acenocoumarol can be increased when combined with Rifabutin.	#1E61A5	0.274045431251593	1
Testosterone	Warfarin	0.167	-Inf	Major	5 (0/5)	Testosterone may increase the anticoagulant activities of Warfarin.	#1E61A5	0.685113578128982	1
Lidocaine	Labetalol	0.034	-Inf	Moderate	1 (0/1)	The serum concentration of Lidocaine can be increased when it is combined with Labetalol.	#1E61A5	0.137022715625796	1
Phenytoin	Rifampicin	0.066	-Inf	Major	2 (0/2)	The serum concentration of Phenytoin can be decreased when it is combined with Rifampicin.	#1E61A5	0.274045431251593	1
Eplerenone	Lithium cation	0.158	-Inf	Moderate	3 (0/3)	The serum concentration of Lithium can be increased when it is combined with Eplerenone.	#1E61A5	0.411068146877389	1
Theophylline	Isoniazid	0.091	-Inf	Moderate	2 (0/2)	The serum concentration of Theophylline can be increased when it is combined with Isoniazid.	#1E61A5	0.274045431251593	1
Terbutaline	Oxprenolol	0.059	-Inf	None	1 (0/1)	Oxprenolol may decrease the bronchodilatory activities of Terbutaline.	#1E61A5	0.137022715625796	1
Piroxicam	Nadolol	0.143	-Inf	Moderate	1 (0/1)	Piroxicam may decrease the antihypertensive activities of Nadolol.	#1E61A5	0.137022715625796	1
Itraconazole	Ciclesonide	0.081	-Inf	Moderate	2 (0/2)	The metabolism of Ciclesonide can be decreased when combined with Itraconazole.	#1E61A5	0.274045431251593	1
Acetaminophen	Imatinib	0.148	-Inf	Moderate	1 (0/1)	Acetaminophen may increase the hepatotoxic activities of Imatinib.	#1E61A5	0.137022715625796	1
Chlorpromazine	Propranolol	0.274	-Inf	Moderate	3 (0/3)	The metabolism of Propranolol can be decreased when combined with Chlorpromazine.	#1E61A5	0.411068146877389	1
Trospium	Galantamine	0.5	-Inf	Moderate	1 (0/1)	The therapeutic efficacy of Trospium can be decreased when used in combination with Galantamine.	#1E61A5	0.137022715625796	1
Primidone	Metronidazole	0.055	-Inf	Moderate	3 (0/3)	The serum concentration of Metronidazole can be decreased when it is combined with Primidone.	#1E61A5	0.411068146877389	1
Amikacin	Cefuroxime	0.333	-Inf	Moderate	1 (0/1)		#1E61A5	0.137022715625796	1
Warfarin	Ceftriaxone	0.034	-Inf	Moderate	1 (0/1)	Ceftriaxone may increase the anticoagulant activities of Warfarin.	#1E61A5	0.137022715625796	1
Betamethasone	Primidone	0.071	-Inf	Moderate	1 (0/1)	The serum concentration of Betamethasone can be decreased when it is combined with Primidone.	#1E61A5	0.137022715625796	1
Alfuzosin	Ketoconazole	0.055	-Inf	Major	2 (0/2)	The serum concentration of Alfuzosin can be increased when it is combined with Ketoconazole.	#1E61A5	0.274045431251593	1
Cyclosporine	Bupropion	0.118	-Inf	Moderate	1 (0/1)	The metabolism of Bupropion can be decreased when combined with Cyclosporine.	#1E61A5	0.137022715625796	1
Repaglinide	Oxprenolol	0.8	-Inf	None	1 (0/1)		#1E61A5	0.137022715625796	1
Isotretinoin	Acenocoumarol	0.086	-Inf	None	2 (0/2)		#1E61A5	0.274045431251593	1
Codeine	Naltrexone	0.418	-Inf	Major	3 (0/3)	The therapeutic efficacy of Codeine can be decreased when used in combination with Naltrexone.	#1E61A5	0.411068146877389	1
Carbamazepine	Ketoconazole	0.071	-Inf	Moderate	1 (0/1)	The metabolism of Ketoconazole can be increased when combined with Carbamazepine.	#1E61A5	0.137022715625796	1
Fluvoxamine	Phenytoin	0.267	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Fluvoxamine.	#1E61A5	0.137022715625796	1
Flutamide	Acenocoumarol	0.348	-Inf	None	3 (0/3)		#1E61A5	0.411068146877389	1
Fluconazole	Ranolazine	0.074	-Inf	Major	3 (0/3)	The serum concentration of Ranolazine can be increased when it is combined with Fluconazole.	#1E61A5	0.411068146877389	1
Fluvastatin	Bezafibrate	0.088	-Inf	None	2 (0/2)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Fluvastatin.	#1E61A5	0.274045431251593	1
Trandolapril	Lithium cation	0.6	-Inf	Moderate	1 (0/1)	The serum concentration of Lithium can be increased when it is combined with Trandolapril.	#1E61A5	0.137022715625796	1
Famotidine	Itraconazole	0.51	-Inf	Moderate	2 (0/2)	The serum concentration of Itraconazole can be decreased when it is combined with Famotidine.	#1E61A5	0.274045431251593	1
Phenytoin	Fluorouracil	0.056	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Fluorouracil.	#1E61A5	0.137022715625796	1
Disulfiram	Metronidazole	0.263	-Inf	Major	2 (0/2)	The risk or severity of adverse effects can be increased when Disulfiram is combined with Metronidazole.	#1E61A5	0.274045431251593	1
Phenylbutazone	Gliclazide	0.038	-Inf	None	1 (0/1)		#1E61A5	0.137022715625796	1
Tizanidine	Rivastigmine	0.09	-Inf	Moderate	2 (0/2)	Tizanidine may increase the bradycardic activities of Rivastigmine.	#1E61A5	0.274045431251593	1
Phenytoin	Isoniazid	0.095	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Isoniazid.	#1E61A5	0.137022715625796	1
Triamcinolone	Rifampicin	0.325	-Inf	Moderate	2 (0/2)	The metabolism of Triamcinolone can be increased when combined with Rifampicin.	#1E61A5	0.274045431251593	1
Carbamazepine	Josamycin	0.029	-Inf	None	1 (0/1)	The metabolism of Carbamazepine can be decreased when combined with Josamycin.	#1E61A5	0.137022715625796	1
Digoxin	Prazosin	0.167	-Inf	None	1 (0/1)		#1E61A5	0.137022715625796	1
Telithromycin	Amiodarone	0.077	-Inf	Major	1 (0/1)	Telithromycin may increase the QTc-prolonging activities of Amiodarone.	#1E61A5	0.137022715625796	1
Cyclosporine	Propafenone	0.409	-Inf	Minor	1 (0/1)	The serum concentration of Propafenone can be increased when it is combined with Cyclosporine.	#1E61A5	0.137022715625796	1
Warfarin	Fludrocortisone	0.111	-Inf	Moderate	1 (0/1)	Fludrocortisone may increase the anticoagulant activities of Warfarin.	#1E61A5	0.137022715625796	1
Codeine	Cimetidine	0.548	-Inf	Moderate	2 (0/2)	The therapeutic efficacy of Codeine can be decreased when used in combination with Cimetidine.	#1E61A5	0.274045431251593	1
Rifampicin	Propafenone	0.167	-Inf	Moderate	1 (0/1)	The serum concentration of Propafenone can be decreased when it is combined with Rifampicin.	#1E61A5	0.137022715625796	1
Sotalol	Terbutaline	0.067	-Inf	Major	2 (0/2)	Terbutaline may increase the QTc-prolonging activities of Sotalol.	#1E61A5	0.274045431251593	1
Phenytoin	Betamethasone	0.053	-Inf	Moderate	1 (0/1)	The serum concentration of Betamethasone can be decreased when it is combined with Phenytoin.	#1E61A5	0.137022715625796	1
Tobramycin	Cefuroxime	0.5	-Inf	Moderate	1 (0/1)		#1E61A5	0.137022715625796	1
Imipramine	Pseudoephedrine	0.048	-Inf	None	1 (0/1)	Imipramine may decrease the antihypertensive activities of Pseudoephedrine.	#1E61A5	0.137022715625796	1
Diltiazem	Triazolam	0.143	-Inf	Moderate	1 (0/1)	The metabolism of Triazolam can be decreased when combined with Diltiazem.	#1E61A5	0.137022715625796	1
Theophylline	Primidone	0.125	-Inf	Moderate	1 (0/1)	The metabolism of Theophylline can be increased when combined with Primidone.	#1E61A5	0.137022715625796	1
Eplerenone	Itraconazole	0.041	-Inf	Major	3 (0/3)	The serum concentration of Eplerenone can be increased when it is combined with Itraconazole.	#1E61A5	0.411068146877389	1
Galantamine	Tizanidine	0.056	-Inf	Moderate	1 (0/1)	Galantamine may increase the bradycardic activities of Tizanidine.	#1E61A5	0.137022715625796	1
Moxifloxacin	Ziprasidone	0.029	-Inf	Major	1 (0/1)	Moxifloxacin may increase the QTc-prolonging activities of Ziprasidone.	#1E61A5	0.137022715625796	1
Acetylsalicylic acid	Heparin	0.125	-Inf	Moderate	1 (0/1)	Acetylsalicylic acid may increase the anticoagulant activities of Heparin.	#1E61A5	0.137022715625796	1
Trazodone	Ketoconazole	0.077	-Inf	Moderate	1 (0/1)	The metabolism of Trazodone can be decreased when combined with Ketoconazole.	#1E61A5	0.137022715625796	1
Warfarin	Disulfiram	0.118	-Inf	Moderate	1 (0/1)	The serum concentration of Warfarin can be increased when it is combined with Disulfiram.	#1E61A5	0.137022715625796	1
Fluorouracil	Warfarin	0.059	-Inf	Major	1 (0/1)	The serum concentration of Warfarin can be increased when it is combined with Fluorouracil.	#1E61A5	0.137022715625796	1
Tetracycline	Cloxacillin	1	-Inf	Moderate	1 (0/1)		#1E61A5	0.137022715625796	1
Pyridostigmine	Dexamethasone	0.5	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Pyridostigmine.	#1E61A5	0.137022715625796	1
